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ABSTRACT OF THE DISSERTATION 
Effects of Resistance Exercise on Postprandial Metabolism in 
Obese Men with Prediabetes 
by 
Adam J. Bittel 
Doctor of Philosophy in Movement Science 
Department of Physical Therapy 
Washington University in St. Louis, 2018 
Professor W. Todd Cade, PT, PhD, Chair 
 
Prediabetes is a metabolic condition defined by elevated fasting (impaired fasting glucose 
(IFG)) and/or postprandial (impaired glucose tolerance (IGT)) glucose. Prediabetes affects nearly 
86 million adults in the United States, with most (up to 70%) progressing to type 2 diabetes 
within as little as one year. Recent studies have indicated that elevated post-prandial glycemia 
and hypertriglyceridemia are early indicators of prediabetes, and are major risk factors for 
complications of prediabetes, including cardiovascular disease (CVD), stroke, elevated blood 
pressure, and obesity. Resistance exercise is a central component of exercise recommendations 
for individuals with type 2 diabetes and prediabetes, but the effect of resistance exercise on 
postprandial lipid and glucose metabolism are not known in this population.   
In Chapter 2, we examine the effects of a single bout of resistance exercise on post-
prandial glucose kinetics, insulin sensitivity, and carbohydrate oxidation after consumption of a 
mixed meal. Our results suggest that a single session of resistance exercise increases glucose 
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tolerance, reduces post-prandial insulin levels, increases insulin sensitivity and glucose 
clearance, and increases carbohydrate oxidation. 
In Chapter 3, we examine the effects of a single bout of resistance exercise on post-
prandial exogenous and endogenous lipid handling and partitioning into plasma chylomicrons, 
VLDL, and free fatty acids (FFA), as well as lipoprotein kinetics, FFA kinetics, and lipid 
oxidation. We found that a single session of resistance exercise reduces exogenous and 
endogenous lipid contributions to circulating lipoprotein and FFA pools, increases lipoprotein 
turnover, escalates FFA clearance rates, and improves lipid oxidation. 
In Chapter 4, we examine the effects of a single bout of resistance exercise on skeletal 
muscle mitochondrial respiration and the expression of key genes known to regulate lipid and 
glucose metabolism. We also identify changes the expression of genes known to influence lipid 
and glucose metabolism in subcutaneous abdominal adipose tissue after the single session of 
resistance exercise. Our results suggest that a single session of resistance exercise increases 
skeletal muscle mitochondrial lipid oxidation, coupled respiration, and uncoupled respiration 
concurrently with increases in the expression of genes that increase lipid oxidation. We also 
found that genes involved in adipose tissue lipolysis and glyceroneogenesis were significantly 
up-regulated in adipose tissue after the resistance exercise session. 
Overall, these results provide evidence for the beneficial effects of resistance exercise on 
postprandial glucose and lipid metabolism in obese men with prediabetes after consumption of a 
mixed meal. Improvements in postprandial lipid and glucose responses could reduce the risk for 
progression to type 2 diabetes, as well as the risk for complications of prediabetes. 
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1.1 What is Prediabetes? 
 Prediabetes is a state of elevated fasting or post-prandial glucose (impaired fasting 
glucose (IFG) and impaired glucose tolerance (IGT), respectively) that develops as a result of the 
onset and progression of peripheral insulin resistance.1 Typically, insulin resistance manifests 
within a constellation of metabolic abnormalities including dyslipidemia, obesity, and 
hypertension collectively known as the “metabolic syndrome.”2 In 2017, the CDC estimated that 
1 in 3 adults (roughly 84 million Americans) have prediabetes.3 Unfortunately, previous studies 
have also estimated that 90% of these individuals are unaware of their condition.4 The lack of 
patient awareness of prediabetes is a major health concern given that prediabetes increases one’s 
risk for life-threatening co-morbidities, including cardiovascular disease (CVD), chronic kidney 
disease, and overt type 2 diabetes.5 Indeed, 70% of individuals with prediabetes will go on to 
develop type 2 diabetes highlighting the importance of developing effective treatment strategies 
for this condition.6 The window to intervene, however, may be limited. For example, the Finnish 
Diabetes Prevention Study showed that 23% of participants with impaired glucose tolerance 
developed overt diabetes within 4 years.7 Likewise, the Diabetes Prevention Program Research 
Group has found that 11% of those with prediabetes developed type 2 diabetes in less than 3 
years.8 
 
1.2  Complications of Prediabetes 
 While nephropathy and chronic kidney disease are commonly recognized as 
complications of type 2 diabetes, previous studies have found that individuals with prediabetes 
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also present with elevated incidence of albuminuria and glomerular hyperfiltration (early 
markers of kidney disease).9 Microalbuminuria (a marker of microvascular injury) is found in 
twice as many patients with prediabetes as those with normoglycemia.10 Moreover, the National 
Health and Nutrition Examination Survey found 17.7% of subjects with prediabetes had chronic 
kidney disease, compared with only 10.6% of those without diabetes or prediabetes.11 While the 
exact mechanism linking prediabetes and chronic kidney disease is not known, studies suggest 
chronic hyperglycermia causes an increase in the absorption of glucose and sodium in the 
proximal tubule of the kidney, thereby reducing sodium delivery to the macula densa, which 
disrupts tubule-glomerular feedback mechanisms designed to regulate glomerular pressure and 
filtration.12  
Another common complication of prediabetes is neuropathy, as evidenced by increased 
prevalence of reduced heart rate variability, reduced postural-associatedin heart rate changes, and 
reduced sympathetic and parasympathetic function.6 There is also evidence of early sensorimotor 
neuropathy in individuals with IGT secondary to demyelination of small nerve fibers.6 
Prediabetes also increases the risk for retinopathy, and facilitates structural changes in the retina, 
including reduced arteriole-to-venule ratio, and increased retinal arteriole or venular caliber.13 
The Diabetes Prevention Program identified diabetic retinopathy in 7.9% of individuals with 
impaired glucose tolerance, suggesting retinopathy is an early complication of diabetes that 
begins to develop in the pre-diabetic state.14 
Most importantly, prediabetes increases the risk for macrovascular disease, including 
coronary artery disease, peripheral arterial disease, and cerebrovascular disease. The DECODE 
study found IGT to be associated with increased risk of coronary death and total cardiovascular 
death, independent of the level of FPG.15 Likewise, Huang et al. (2016) found that the risk for 
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cardiovascular disease increased by 13-30% in individuals with IFG or IGT based on the plasma 
glucose cutoffs used (American Diabetes Association vs. World Health Organization).16 Multiple 
studies have implicated the development of hyperglycemia, central obesity, high blood pressure, 
and elevated triglycerides and lipoproteins (particularly in the postprandial period as discussed 
below) as contributing factors to the elevated risk for macrovascular disease in prediabetes.17 In 
the United States, heart disease is the leading cause of death, while stroke and diabetes are the 5th 
and 7th leading causes of death, respectively.18 Therefore, it is imperative that individuals with 
prediabetes take the necessary steps to mitigate the severity of their condition and reduce their 
risk for these life-threatening complications.  
 
1.3  Pathophysiology of Prediabetes 
1.3.1 Progression from Normoglycemia to Prediabetes 
In 2009, Tabak et al. used results from the Whitehall II Study to define identifiable changes 
in fasting glucose, oral glucose tolerance, insulin sensitivity, and beta cell function that precede 
diagnosis of type 2 diabetes. Specifically, the authors found that among individuals who did not 
develop diabetes over a 13-year follow-up, plasma glucose increased linearly at a rate of .004 
mmol/L/year. In contrast, individuals who developed overt diabetes demonstrated a linear 
increase in plasma glucose of .028 mmol/L/year beginning 13 years prior to diagnosis, followed 
by a rapid, quadratic increase in plasma glucose 3 years before diagnosis.19 When looking at 
changes in 2-hour oral glucose tolerance test results, individuals developing type 2 diabetes 
demonstrated a linear increase in post-load glucose from 13 years to 6 years before diagnosis, 
 
 5 
with a sudden rapid, cubic increase in plasma glucose starting 6 years before diagnosis.19 Similar 
results were found for changes in insulin sensitivity and beta cell function, with rapid declines 
identified ~4-5 years before diagnosis.19 
The changes identified in the Whitehall II Study coincide closely with the work by Weir 
et al (2004), who defined five stages in the progression from normal glucose tolerance to type 2 
diabetes.20 Stage one was defined as a compensatory period in which beta cells increase insulin 
secretion (secondary to an increase in beta cell mass) to maintain plasma glucose concentrations 
in the face of increasing insulin resistance.20 In Stage two the body begins to struggle to maintain 
plasma glucose concentrations, with plasma glucose rising to the upper end of the normal range. 
Early elevations in plasma glucose are caused by reductions in beta cell mass due to beta cell 
apoptosis and diminished glucose-stimulated insulin secretion in remaining beta cells.20 The 
second stage is also defined by a loss of acute insulin secretion, which further exacerbates the 
struggle for glucose homeostatsis.20 Eventually, in Stage three, the individual loses the ability to 
compensate for the rising insulin resistance and beta cell dysfunction, causing plasma glucose 
levels to rise rapidly (as identified in the British Whitehall Study outlined above).20 Stage four 
also marks the onset of prediabetes, with the final two stages (four and five) characterized by 
further decompensation and progression to overt type 2 diabetes.20 
 
1.3.2 Insulin Resistance  
In the fasted and fed state, insulin serves as a master regulator of nutrient metabolism. 
Derangements of normal insulin regulation are a central component of the pathophysiology of 
both prediabetes and type 2 diabetes. This section includes a brief outline of the regulation of 
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insulin action and regulation, followed by a discussion of how insulin resistance leads to the 
metabolic abnormalities identified in individuals with prediabetes.    
Insulin synthesis in the pancreas is controlled by multiple factors, including the uptake 
and metabolism of glucose, which stimulates insulin gene transcription and translation, and 
promotes transcript stability.21 Glucose enters the beta cell through the GLUT2 transporter via 
facilitated diffusion where it is metabolized, thereby increasing the intracellular ATP/ADP ratio 
and stimulating insulin secretion.21 In addition to glucose stimulation, insulin secretion can be 
directly or indirectly stimulated by specific combinations of amino acids (glutamine and 
leucine), fatty acids (fatty acid deficiency reduces glucose-stimulated insulin secretion), and a 
number of hormones (eg. estrogen, melatonin, GLP-1, leptin, growth hormone).21 In the post-
absorptive period, pancreatic beta cells (which connect glucose uptake and metabolism with 
insulin secretion) reduce insulin secretion in parallel with falling glucose levels.22 Plasma insulin 
concentrations are further suppressed by the secretion of glucagon from pancreatic alpha cells, 
and by catecholamines (secreted from the sympathetic nervous system) that further augment 
glucagon release.22 Moreover, a transient state of insulin resistance develops in the post-
absorptive state as a result of increased fatty acid oxidation (which can negatively affect 
signaling from the insulin receptor) in skeletal muscle, as well as the influence of hormones like 
growth hormone and cortisol; both which can contribute to the development of chronic insulin-
resistance.23  
In the post-prandial period, glucose levels rise quickly. In response to the increase in 
plasma glucose, pancreatic beta cells increase their glucose uptake and ATP production, thereby 
increasing insulin secretion – a process further facilitated by declines in glucagon 
concentrations.22 Insulin secretion is also augmented by: 1) the parasympathetic nervous system 
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through acetylcholine release, which activates protein kinase C to enhance insulin secretion in 
beta cells, and 2) enteroendocrine L and K cells secretion of incretin hormones (GLP-1 and GIP, 
respectively) which have been shown to improve beta cell glucose sensitivity, reduce hepatic 
glucose production, and diminish adipose tissue lipolysis.24 Additionally, as plasma glucose and 
insulin concentrations rise, skeletal muscle glucose uptake and metabolism increase, which 
inhibits fatty acid oxidation and improves insulin sensitivity.22 
The nature of insulin resistance in prediabetes has been shown differ between those with 
impaired fasting glucose (IFG, fasting glucose >100 but <125 mg/dL) and those with impaired 
glucose tolerance (IGT, 2-hour oral glucose tolerance test post-load plasma glucose 140-200 
mg/dL). Using the oral glucose tolerance test (OGTT) model, previous studies have found that 
individuals with IFG demonstrate reductions in hepatic insulin sensitivity, as well as defective 
early insulin secretion from pancreatic beta cells (those vesicles that are already docked to the 
beta cell membrane and are released within 30 minutes of ingesting an oral glucose load).25 In 
contrast, the late phase of insulin secretion, as well as skeletal muscle insulin sensitivity, are 
normal or nearly normal, allowing plasma glucose to return to fasting levels within 2 hours 
during the OGTT.25 In contrast, individuals with IGT are characterized by skeletal muscle insulin 
resistance, and impaired late insulin secretion responses during the OGTT.25 Because fasting 
glucose primarily reflects hepatic glucose production (through glycogenolysis and 
gluconeogenesis), fasting glucose concentrations are normal, while post-prandial glucose 
excursions are elevated and sustained for a longer duration. 
Insulin resistance has been shown to develop in conditions characterized by activation of 
the innate immune system. TNF alpha (α) secretion from activated macrophages in adipose 
tissue of obese subjects was associated with insulin resistance, which was improved with 
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declines in TNFα expression after weight loss. 26 Likewise, cytokines levels are elevated in obese 
subjects, which have been shown to increase adipose tissue lipolysis.27 Increases in adipose tissue 
lipolysis can contributing to ectopic lipid accumulation and impaired insulin signaling.27 
Moreover, the work by Nunez Lopez et al. (2016) suggests different cytokines may be expressed 
at different stages of disease, suggesting that changes in cytokine expression may contribute to 
the progression to prediabetes and type 2 diabetes.28 The development of insulin resistance has 
also been linked to deficits in glycogen synthesis, glucose transport, and hexokinase II activity, 
as well as genetic or epigenetic changes inherited from parents who are diabetic.29 
 
1.3.3 Beta Cell Dysfunction 
In addition to changes in insulin sensitivity, two stages of beta cell function have been 
identified in prediabetes. Using the Leprdb mouse model of type 2 diabetes, Do and colleagues 
(2016) found that the early stages of prediabetes are characterized by increased insulin secretion 
secondary to increases in islet size and insulin content with concomitant reductions in alpha cell 
content.30 As the severity of prediabetes progresses, beta cells demonstrate reduced exocytic 
capacity – an adaptation driven by reduction in vesicle fusion, defective intracellular calcium 
responses (needed to stimulate exocytosis), and declines in insulin sensing capacity.30 The 
reduction in glucose sensing could be attributed to declines in Slc2a2 mRNA content, which 
codes for the integral GLUT2 transporter.31  
Multiple molecular mechanisms have implicated in the progression of beta cell 
dysfunction. Exposure to chronic hyperglycemia, often occurring as a result of a poor diet, 
induces oxidative stress and inflammation in beta cells. Activation of inflammatory pathways 
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involving a number of different cytokine responses can damage mitochondria and other vital 
organelles, induce protein, lipid, and nucleic acid damage, and promote beta cell apoptosis.32 
Specifically, reactive oxygen species facilitate uncoupling of glucose sensing and insulin 
secretion that occurs in prediabetes (exacerbated by the low intrinsic expression of antioxidant 
enzymes in beta cells).33 Moreover, prediabetes often develops in those with obesity – a 
condition defined by the secretion of damaging adipokines (such as resistin) that: 1) interfere 
with insulin signaling and thereby inducing beta cell stress, and 2) reduce beta cell viability and 
enhances cell death.34 Previous studies have also provided evidence to support the role of 
pancreatic adiposity in genetic reprogramming that further exacerbates beta cell dysfunction.35 
Moreover, beta cell necrosis secondary to macrophage infiltration and impaired autophagy (a 
process that clears the beta cell of defective organelles, including mitochondria) contributes to a 
loss of beta cell mass in prediabetes.36 
 
1.3.4 Impaired Incretin Responses 
Incretin hormones are secreted from enteroendocrine L and K cells in response to the 
entry of glucose, amino acids, and fatty acids into the small intestine after a meal.37 The major 
incretins are Glucagon-Like Peptide-1 (GLP-1, secreted from K cells of the small intestine) and 
Glucose-dependent Insulinotropic Peptide (GIP, secreted from L cells of the small intestine) – 
both known to reduce plasma glucose concentrations by increasing insulin secretion and 
reducing gastrointestinal motility.37 Evidence for the role of incretins in glucose homeostasis was 
demonstrated by comparing the amount of glucose needed to be given orally vs. intravenously to 
produce the same plasma glucose concentration.38 Nauck et al. demonstrated that to achieve 
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similar plasma glucose concentrations,  25 grams of glucose needed to be administered orally 
vs.only 19 grams of glucose intravenously, indicating activation of a orally-induced glucose 
disposal mechanism that increases glucose uptake by ~24%.39 This mechanism, now identified as 
the incretin effect, is attributed to the secretion of incretin hormones immediately before, and 
during, the meal.  
Given the role of incretin hormones in glucose regulation, it is not surprising that deficits 
in incretin secretion have been found in individuals with insulin resistance. Rask et al. (2001) 
found that in 35 nondiabetic men, the degree of insulin resistance was directly related to the area 
under the curve of postprandial GLP-1 and GIP concentrations.40 Likewise, in the Danish 
ADDITION-PRO study of 755 subjects, individuals with prediabetes demonstrated lower GLP-1 
responses (up to 121% lower) to an OGTT than individuals with normal glucose tolerance, even 
after controlling for age and obesity.41 This study also identified that obesity alone was 
associated with further reductions in GLP-1 responses (by 20% compared to normal weight 
individuals), providing another potential mechanism contributing to reduced incretin responses 
in this condition.41  
The rate of gastric emptying is a tightly regulated process designed to control 
gastrointestinal motility to generate a relatively constant rate of nutrient passage from the 
stomach to the small intestine. Previous studies have demonstrated that the rate of 
gastrointestinal motility is regulated by plasma glucose concentrations through stimulation of 
incretin secretion. For example, food passage from the stomach to the small intestine stimulates a 
constant incretin response that lasts until the stomach is completely emptied.38 Moreover, a 
truncated form of GLP-1 has been found to inhibit the rate of gastric emptying, indicating a 
feedback loop between gastric contents, plasma glucose concentrations, and gastric motility 
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through central inhibition of parasympathetic outflow.42 This feedback loop is an essential 
mechanism of controlling blood sugar because the rate of gastric emptying affects the duration of 
the small intestine’s is exposed to the contents of the meal. The slowing influence of GLP-1 
serves to reduce blood glucose concentrations, with some studies suggesting the glucose-
lowering influence of GLP-1 may be attributed more so to its influences on gastric emptying 
than its influence on beta cell insulin secretion.43 Moreover, Boronikolos et al. (2015) found that 
the rate of gastric emptying increased with severity (Hba1c) and duration of diabetes, suggesting 
a direct role in the rate of nutrient absorption in the pathophysiology of glucose dysregulation.44 
 
1.3.5 Lipotoxicity 
Multiple studies have implicated the development of lipotoxicity in the pathophysiology 
of prediabetes and its progression to overt diabetes.  It is important to acknowledge that 
prediabetes often occurs in individuals who are obese. In obesity, adipocytes become enlarged to 
accommodate the increased demand for triglyceride deposition.45 Initially, adipocytes can 
accommodate these increased levels of triglycerides (secondary to an increased activity of 
triglyceride synthesis pathways) while maintaining a normal level of lipolysis.46 Over time, 
however, the ability of the adipocyte to continue to accommodate increased triglycerides slows 
and their signaling functions becomes altered.46 Hypertrophied adipocytes secrete 
chemoattractants that enhance macrophage infiltration of the adipocyte, which has been shown to 
increase lipolysis and reduce triglyceride synthesis.46 The ensuing inflammatory response 
negatively affects adipocyte function, and is commonly found in individuals with obesity.47 
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These adipocyte adaptations lead to increased levels of circulating plasma free fatty acids 
and triglycerides, which can be taken up and accumulate in non-adipose tissues including 
skeletal muscle and the liver after hydrolysis by endothelial lipoprotein lipase.  Several studies 
suggest that the accumulation of fatty acids in skeletal muscle is caused by an imbalance 
between free fatty acid delivery/availability, free fatty acid uptake, and elimination (re-
esterification to intramyocellular triglycerides or oxidation).48 The “mitochondrial lipid 
overflow” hypothesis posits that excess delivery of fatty acids to mitochondria leads to 
incomplete beta oxidation and the accumulation of lipid intermediates, including acetyl-coA 
(produced by the repetitive splitting of 2 carbon subunits from the larger fatty acyl-coA in the 
mitochondria), NADH, diacylglycerols, cytosolic citrate, and long-chain acyl carnitine CoA: all 
which negatively regulate insulin signaling and glycolytic enzyme activity through Randle Cycle 
inhibition.49,50 The inability to completely oxidize fatty acids directed toward mitochondria also 
promotes mitochondrial stress and depletion of organic acid intermediates of the TCA cycle.49  
In addition to excess skeletal muscle and hepatic delivery of fatty acids, studies have 
demonstrated that processing of intramyocellular triglycerides (IMTG) may be an important 
determinant of insulin sensitivity. Perreault et al. (2010) found that individuals with prediabetes 
had a trend toward reduced IMTG synthesis rates at rest, and failed to suppress IMTG synthesis 
during exercise – suggesting inflexibility of the IMTG pool during progression to type 2 
diabetes.51 In support of this hypothesis, Sparks et al. (2014) found reduced free fatty acid 
incorporation into IMTG in skeletal muscle and primary myoblasts in individuals with diabetes 
compared to BMI-matched controls.52 Further evidence for the importance of improving IMTG 
synthesis to slow the progression of insulin resistance comes from Liu et al (2007).53 These 
authors overexpressed diglyceride acyltransferase 1 (DGAT1, catalyzes the formation of 
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triglyceride from diglyceride) in differentiated C2C12 cells, causing a 6-fold increase in IMTG 
and a 50% reduction in lipotoxic diacylglycerols.53And in a separate study, mice overexpressing 
DGAT1 in skeletal muscle were able to store 12% more IMTG and prevent diet-induced insulin 
resistance.53 
As identified by Schenk and Horowitz (2007), IMTG serve as a reservoir for fatty acids 
that is protective from the development of insulin resistance.54 Therefore, a loss of flexibility to 
store fatty acids as IMTG may be a catalyst for increasing insulin resistance in prediabetes. 
However, the derangement in IMTG handling may be different in individuals with IGT vs. IFG. 
Goossens et al. (2016) found that individuals with impaired glucose tolerance had reduced 
fractional synthetic rates of IMTG, with increased saturation of the free fatty acid pool and 
retention of saturated fatty acids than those with impaired fasting glucose.55 Individuals with 
prediabetes may not maintain the oxidative capacity to match the elevated rate of free fatty acid 
delivery to the mitochondria, as suggested by the work of Fabri et al. (2017).56 In this study, the 
authors assessed 248 individuals from the Baltimore Longitudinal Study of Aging and found that 
a longer duration of prediabetes and more severe hyperglycermia were associated with longer 
phosphocreatine recovery (a measure of mitochondrial oxidative metabolism capacity, longer 
denotes worse capacity) using 31P MRS.56 Moreover, Straczkowski et al. have demonstrated that 
ceramide levels are elevated in skeletal muscle of individuals with IGT and offspring of diabetic 
parents.57 Ceramide is a sphingolipid widely distributed in the cell membrane that can interfere 
with insulin signaling and has been implicated in the development of insulin resistance.57 Taken 
together, these results suggest that a failure to maintain balance between free fatty acid entry into 
skeletal muscle, and its removal through oxidation or IMTG synthesis, leading to the 
accumulation of lipotoxic intermediates that exacerbate insulin resistance. Worse still, pre-
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diabetic muscle may have a reduced capacity to protect itself from lipotoxic damage, as 
evidenced by reduced levels of uncoupling protein 3 – a protein known to protect the 
mitochondrial matrix from lipid-induced damage.58. Specific deficits in oxidative capacity will be 
discussed below.58 
 
1.3.6 Mitochondrial Abnormalities 
As indicated above, the development of lipoxicity may be related to deficits in skeletal 
muscle oxidative capacity. Because mitochondria are responsible for oxidative metabolism, 
several studies have probed for abnormalities in mitochondrial function in skeletal muscle from 
individuals with insulin resistance. In 2005, Sparks et al. found that a high fat diet reduced the 
expression of genes related to oxidative phosphorylation, proteins composing mitochondrial 
complex I, proteins in mitochondrial complex II, mitochondrial carrier protein SLC25A12, 
PGC1alpha, and PGC1beta in skeletal muscle.59 These changes could be driven by epigenetic 
mechanisms leading to repression of key mitochondrial proteins. For example, Zheng et al. found 
that DNA methylation of NADH Dehydrogenase subunit 6  (suppressing transcription of the 
gene coding for this subunit) increased with increasing severity of BMI, as well as insulin 
sensitivity (HOMA-IR) in early stage prediabetes.60  
In addition to changes in protein content and gene expression, several studies have 
implicated reactive oxygen species in the pathophysiology of prediabetes and overt diabetes. 
Hayder Al-Aubaidy et al. found that serum 8-OHdG, a marker of DNA damage secondary to 
oxidation of deoxyguanosine, was markedly elevated in both prediabetes and type 2 diabetes.61 
Moreover, Bhansali et al. (2017) found that individuals with prediabetes and type 2 diabetes 
 
 15 
presented with elevated reactive oxygen species in peripheral blood mononuclear cells 
concordant with their level of glucose dysregulation (prediabetes < newly diagnosed type 2 
diabetes < advanced type 2 diabetes).62 Moreover, the authors found that mRNA expression for 
mitophagy-related genes were elevated in prediabetes, but down-regulated in type 2 diabetes – 
suggesting a potential compensation that delays the onset of type 2 diabetes by eliminating 
mitochondria damaged by oxidative stress.62 The impairment of mitophagy in more advanced 
disease may lead to the accumulation of dysfunctional mitochondria and worsening insulin 
sensitivity. Additionally, in obese Zucker rats (a model frequently used to study prediabetes), the 
administration of antioxidants R-Alpha Lipoic Acid and pyridoxamine reduced the accumulation 
of advanced glycation end products, reduced muscle protein carbonyls and urine conjugated 
dienes (markers of oxidative damage), and improved both fasting glucose and insulin 
sensitivity.63   
 
1.4 Postprandial Lipid Metabolism in Prediabetes 
1.4.1 Physiology of Post-prandial Lipid Metabolism 
Based on the literature presented above, it is clear that derangements in lipid metabolism 
contribute to the onset and progression of insulin resistance and diabetes. While lipid metabolism 
is important during the fasted state, recent studies have suggested that postprandial lipid 
responses may contribute more strongly to prediabetes and its associated comorbidities. Post-
prandial changes in plasma triglycerides reflect a complex interaction between multiple 
metabolic and hormonal influences. Plasma triglycerides are carried in lipoprotein particles 
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called triglyceride-rich lipoproteins (TRLs).64 TRL particles consist of chylomicrons (produced 
by enterocytes in the small intestine), very low density lipoproteins (VLDL, produced in the 
liver), and their remnant particles: low density, intermediate density, and high density 
lipoproteins.64  
After ingestion, meal triglycerides are emulsified by bile salts to formed mixed micelles, 
which are subsequently hydrolyzed by enzymes in brush border membrane of the small intestine 
to release free fatty acids and monoacylglycerol for uptake by enterocytes.65 In the enterocyte, 
free fatty acids and monocacylglycerol are re-esterified to triglycerides and packaged with 
cholesterol, fat soluble vitamins, and intracellular lipid droplets (formed from excess 
triglycerides absorbed during previous meals) into chylomicron particles in the Golgi 
apparatus.65 The chylomicrons contain the structural protein Apolipoprotein B48 and AI (acting as 
a stabilizing agents and receptor ligands), an inner core of triglycerides and cholesterol ester, and 
an outer core of phospholipid and free cholesterol.66 While enterocytes continuously releases 
chylomicrons throughout the day, chylomicron concentrations rise sharply after the meal, as does 
their size (driven by the fusion of meal triglycerides with triglycerides left over from previous 
meals).64 These chylomicron lipoproteins are secreted into the lymphatic system, ultimately 
entering the plasma compartment through the thoracic duct. Once in the circulation, chylomciron 
ApoA-I dissolves and is replaced by Apo-Cs, which facilitates the unloading of packaged 
triglycerides after hydrolysis by the enzyme lipoprotein lipase (LPL) in tissue endothelium.64  
In contrast to chylomicrons, VLDL particles are formed through the sequential lipidation 
of the apoB-100 protein in the liver – a process initiated by the microsomal triglyceride transfer 
protein in the rough endoplasmic reticulum.64 The size and maturation of the VLDL particle is 
highly dependent on the accumulation of cytosolic triglyceride in the hepatocyte (a feature 
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pointing to the importance of fatty acid delivery to the liver from adipose tissue, and from 
chylomicron remnants incompletely hydrolyzed after the meal).67 After secretion from the liver, 
VLDL, like chylomicrons, are hydrolyzed by lipoprotein lipase, forming intermediate density 
lipoproteins (IDL).67 IDL can be further hydrolyzed in the circulation to low density lipoprotein 
(LDL), which is primarily removed from the circulation in the liver (through LDL receptor) and 
peripheral tissues where cholesterol is needed for biosynthetic purposes.67 
It is important to note that both chylomicrons and VLDL compete for the hydrolysis 
reactions driven by lipoprotein lipase.68 Previous studies have shown that endogenous TRLs 
(VLDL) accumulate in the plasma after fat ingestion due to a delay in their lipolysis secondary to 
competition for LPL with chylomicrons.68 This delay has been attributed to LPL’s preference for 
larger lipoproteins, and for a reduced efficiency of hydrolyzing VLDL triglycerides – both of 
which lead to a preference for chylomicrons.64 The competition for LPL is so strong, that some 
authors suggest postprandial triglyceride concentrations are driven primarily by VLDL secretion 
responses.68  
The metabolism of post-prandial lipoprotein triglycerides, like glucose, are closely 
regulated by hormones like insulin and incretins. In the liver, insulin suppresses VLDL 
concentrations by: 1) promoting apoB degredation to promote triglyceride storage; 2) inhibition 
of adipose tissue lipolysis, thereby reducing the availability of plasma free fatty acids from as a 
substrate for triglyceride synthesis (known as de novo lipogenesis which also contributes to 
elevations in chylomicron production in insulin resistance); 3) activation of lipoprotein lipase for 
triglyceride hydrolysis; and 4) suppression of apo CIII secretion (an inhibitor of lipoporotein 
lipase).69 The incretin GLP-1 has been found to reduce chylomicron production and post-prandial 
triglycerides.70 While the exact mechanism of this reduction is not completely understood, the 
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beneficial effects of GLP-1 on postprandial triglycerides could be related to the inhibition of 
gastric emptying, which may reduce the efficiency of dietary fat absorption or processing.71 
GLP-1 may also improve lipid metabolism by increasing insulin secretion, reducing lymph 
output (reducing chylomicron secretion into the plasma), reducing circulating plasma free fatty 
acids, reducing apoB48 production, and/or reducing the triglyceride concentration of individual 
lipoprotein particles.72  
  
1.4.2 Derangements of Post-prandial Lipid Metabolism in Prediabetes 
One of the hallmark features of prediabetes is the development of elevated post-prandial 
lipemia, which is defined as an exaggerated rise in plasma triglycerides and TRLs after 
consuming a mixed meal.73 A number of metabolic abnormalities in post-prandial lipid 
metabolism have been identified in prediabetes that may contribute to elevated lipemia, 
including increased TRL-TG production rates, reduced expression of lipid oxidative genes, and 
reduced intramyocellular partitioning of non-esterified fatty acids (NEFA) toward re-
esterification (see “Lipotoxicity,” above) – an important intracellular mechanism of clearing free 
fatty acids liberated from triglyceride hydrolysis.74,75  This is evidenced by Shojaee-Moradie et 
al.(2013) who reported elevated triglyceride levels, larger VLDL and chylomicrons pool sizes, 
and lipoprotein production rates in individuals with prediabetes compared to lean controls.76 
Importantly, clearance rates were not different between groups, indicating an imbalance between 




Previous studies have also reported that insulin resistance is associated with elevations in 
ApoB-48 particles (chylomicrons), which may be exacerbated by abdominal obesity.77 Compared 
to nondiabetic women, women with diabetes demonstrated elevated Apo-B 48 particles and 
reduced fractional catabolic rate of chylomicron remnants.78 Furthermore, Duez et al. (2006) 
demonstrated that ApoB-48 particle production rates were significantly higher in 
hyperinsulinemic, insulin resistant men in the absence of a difference in clearance rates -- again 
suggesting a mismatch between lipoprotein production and clearance favoring lipoprotein 
accumulation.79 
Like chylomicrons, impairments in VLDL metabolism have also been identified during 
the post-prandial period in obesity, prediabetes, and type 2 diabetes. In 2002, Pont et al. reported 
that insulin resistant, abdominally obese women have elevated ApoB-100 particle production 
rates (the apolipoprotein in VLDL particles), as well as IDL and LDL production rates without 
changes in their clearance rates compared to healthy controls.80 This study also demonstrated 
increased hepatic production of large VLDL particles using 3H glycerol and VLDL exogenously 
labeled with iodine.80 Using a dual tracer approach, Adiels et al. (2006) found that liver fat 
content and plasma glucose predicted VLDL production rate, which was elevated in diabetic 
men.81 The presence of abdominal obesity alone may disturb lipid metabolism, as Chan et al. 
(2002) found that individuals with abdominal obesity presented with reduced uptake of VLDL, 
LDL, and IDL, which may further contribute to the accumulation and prolonged residence time 
of these lipoprotein particles.82  
These imbalances in post-prandial lipid metabolism are important because it places 
individuals with prediabetes at a greater risk for cardiovascular disease. Several large cohort 
studies have found that postprandial dyslipidemia is associated with an increased risk for 
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myocardial infarction, ischemic heart disease, death, and ischemic stroke in both men and 
women.83 The Women’s Health Study, which followed nearly 27,000 women for more than 11 
years, demonstrated that higher non-fasting triglyceride levels were strongly associated with an 
increased risk of future cardiovascular events, independent of baseline cardiac risk factors.83 In 
contrast, fasting triglyceride levels showed little independent association with cardiovascular 
events, leading the authors to hypothesize that cardiovascular disease may be a post-prandial 
phenomenon.83 
 
1.5 Effects of Exercise on Substrate Metabolism in 
Prediabetes 
1.5.1 General Benefits of Exercise on Disease Progression 
Despite the myriad of metabolic abnormalities that contribute to the pathysiology of 
prediabetes, individuals can have a meaningful impact on their skeletal muscle health, and 
whole-body function, through regular exercise. Fortunately, multiple studies have suggested that 
prediabetes is a reversible with lifestyle interventions utilizing exercise regimens. The Da Qing 
IGT and Diabetes Study evaluated 577 subjects with IGT who were randomized to a control 
group or to one of three active treatment groups (diet only, exercise only, or diet plus exercise).84  
After a 6-year follow-up, the study found that the diet, exercise, and diet-plus-exercise 
interventions were associated with a 31%, 46%, and 42% reduction in risk of developing 
diabetes, respectively.84 Likewise, the Finnish Diabetes Prevention Study (DPS) showed that the 
combination of diet and exercise in individuals with IGT (n=522) reduced the risk of diabetes by 
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58% (with a cumulative incidence of type 2 diabetes of 11% in 4 years vs. 23% in the control 
group).85 Moreover, the Diabetes Prevention Program (DPP) Research Group demonstrated that 
after randomizing 3,234 subjects with IFG or IGT into groups receiving placebo, metformin, or a 
lifestyle intervention, the lifestyle intervention group had the lowest incidence of diabetes (4.8 
per 100 person-years) compared to the other groups.86 Taken together, these results support for 
the potential for exercise interventions to reduce the risk for disease progression, as well their use 
for primary prevention of type 2 diabetes.   
 
1.5.2 General Benefits of Aerobic Exercise  
Aerobic exercise is traditionally utilized in lifestyle interventions for individuals with 
obesity and metabolic conditions as a means to increase skeletal muscle fatty acid oxidation and 
oxidative capacity. The term “aerobic” is used to describe repetitive, low resistance, submaximal 
exercise lasting several minutes to hours at various intensities. Aerobic exercise has been shown 
to increase muscle mitochondrial content and respiration, fatty acid oxidative capacity, resting 
energy level, oxidative enzyme activity, and insulin sensitivity.87,88 Increases in mitochondrial 
content are achieved through mitochondrial biogenesis – a process relying on coordination 
between transcription factors expressed by the mitochondria and the nucleus.89 Contractile 
activity has a direct effect on the expression of nuclear-encoded transcription factors, which are 
expressed to elicit specific phenotypic changes in skeletal muscle (eg. enhanced oxidative 
capacity, hypertrophy, improved metabolic flexibility).89 For example, Tfam expression (a 
transcription factor encoded by the nucleus that translocates to the mitochondria to regulate the 
transcription of ETC chain complex IV) is up-regulated following muscle contraction.90 
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Likewise, reductions in the expression of mitochondrial transcription factors correlated 
negatively with aerobic exercise capacity, suggesting that exercise can have positive effects on 
mitochondrial gene transcription.90 
 Further adaptations in mitochondrial content are driven by mitochondrial fusion and 
fission reactions in skeletal muscle. The fusion of dysfunctional and healthy mitochondria 
facilitates the sharing of proteins, lipids, and RNA, and the elimination of DNA mutations 
through cross-complementation.91 Likewise, mitochondrial fission involves the replication of 
mitochondrial DNA and subsequent mitochondrial division. In 2005, Cartoni et al. reported 
increases in muscle mitofusin 1 and 2 (involved in fusion) expression measured 24 hours after 
cycling exercise.92 Furthermore, Garnier et al., (2005) demonstrated mRNA levels of Drp1 
(involved in fission) increased proportionately with the VO2max of 18 individuals.93  
One of the most highly investigated regulatory proteins associated with aerobic exercise 
is PGC-1alpha (peroxisome proliferator-activated receptor gamma coactivator 1-alpha). PGC-
1alpha is a transcriptional co-activator involved in a number of metabolic functions through its 
regulation of transcription factor activation (including estrogen-related receptor alpha, thyroid 
receptor, nuclear respiratory factor 1, NRF2, myocyte enhancer factor 2) and mitochondrial-
nuclear cross-talk.94 PGC-1alpha expression is associated with enhanced mitochondrial 
biogenesis, angiogenesis, phenotypic switching to a more oxidative muscle phenotype (ie. 
increasing type 1 muscle fiber content), enhancement of GLUT4 translocation, increased fatty 
acid oxidation, reduced accumulation of lipid metabolites (cerimide, diacylgycerol, long chain 
fatty-acyl-coAs), and increased  metabolic flexibility (or the ability of skeletal muscle to switch 
between substrates based on their abundance).95 Aerobic exercise has been associated with 
increases in multiple regulators of PGC-1alpha expression, including Ca2+/calmodulin-dependent 
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serine/threonine protein phosphatase calcineurin (CnA), Ca2+/calmodulin-dependent protein 
kinases (CaMKs), AMPK, nitric oxide synthase, and hydrogen peroxide.96-98 Finally, aerobic 
exercise is associated with the nuclear export, and inactivation of class IIa histone deacetylase 
(HDAC)4 and HDAC5, which normally inhibits MEF2 and prevent PGC-1alpha transcription in 
skeletal muscle.99   
Aerobic exercise has also been show to reduce body fat mass, increase insulin sensitivity, 
increase glucose tolerance, and augment glucose uptake via stimulation of GLUT4 transcription 
as well as translocation of intracellular GLUT4 to the sarcolemma in healthy and prediabetic 
populations. 100-102 Moreover, a recent meta analysis found that aerobic exercise reduces HbA1c, 
fasting plasma glucose, LDL, plasma triglycerides, BMI, and systolic blood pressure while 
improving VO2peak in individuals with type 2 diabetes. (Yang, 2014).103 Taken together, these 
findings highlight the ability of aerobic exercise to target the metabolic impairments 
characteristic of the prediabetic population. 
 
1.5.3 General Benefits of Resistance Exercise  
In contrast to aerobic exercise, resistance training is characterized by the use of short 
bouts of very intense muscle contraction, which relies primarily on the use of phosphocreatine 
and glycolytic ATP production. Chronic resistance training is associated with muscle 
hypertrophy (especially in type II fibers), increased motor unit activation, stimulation of muscle 
protein synthesis, reductions in the rate of protein degredation, increased basal metabolic rate, 
and improved insulin sensitivity and glucose tolerance.104  
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Additionally, several studies have presented strong evidence for the ability of resistance 
exercise to improve lipid metabolism, particularly in the hours after the exercise session. Hunter 
et al. (2004) found that 26 weeks of resistance training increased strength, lean mass, resting 
energy expenditure by 6.8%, and reduced the resting respiratory exchange ratio (RER) from 0.86 
to 0.83 – indicative of a higher contribution of fatty acid oxidation to energy production.105 
Similar results have been reported by Kirk et al. (2009) after 6 months of resistance training 
performed 3 times per week in sedentary young adults, and Van Etten et al. (1995) after 12 
weeks of resistance training in young males.106,107 Gillette et al. (1994) demonstrated that 
resistance exercise caused a large decline in post-exercise RER during the first hour of recovery 
in males aged 25-35.108 Osterberg & Melby (2001) reported that a single bout of resistance 
training (100 minutes) increased resting fat oxidation rate, indicating that strenuous resistance 
exercise is capable of producing modest and prolonged elevations in fatty acid oxidation in 
young women.109  Jubrais et al. (2001) found that resistance training resulted in a 57% increase in 
oxidative capacity, as well as a 31% increase in mitochondrial volume density and muscle size in 
older adults.110 Magkos et al. (2008) found that a single session of resistance training 
significantly increased fatty acid oxidation the morning after exercise in untrained young men.111 
Shepherd et al. (2014) reported increases in peak O2 uptake, cytochrome c oxidase protein 
content, and intramuscular triglyceride breakdown after 6 weeks of resistance training, which 
were associated with improved insulin sensitivity in sedentary young men.112 Finally, Meex et al. 
(2010) found that a combined program of aerobic and resistance exercise significantly increased 
fatty acid oxidation after 12 weeks of training in individuals with type 2 diabetes.113 These 
studies provide strong evidence for the capacity for resistance exercise to improve lipid oxidation 
and mitochondrial function in healthy subjects and in those with type 2 diabetes. 
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In addition to resting measurements of fatty acid oxidation, multiple studies have shown 
that resistance training promotes significant increases in excess post-exercise oxygen 
consumption (EPOC) – a prolonged increase in energy expenditure after exercise needed to 
restore myocyte homeostasis (eg. the removal of lactate). EPOC mainly involves oxidative 
metabolism, with multiple studies reporting lower respiratory quotients during recovery from 
exercise than at rest.114 For example, Binzen et al. reported elevated fatty acid oxidation 
following a single bout of resistance exercise, and an 18.6% increase in oxygen consumption 
above rest.114 Likewise, Osterberg & Melby (2001) reported elevated EPOC after a single bout of 
resistance training, with a lower RER during EPOC than rest.109 And Farinatti et al (2016) also 
found lower RERs and higher fatty acid oxidation during EPOC following a single session of 
resistance exercise when compared to resting RER.115  
The meta analysis conducted by Yang et al. (2014) also showed that resistance exercise 
effectively reduces HBA1c, fasting blood glucose, insulin resistance, LDL, total triglycerides, 
body weight, body fat, and systolic blood pressure.103 Moreover, Yardley et al. (2013) found that 
resistance exercise produced greater reductions in plasma glucose than aerobic exercise during a 
one-hour recovery period in individuals with type 1 diabetes, suggesting resistance exercise may 
have a stronger impact on blood sugar control than aerobic exercise.116 Taken together, these 
studies highlight the potential for resistance exercise to improve both lipid and glucose 
metabolism, and the major metabolic derangements in prediabetes.  
 
1.5.3.1 Examples of Resistance Exercise Prescriptions Studied 
It is important to note that the studies identified above primarily utilize traditional 
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resistance training prescriptions. They did not require special modifications to make them more 
aerobic in nature, highlighting the intrinsic ability of resistance exercise to improve lipid 
metabolism. For example, the study by Magkos et al. utilized 80% maximum torque production 
for 3 sets of 10 on 12 exercises on a biodex isokinetic dynamometer.111 Shepherd et al., utilized 3 
sets of 12 reps at 80% 1RM; Gillette et al. (1994) utilized five sets of 8-12 reps at 70% 1RM on 
10 different exercises; Osterberg et al. (2000) used five sets of 10 exercises each performed for 
10-15 reps at 70% 1RM; and Kirk et al. (2009) used one set of 9 exercises at 85-90% 1RM.106-112  
 
1.5.4 General Benefits of Concurrent Training 
Currently, exercise programs combining aerobic and resistance exercise are 
recommended for the management of metabolic conditions over either mode alone. The clinical 
trial by Siagl et al. (2008) found that the combination of aerobic and resistance training produced 
significantly greater reductions in HbA1c than aerobic or resistance training in isolation after 22 
weeks in individuals with type 2 diabetes.117 Similarly, Yavari et al. (2012) found that combined 
training for 52 weeks promoted additional benefit in reducing HbA1c, plasma triglycerides, body 
fat percentage, and muscular percentage when compared to aerobic or resistance training alone in 
diabetes.118 In 2009, Marcus et al. demonstrated that a program combining aerobic and eccentric 
resistance exercise produced greater gains in thigh lean mass and reductions in BMI than aerobic 
exercise alone after 16 weeks.119 However, the use of concurrent training over either aerobic or 
resistance training alone may depend on the goals of the exercise regimen. For example, 
Kraemer et al. found that performing concurrent running and strength training produced less 
muscle hypertrophy when compared to strength training alone.120 Furthermore, Monteiro et al. 
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(2015), found equivalent reductions in body fat after 20 weeks of either aerobic exercise or 
combined aerobic and resistance exercise.121 Further research is needed to determine when, and 
how best, to combine aerobic and resistance exercise to maximize metabolic benefit. 
 
1.5.5 Optimal Lifestyle Intervention Study 
  We recently completed a study assessing the effects of a 32-week lifestyle intervention 
combining diet and structured exercise to reduce the severity of type 2 diabetes. Fifteen 
(n=15)individuals with obesity and prediabetes were randomly assigned to the lifestyle 
intervention (ILT, n=8) or standard of care (SC, n=7). The ILT group received physical therapist 
supervised structured exercise sessions (1-hour) four times per week. The exercise consisted of 1 
hour of interval aerobic exercise at 80-100% HRmax twice per week, 1 hour of resistance exercise 
(80-90% 1RM, 2 sets, 6 exercises, momentary muscular failure) once per week, and 
functional/free-weight training once per week in addition to 1-2 hours of unsupervised physical 
activity (walking, core stability, body weight exercises) on the weekend. Participants in the ILT 
group were instructed to maintain a high-protein, low-carbohydrate diet throughout the study. In 
contrast, participants in the SC received a one time information session discussing lifestyle 
modifications for individuals with type 2 diabetes, and informational materials that encouraged 
them to increase their physical activity and that contained information regarding current ADA 
dietary recommendations. Participants in the SC had follow-up visits once per month over the 











Fig. 1 Lipid handling after 32 weeks of ILT  vs SC. A. Participants had a significant reduction in 
plasma triglycerides after ILT but not after SC. B. Participants tended to reduce plasma free fatty 
acids after ILT, but it was not significant (p>.05). C. ILT reduced resting respiratory quotient 
(RQ), whereas there was no change after SC. † significant interaction group x time. * Significant 
difference pre-post. § Significant effect of time. 
 
In response to regular exercise and diet, individuals in the ILT demonstrated significantly 
greater improvements in lipid metabolism including reductions intotal plasma triglycerides and 
resting respiratory quotient (indicating a greater contribution from lipid oxidation to resting 

















Fig. 2. Glucose handling after 32 weeks of ILT  vs SC. A. ILT resulted in a significant reduction 
in glucose AUC on the modified 5-hour OGTT. B. ILT produced significant declines in plasma 
insulin AUC on the modified 5-hour OGTT. C. ILT significantly improved hepatic insulin 
sensitivity. D. ILT significantly increased insulin-mediated glucose disposal. † significant 
interaction group x time. * Significant difference pre-post. § Significant effect of time  
 
Likewise, individuals in the ILT presented with significantly improved glucose metabolism 
(reduced areas under the glucose and insulin concentration curves on a modified 5-hour OGTT) 
compared to SC. . These reductions were mediated by significant improvements in hepatic 
insulin sensitivity and insulin-stimulated glucose disposal (determined using the 
hyperinsulinemic-euglycemic clamp technique). These results suggest that exercise can improve 
glucose and lipid metabolism in individuals with type 2 diabetes. However, all measurements 
were taken in the fasted state. The next section will discuss current evidence for the benefits of 
exercise on post-prandial metabolism. 
 




In individuals with prediabetes -- a population with marked derangements in lipid 
metabolism – a single bout of aerobic exercise has been shown to attenuate post-prandial lipemia 
and improve insulin sensitivity.122 For example Ho et al. (2012) utilized a cross-over design to 
investigate the effects of a 30 minute bout of aerobic or resistance exercise on post-prandial 
lipemia (participants exercised in the evening prior to a breakfast test meal).123  The authors 
found that aerobic exercise reduced postprandial plasma triglycerides by 8%, while resistance 
exercise reduced postprandial insulin levels by 30%.123 While few studies have directly 
compared aerobic vs. resistance exercise on post-prandial substrate responses, significant insight 
can be gained from studies assessing each mode of exercise individually. 
 
1.5.7 Influence of Aerobic Exercise Prescription on Post-prandial Glucose and 
Lipid Metabolism 
Previous studies have demonstrated that improvements in post-prandial substrate 
metabolism in response to aerobic exercise are influenced by a number of factors, including age, 
gender, exercise intensity, exercise duration, and the timing of exercise. Cox-York et al. (2012) 
found that 60 minutes of aerobic exercise did not effectively alter postprandial triglyceride 
responses to a series of moderate fat meals given throughout the day after a morning exercise 
bout  in men or women with and without metabolic syndrome.124 However, women had a lower 
postprandial triglyceride response than men, with the greatest difference between men and 
women with metabolic syndrome.124 These results suggest that women and men metabolize 
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meal-derived triglycerides differently and could be an important variable to control for in future 
exercise studies. With regard to exercise intensity, Rynders and colleagues (2014) compared the 
effects of moderate vs. high intensity aerobic exercise (one hour) followed by an oral glucose 
tolerance test in prediabetic men and women.122 Both intensities resulted in improvements in 
insulin sensitivity, but only the high intensity condition resulted in significant reductions in 
glucose, insulin, and c-peptide areas under the curve -- indicating postprandial responses may be 
larger after higher intensity exercise.122  To determine the optimal duration of exercise needed to 
reduce hypertriglyceridemia in men with prediabetes, Zhang et al. (2007), compared the effects 
of 30, 45, and 60 minutes of aerobic exercise at 60% of their VO2peak.125 The authors 
demonstrated that while 30 minutes of exercise was sufficient to promote improvements in 
insulin sensitivity, 45 minutes were required to see reductions in postprandial triglyceride 
concentrations.125 Evidence also suggests that exercise performed prior to eating a meal may be 
more effective than exercising in the postprandial period. Derave et al. (2007) had participants 
with prediabetes perform aerobic exercise for 45 minutes at 60% of their VO2 max before eating, 
or after eating, breakfast.126 The authors found that exercising prior to eating breakfast resulted in 
a higher fat oxidation rate (determined with indirect calorimetry) than exercising after 
breakfast.126 Similarly, the glycemic response was improved more when exercising before 
compared with when exercising after breakfast.126 Zhang et al. (2004) reported similar results, 
adding that the acute benefits of aerobic exercise on glucose metabolism may be short lived 
(lasting ~12 hours) and dissipate by 24 hours.127  
 




Like aerobic exercise, evidence supports the ability of resistance exercise to improve 
post-prandial lipid metabolism. In 2007, Burns et al. found that repeated resistance exercise 
bouts at relatively low intensity (5 bouts, 5 exercises, 30-40% 1RM) reduced postprandial 
triglycerides by 12% in healthy subjects.128 Similarly, using a stable isotope tracer approach, 
Magkos et al. (2008) found that high intensity resistance exercise (3 sets of 10 repetitions for 12 
exercises at 80% of peak torque production) reduced VLDL triglyceride concentrations, 
increased VLDL plasma clearance rates, and shortened the VLDL mean residence time 
compared to rest in healthy men.111 Moreover, these reductions were greater after the resistance 
exercise session than an equivalent bout of aerobic exercise.111 These results are further 
supported by the work of Davitt et al. (2013) – one of the few studies to evaluate the effects of 
resistance exercise outside of a healthy population.129 Davitt et al. found that resistance exercise 
reduced total and endogenously-derived triglyceride (triglycerides not coming from the meal) 
content, and increased total lipid oxidation rate in obese women.129 However, the authors also 
found that exogenously-derived triglyceride concentrations increased after both aerobic and 
resistance exercise, and that the reductions in postprandial lipemia are driven primarily through 
reduced concentrations of endogenous triglycerides rather than through enhanced clearance.129 
Multiple studies have confirmed that resistance exercise can improve post-prandial triglycerides 
and improve fat oxidation for up to 16 hours after a single exercise session in healthy and 
populations.130  
However, not all studies have reported positive effects of resistance exercise on post-
prandial metabolism. Burns et al. (2006) found that a single session of resistance exercise 
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completed the same day prior to a test meal increased postprandial triglyceride concentrations 
linked to the onset of post-exercise muscle damage in healthy males.131. Additionally, Burns et al 
(2005) found that resistance exercise had no effect on postprandial triglyceride concentrations or 
area under the curve (however, participants exercised the afternoon before the trial, thereby 
negating any acute benefits from this type of exercise).132 These inconsistencies require further 
study.  
 
1.5.8 Effects of Resistance Exercise Prescription on Post-prandial Metabolism 
Similar to aerobic exercise, there is evidence to suggest the benefits derived from 
resistance exercise are linked to gender, intensity, volume, type of resistance exercise, and 
previous training status. In 2005, Shannon et al. compared different volumes of resistance 
exercise (1, 3, and 5 sets) on postprandial substrate metabolism following a high fat meal.133 
While no significant effects on post-prandial triglycerides or in insulin or glucose areas under the 
curve were found for any exercise volume in men and women combined,, women demonstrated 
significantly lower postprandial triglycerides than men after exercise suggesting a potential 
effect of gender on postprandial lipid responses to exercise.133 Other studies examining the 
influence of training volume in healthy young men have also found that both high volume and 
low volume resistance exercise reduced postprandial triglyceride areas under the curve, with 
greater improvements coming after high volume vs. low volume prescriptions.134 However, the 
the effects of a single bout of resistance exercise may dissipate over time like aerobic exercise, as 
Correa et al. failed to find differences in post-prandial triglycerides when consuming a meal 16 
hours after the exercise session.135  
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The intensity of resistance exercise has also shown to have an effect on postprandial 
substrate metabolism. Singhal et al. (2009) compared no exercise, moderate intensity resistance 
exercise (50% 8RM), and high intensity resistance exercise (100% 8RM) on postprandial 
triglyceride responses.136 The study found that only high intensity resistance exercise 
significantly reduced fasting and post-prandial triglyceride areas under the curve, and increased 
postprandial fat oxidation for up to 3 hours compared to the no-exercise condition.136 However, 
both moderate and high intensities improved insulin sensitivity.136 In addition to exercise 
prescription, the training status of the participant may also impact post-prandial responses. 
Thyfault et al. (2004) found that individuals with a history of resistance training demonstrated 
lower fat oxidation normalized for lean body mass in response to high carbohydrate and high fat 
meals, but higher carbohydrate oxidation per lean body mass after a high carbohydrate meal.137 
Moreover, the resistance training group demonstrated higher diet-induced thermogenesis and 
reduced postprandial insulin and glucose areas under the curve, indicating differences in meal 
responses based on previous lifting history.137 Finally, even the type of resistance exercise may 
affect exercise responses. Pafili et al. (2009) fond that eccentric leg press exercise reduced 
postprandial triglyceride area under the curve by 12% 16 hours after the training session 
compared to a no-exercise control condition.138 Similar to previous studies, these benefits were 
was shown to disappear by 40 hours after exercise.138 However, differences between concentric 
and eccentric training, machines vs. free weights, or whole body vs. upper or lower body training 
have received little investigative attention. 
 
1.6 Knowledge Gaps in Current Literature 
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In light of the evidence presented above, the following knowledge gaps need to be 
addressed: 
1. Exercise non-responsiveness in Prediabetes 
There is significant evidence to suggest that a large number of individuals with 
prediabetes are do not demonstrate improvements in glucose and lipid metabolism (i.e. non-
responders) following exercise or lifestyle interventions. In the Finnish Diabetes Prevention 
Study, despite significant reductions in fat mass, the number needed to treat was 7 (meaning 7 
individuals needed to be treated in order to prevent the development of type 2 diabetes in one 
participant).139 Further evidence suggests that individuals with both IFG and IGT demonstrate 
blunted responses to exercise interventions, even after high volume or high-intensity exercise 
and weight loss.140 These blunted responses could apply to post-prandial metabolism as well. 
Further research is needed to determine if individuals with prediabetes respond to a single bout 
of exercise. Moreover, additional research is needed to determine the exercise type, timing, and 
prescription that optimizes lipid and glucose metabolism in the post-prandial period – 
particularly with regard to resistance exercise, which has reported conflicting results in previous 
studies.  
2. Influence of resistance exercise on post-prandial glucose metabolism in prediabetes 
Most studies measure the effects of resistance exercise on fasted outcomes, or after an 
oral glucose tolerance test and have reported generally favorable results for glucose and insulin 
areas under the curve, insulin sensitivity, and glucose clearance.141-146 However, investigating the 
effects of resistance exercise on mixed meal (composed of glucose, fat and protein) glucose 
metabolism would more accurately reflect free-living conditions.147 Additionally, the 
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mechanisms of any corrective influence of resistance exercise on post-prandial glucose 
metabolism needs to be identified, including changes in beta cell function, insulin sensitivity, 
hepatic insulin sensitivity, and skeletal muscle glucose oxidation in this population. Skeletal 
muscle is a major source of glucose disposal after exercise, but the fate of post-prandial glucose 
absorbed by muscle (eg. oxidation vs. storage) after resistance training hasn’t been studied 
3. Influence of resistance exercise on post-prandial lipid metabolism in prediabetes 
Resistance exercise is a central component of exercise recommendations for individuals 
with type 2 diabetes and prediabetes, but its effects on post-prandial lipid metabolism are 
unclear. Some studies have reported reduced triglycerides, VLDL triglyceride concentrations and 
mean residence time, improved fatty acid oxidation rates, and increased IMTG turnover in both 
the fasted and post-prandial state in healthy and obese men and women.148-153 However, other 
studies reported no benefit of resistance exercise in these populations.154,155 The effects of 
resistance exercise on post-prandial lipid metabolism in those with prediabetes hasn’t been 
studied.  Moreover, the potential mechanisms of improved post-prandial lipid handling after 
resistance exercise remain unknown, including changes in exogenous or endogenous lipid 
metabolism, lipid oxidation, lipoprotein turnover and clearance, and FFA kinetics. 
4. Influence of resistance exercise on skeletal muscle oxidative capacity and gene expression 
The mitochondrial oxidative responses (lipid and carbohydrate) to an acute bout of 
resistance exercise have received little investigative attention despite the central role of skeletal 
muscle oxidation in post-prandial substrate clearance. This includes changes in the expression of 
key genes involved in lipid and glucose metabolism and how skeletal muscle substrate oxidation 




1.7. Purposes and Specific Aims 
The primary purposes of this dissertation are to determine the influence of an acute bout of 
resistance exercise on: 1) post-prandial lipid absorption and clearance, 2) post-prandial glucose 
absorption, clearance, and insulin sensitivity, and 3) skeletal muscle mitochondrial oxidative 
capacity, and muscle and adipose tissue gene expression and signaling in obese men with 
prediabetes. This study may help to improve the exercise prescription recommendations for 
individuals with prediabetes, and clarify how resistance exercise may reduce the risk for disease 
progression (to overt type 2 diabetes) and life-threatening complications (eg. CVD). 
 
Specific Aim 1 (Chapter 2). To characterize the effect of acute resistance exercise on basal and 
post-prandial glucose metabolism  
Hypothesis 1a. Resistance exercise will decrease basal glucose production rate due to increased 
hepatic insulin sensitivity 
Hypothesis 1b. Resistance exercise will increase post-prandial glucose disposal rate due to 
increased insulin sensitivity 
 
Specific Aim 2 (Chapter 3):  To characterize the effect of acute resistance exercise on basal and 
post-prandial lipid metabolism compared to rest 
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Hypothesis 2a. Resistance exercise will reduce adipose tissue lipolytic rate during the basal 
period due to increased adipose tissue insulin sensitivity 
Hypothesis 2b. Resistance exercise will increase postprandial total lipid oxidation and meal-
derived TRL-TG clearance rate 
Hypothesis 2c. Resistance exercise will reduce post-prandial TRL-TG, chylomicron TG, and 
VLDL-TG concentration 
 
Specific Aim 3 (Chapter 4). To characterize the effect of acute resistance exercise on skeletal 
muscle mitochondrial respiration, and skeletal muscle and subcutaneous adipose tissue gene 
expression  
Hypothesis 3a. Resistance exercise will increase skeletal muscle mitochondrial lipid- and 
carbohydrate-supported oxidation  
Hypothesis 3b. Resistance exercise will increase skeletal muscle PGC-1alpha mRNA content, as 
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Chapter 2: Acute Effects of Resistance 
Exercise on Postprandial Glucose 



















Prediabetes is a metabolic condition defined by elevated fasting (impaired fasting glucose 
(IFG)) and/or postprandial (impaired glucose tolerance (IGT)) glucose.1 Prediabetes affects 
nearly 86 million adults in the United States, with most (up to 70%) progressing to type 2 
diabetes within as little as one year.2 While evidence suggests that type 2 diabetes can be 
reversed, most cases of remission involve invasive treatment strategies, including bariatric 
surgery to promote weight loss, or extreme lifestyle changes (eg. severe caloric restriction) that 
have poor long-term adherence.3,4 Therefore, preventing the progression of prediabetes to type 2 
diabetes would have profound  health implications globally.  
Previous studies have shown that lifestyle interventions combining diet and exercise can 
reverse prediabetes and restore normoglycemia. In 2002, the Diabetes Prevention Program 
Research Study demonstrated that lifestyle interventions aiming for 7% weight loss and 150 
minutes per week of physical activity reduced the incidence of type 2 diabetes by 58% and was 
significantly more effective than treatment with metformin alone in individuals with prediabetes. 
5 Likewise, the Finnish Diabetes Prevention Study found that a lifestyle intervention focusing on 
weight loss, reducing total fat intake, and physical activity reduced the incidence of type 2 
diabetes by 58% in obese men and women with impaired glucose tolerance.6 In light of these 
large-scale studies, the American Diabetes Association currently recommends individuals with 
prediabetes improve their diet and increase their physical activity levels (150 min/week of 
physical activity) to prevent or delay the onset of type 2 diabetes.7 However, recommendations 
regarding the use of resistance exercise for the prevention of prediabetes and type 2 diabetes are 
weakly supported (evidence grade B or C) and understudied.7 
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Several studies have demonstrated that resistance exercise improves post-prandial 
glucose metabolism in healthy individuals and in those with type 2 diabetes, but most of these 
studies simply assessed changes in glucose concentration, providing little insight into the 
mechanisms of these improvements.14-19 Investigating the effects of resistance exercise on mixed 
meal glucose metabolism more accurately reflects free-living conditions as most meals consist of 
a mixture of carbohydrates and lipid.20 Additionally, since most of the day is spent in the 
postprandial state after consumption of mixed meals, changes in postprandial glucose 
metabolism after a mixed meal might be expected to best elucidate the benefits of resistance 
exercise for glucose control and disease progression.21 Indeed, recent evidence suggests that 
postprandial hyperglycemia is a major, independent risk factor for cardiovascular disease (CVD) 
and other comorbidities associated with prediabetes, including hypertension, BMI, intraocular 
pressure, progression to type 2 diabetes, and all cause mortality.22,23  
Despite the strong connection between postprandial hyperglycemia and disease severity, 
no studies have evaluated the influence of pre-meal resistance exercise on postprandial glucose 
metabolism after consumption of a mixed meal in individuals with prediabetes. Moreover, the 
mechanisms for the potential effects of resistance exercise on postprandial glucose metabolism 
including beta cell function, insulin sensitivity, hepatic insulin sensitivity, and skeletal muscle 
glucose oxidation in individuals with prediabetes, are not known .24 Therefore, the purpose of 
this study was to determine the effects of a single bout of resistance exercise on postprandial 






Participants were recruited from the Washington University School of Medicine Diabetes 
Clinic, Washington University’s Volunteers for Health, the Center for Community Based 
Research, and from the surrounding St. Louis Community. Participants were included if they 
were male, aged 30-65 years with, a BMI of 28-45 kg/m2, and diagnosis of prediabetes (HbA1c 
>5.7 but <6.5%, or fasting plasma glucose >100 mg/dl, or 2-hour OGTT >140 mg/dL but <200 
mg/dL).  
Participants were excluded for having diagnosis of type 2 diabetes, use of insulin, 
participation in regular exercise (≥ 2x/week) within the previous 6 months; criteria meeting Class 
C or Class D of the American Heart Association Risk Stratification; history or evidence of 
serious pulmonary or cardiovascular disease including acute coronary syndrome, heart failure 
requiring medications, or New York Heart Association class III heart failure (patients with 
marked limitation of activity and who are comfortable only at rest) or IV heart failure (patients 
who should be at complete rest, confined to bed or chair and who have discomfort with any 
physical activity); coagulation disorders (platelets <100,000, PT >2 seconds above control or 
INR >1.5); anemia (hemoglobin <10.0 g/dL); any orthopedic, neurologic, metabolic or other 
medical condition that would prohibit the ability to perform resistance exercise; or joint 
replacement within the last year. Each participant read and signed an IRB-approved protocol and 
informed consent that was approved by the Human Research Protection Office at Washington 





This study utilized a randomized crossover design to assess changes in postprandial glucose 
metabolism after a single bout of resistance exercise versus an equivalent period of rest. 
Participants who qualified for the study were then randomly assigned to one of two treatment 
orders: a rest visit followed by an exercise visit, or an exercise visit followed by a rest visit. In 
both groups, participants completed the rest and exercise visits on separate days >1 week apart.  
 
Screening Visit: Participants were screened prior to enrollment to confirm diagnosis of 
prediabetes and absence of exclusion criteria. After an overnight fast, participants reported to the 
Washington University Clinical Research Unit (CRU) where their height, weight, BMI, and body 
composition were measured (using dual x-ray absorptiometry, DXA) and a medical history and 
physical were performed by the study physician. An intravenous (IV) catheter was inserted into 
the antecubital vein to collect fasting blood samples, which were analyzed for plasma glucose, 




Following admission, each participant received whole-body dual energy X-ray absorptiometry 
(DXA) scans (Hologic Discovery GDR 1000/W, software version 12.6.2 OD; Waltham, MA) to 
assess regional and composite lean and fat mass in grams. Image analysis and sub-region (thigh, 
leg, trunk, upper extremities) composition quantification were performed following the 




Oral Glucose Tolerance Test (OGTT) 
Following the collection of fasting blood samples a two-hour, 75-gram OGTT was performed 
after a 12-hour overnight fast. All OGTTs were started between 7am and 9am. Plasma glucose 
was measured by the glucose oxidase method (YSI Stat Plus, Yellow Springs, OH) and insulin 
by double antibody radioimmunoassay. 
 
Strength Testing 
One repetition maximum (1RM) assessments were performed at the end of the screening visit on 
a Hoist single pod machine (San Diego, CA, USA) according to guidelines established by the 
American College of Sports Medicine.25 The maximum weight lifted through the full range of 
motion with proper form was recorded for the leg press, bench press, biceps curl, seated row, 
pull down, knee extension, and shoulder press. 
 
Accelerometry 
Daily physical activity over one-week was determined using a ActiGraph GT3X+ accelerometer 
(ActiGraph LLC, Pensacola, FL). The GTX3+ was placed on the non-dominant at the end of the 
screening visit wrist with Actigraph non-removable wristband. The wristbands were cut off by 
the study team when they returned for their rest or exercise visit to ensure the accelerometers 
were worn for the entire data collection period. ActiGraph data was collected for seven 
consecutive days at 30 Hz. The accelerometer output was sampled by a 12-bit analog-to-digital 
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converter. The percentage of time spent sedentary as well as the amount of time spent 
participating in different categories of physical activity including light, lifestyle, moderate, and 
vigorous were calculated using algorithms from Freedson in the ActiGraph software.26 
 
Rest Visit: The day prior to the rest visit, subjects consumed a standardized breakfast (522 Kcal), 
lunch (722 Kcal, snack 180 Kcal), and dinner (779 Kcal) provided by the Washington University 
Institute of Clinical and Translational Sciences Bionutrition Service.  Participants also consumed 
a liquid formula (Ensure; Ross Laboratories, Columbus, OH) containing 250 kcal (40 g 
carbohydrates, 6.1 g fat, and 8.8 g protein) to ensure complete filling of hepatic glycogen stores 
as a snack before bedtime. Participants then fasted overnight (10hrs) with nothing taken by 
mouth except water and reported to  the CRU at 0730 the following morning.. After admission, 
height and weight were measured using a standard scale and stadiometer, and an IV catheter was 
inserted into the antecubital vein to collect baseline fasting blood samples. Fasting blood samples 
were collected in heparinized tubes for glucose, insulin, c-peptide, citrate-lined tubes for PT-
INR, and EDTA lined tubes for lipid kinetics analysis.  
 Following collection of baseline blood samples, participants rested quietly in the semi-
recumbent position for 1 hour. At the end of the rest period, a second catheter was inserted into a 
hand vein on the contralateral arm, with the hand warmed to 55°C using a thermostatically 
controlled hot box to obtain arterialized blood samples. Thirty minutes after the rest period, a 
primed, constant infusion of [6,6-2H2]glucose (28 μmol/kg prime and 0.28 μmol•kg-1•min-1 
continuous infusion, Cambridge Isotopes, Tewksbury, MA), was administered for 180 minutes to 
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achieve isotopic steady state. Blood samples were collected at -10, 140, 160, and 180 minutes 
from the start of the tracer infusion to quantify basal (i.e. fasting) glucose metabolism kinetics.  
 Following the 180-minute baseline period, participants consumed a liquid study meal 
consisting of 20 Kcal/FFM, with a composition of 47.8% CHO, 36.1% fat, and 16.1% protein. 
To ensure individuals meal consistency for both visits, one large mixture was prepared and then 
split in half (each half consumed during the rest and exercise visit). Participants were asked to 
consume the liquid meal within 16 minutes (1/4 of the meal provided every 4 minutes). The sides 
of the liquid meal container were rinsed with 10 ml of water and the rinse was also consumed to 
ensure participants ingested the entire meal. Blood samples were collected at 0, 15, 30, 45, 60, 
90, 120, 150, 180, 240, 300, and 360 minutes post-meal ingestion. Isolated plasma was analyzed 
for glucose and insulin concentration, as well as glucose tracer enrichment. Samples of the liquid 
test meal, as well as the tracers used, were collected for enrichment analysis. The infusion of 
[6,6-2H2]glucose was continued throughout the postprandial period. An overview of the study 
protocol is provided in Figure 1. The [6,6-2H2]glucose was purchased from Cambridge Isotopes 
(Tewksbury, MA). 
 
Exercise Visit: The exercise visit was identical to the rest visit except participants performed ~1 
hour of moderate intensity resistance exercise rather than rest. The exercise session consisted of 
8 lifts (bench press, pull down, seated row, biceps curl, knee extension, leg press, and overhead 
press) performed for 3 sets of 8-12 reps at 80% of their measured 1RM until volitional fatigue. 
Participants were given no more than 1 minute of rest between sets, and no more than 3 minutes 





Whole body carbohydrate oxidation was measured using indirect calorimetry (Parvo 
Medics, Sandy, UT) and the ventilated hood technique prior to, and throughout, the postprandial 
period. VO2, and VCO2 were measured continuously for 15 minutes for the determination of 
resting energy expenditure, respiratory exchange ratio and carbohydrate oxidation while the 
participant laid quietly in bed. Measurements were taken at baseline (prior to exercise/rest 
period, 120 minutes after the start of the exercise/rest period, and then at 30, 60, 150, 210, 270, 
and 330 min after consuming the liquid test meal. Total carbohydrate oxidation rate 
(grams/minute) was calculated as previously described.27  
 
Muscle Biopsies 
Muscle biopsy samples (~200 mg) were obtained from the vastus lateralis under local 
anesthesia (lidocaine, 2%) 90-minutes after consuming the liquid test meal usingTilley-Henkel 
forceps. One sample was immediately transferred into ice-cold relaxing medium (BIOPS) 
containing 10 mmol/l Ca2+/EGTA buffer, 20 mmol/l imidazole, 50 mmol/l K+-4-
morpholinoethanesulfonic acid (Mes), 0.5 mmol/l dithiothreitol, 6.56 mmol/l MgCl2, 5.77 
mmol/l ATP; 15 mmol/l phosphocreatine at pH 7.1 for mitochondrial respirometry analysis. A 
second samples was flash frozen in liquid nitrogen and stored at -80 C until further analysis. 
 
Mitochondrial Respiration 
Subsamples of 5 mg wet weight (Ww) were transferred into BIOPS onto a small petri dish 
on an ice-cold metal plate and separated using forceps with sharp tips. To ensure complete 
permeabilization the fibers were incubated by gentle agitation at 4°C in BIOPS solution 
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containing 50 μg/ml saponin for 20 min. Fibers were washed for 15 min at 4°C in ice-cold 
mitochondrial respiration medium [MiR06; 0.5 mM EGTA, 3 mM MgCl2, 60 mM K-
lactobionate, 20 mM taurine, 10 mM KH2PO4, 20 mM HEPES, 110 mM sucrose and 1 g/l BSA 
essentially fatty acid free, adjusted to pH 7.1, 2,800 units/mg solid catalase lypophilized 
powder], and wet weight of the fibers was measured on a microbalance (Mettler Toledo, 
Greifensee, Switzerland). With this method, the cholesterol-rich plasma membrane is selectively 
permeabilized, leaving intracellular membrane structures, such as mitochondria intact, and the 
entire mitochondrial population can be studied in the muscle sample. 
Three milligrams (3 mg) wet weight was used per respirometer chamber (Oxygraph-2k; 
Oroboros Instruments, Innsbruck, Austria) containing 2.090 ml MiR06 at 37°C. Oxygen 
concentration (μM = nmol/ml) and oxygen flux (pmol·s−1·mg−1; negative time derivative of 
oxygen concentration, divided by muscle mass per volume) were recorded using DatLab 
software (Oroboros Instruments). The Oxygraph-2k is a two-chamber titration-injection 
respirometer with a limit of detection of volume-specific oxygen flux of 1 pmol·s−1·ml−1. 
Instrumental background oxygen flux was corrected online, accounting for sensor oxygen 
consumption and oxygen diffusion between the medium and the chamber boundaries. The 
oxygen concentration in the chamber was maintained between 150 and 400 μM to avoid oxygen 
limitation of fiber respiration. Intermittent re-oxygenations were achieved by injecting 0.5 mL 
oxygen. 
In the substrate-uncoupler-inhibitor titration protocol the following substrates were added 
(final concentrations): palmitoylcarnitine (0.05 mM), L-carnitine (5 mM), and malate (0.5 mM) 
to support electron entry from fatty acid β-oxidation through electron-transferring flavoprotein 
(ETF) and Complex I (CI) to coenzyme Q. Prior to the addition of ADP, oxygen utilization 
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occurs due to proton slip across the inner mitochondrial membrane (LEAK respiration). ADP (4 
mM) was then added to stimulate fatty-acid supported oxidative phosphorylation (ETF + CI)Lip. 
The subsequent addition of pyruvate (10 mM) stimulates glycolytic oxidative phosphorylation. 
Glutamate (10 mM) was then added, followed by succinate (10 mM) to recapitulate the TCA 
cycle and stimulate maximal oxidative phosphorylation [(ETF + CI + CII)Lip + Pyr] through both 
ETC complex I and complex II. Cytochrome c (10 μM) is added to test the integrity of the outer 
mitochondrial membrane. The increase of flux with cytochrome c was on average 3.3 ± 0.4%. 
Electron transfer system capacity (CI+IIE) was reached by stepwise (.5 μM) addition of the 
uncoupler carbonylcyanide p-trifluoromethoxyphenylhydrazone (FCCP). Finally, the addition of 
rotenone (0.5 μM), an inhibitor of complex I was used measure succinate-supported ETS 
capacity (CIIE). A measure of pyruvate-supported respiration was determined as maximal 
oxidative phosphorylation [(ETF + CI + CII)Lip + Pyr] - lipid supported oxidative phosphorylation 
(ETF + CI)Lip.   
 
Sample Analyses 
Blood for plasma hormone and metabolite analysis was collected from an antecubital 
vein, immediately placed in chilled EDTA tubes, centrifuged at 2000xg for 10 minutes, and the 
supernatant collected and frozen at -80°C until analysis. Fasting samples were analyzed were 
used for comprehensive metabolic panel, lipid panel, CBC, and HbA1c by the Washington 
University Core Lab for Clinical Studies. Plasma glucose was measured using an automated 
glucose analyzer (Yellow Spring Instruments, Yellow Springs, OH). Plasma insulin 





The tracer-to-tracee ratio (TTRs) for plasma [2H2]glucose was quantified using capillary GC-
MS (Agilent 6890N gas chromatograph and Agilent 5973N mass selective detector; Agilent, 
Palo Alto, CA), as previously described.28 For [2H2]glucose enrichment quantification, plasma 
proteins were precipitated with cold acetone, lipids were extracted into hexane, and the aqueous 
phase was dried (Labconco, Kansas City, MO). The heptafluorobutyric derivative of glucose was 
formed, and [2H2]glucose enrichment was quantified using GC-electron ionization-MS and 
selective ion monitoring (mass/charge ratio [m/z] 519 and 521). 
From the plasma glucose and insulin values on the OGTT, an index of insulin resistance (IR), 
beta cell function (HOMA-%B), and insulin sensitivity (HOMA-%S) were calculated using the 
Homeostatic model assessment (HOMA) 2 using the HOMA2 calculator.29 
During the last 300 minutes of the baseline period (160-, 170-, and 180-min), a physiological 
and isotopic state was reached, and therefore Steele’s equation for steady state was used to 
calculate glucose flux (rate of appearance [Ra] and rate of disappearance [Rd]. Ra was calculated 
by dividing the [6,6-2H2]glucose infusion rate (umol/min) by the plasma tracer enrichment 
(TTR6,6, mean of all three measurements). Glucose Rd was calculated as glucose Ra + [6,6-
2H2]glucose infusion rate. Ra and Rd were normalized per kg of fat-free mass (FFM) from DXA. 
The hepatic insulin resistance index (HIRI) was calculated as the product of basal glucose Ra 
and plasma insulin.30 
After mixed meal ingestion, the total glucose rate of appearance (RaTOT) was calculated from 
TTR6,6 using Steele’s equation:  
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where IR is the 6,6-[2H2]glucose infusion rate, C is the plasma glucose concentration, and V is 
the volume of distribution of glucose (55 ml/kg, fixed).31 Before applying Steele’s equation, 
plasma TTR6,6 data were smoothed using a spline fitting approach to stabilize the calculation of 
the derivative of enrichment. Total Ra represents the splanchnic Ra of glucose from ingested 
glucose, the liver and potentially some glycogenolysis and gluconeogenesis from the kidneys. 
Rate of disappearance (Rd) was calculated as:  
Rd 𝑡 =   𝑅𝑎!"! 𝑡 −   
𝑑𝐶 𝑡
𝑑𝑡 ∗ 𝑉 
Both Ra and Rd were normalized to kg FFM from DXA.31 The glucose metabolic clearance rate 
(MCR) was estimated as the Rd during the meal divided by the average plasma glucose. A 
measure of peripheral insulin resistance was then calculated by dividing the MCR by average 
plasma insulin as described by Gastaldelli et al. (2007).31 Rd(t) was also divided by plasma 
insulin at each point during the postprandial period to track changes in insulin sensitivity over 
time. The total area under the curve was also calculated for total Ra and total Rd using the 
trapezoid rule.  
 Areas under the curve, and incremental area under the curve for plasma glucose and 
insulin were calculated using the trapezoid rule. Oral insulin sensitivity was estimated using the 
oral glucose insulin sensitivity (OGIS) index from 3-h glucose and insulin values using methods 
described by Mari et al. (2001) accounting for the meal glucose load (90.3 grams).32 Postprandial 
glucose-stimulated insulin secretion (insulinogenic index, IGI) was calculated from the ratio of 
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total insulin secretion during the 6-hour postprandial period (AUC Insulin0-360), by the total 
plasma glucose load during the postprandial period (AUC Glucose0-360). Glucose tolerance was 
calculated according to the method proposed by Sluiter et al. (1976) as: 
GT =   
10!
(𝐺𝑝)! ∗ (𝐺𝑝 − 70) 
where Gp is the peak plasma glucose during the postprandial period.33 Finally, the oral 
disposition index was calculated as AUCins/glu from 0 to 120 min*Matsuda ISI as described by 
Bi et al. (2012).34  
 
Statistical Analysis 
Participant demographics were analyzed using mean ± SEM. Data were analyzed for 
normality using the Shapiro-Wilk test. Differences between rest and exercise conditions on 
measures of plasma glucose concentration, insulin concentration, insulin sensitivity, and glucose 
kinetics were assessed using a 2x2 mixed, repeated measures ANOVA with treatment (rest or 
exercise) and time (time the sample was collected in the study) entered as repeated measures, and 
order (rest>exercise or exercise>rest) as a between subjects factor to rule out confounding by 
carryover effects (to determine if the washout period between the rest and exercise visits was 
sufficient). The assumption of sphericity was assessed using Mauchly’s test. Huyn-feldt adjusted 
F values were used in cases of the violation of the assumption of sphericity. Significant 
interactions between treatment and time were further analyzed using paired t-tests. The 
Benjamini–Hochberg procedure was used to control for multiple comparisons. The two-way 
interaction between time and order, treatment and order, and the three-way interaction between 
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treatment, time, and order were tested identify the presence of a carry-over effect. Areas under 
the curve between conditions were analyzed according to the procedures outlined by Wellek and 
Blettner (2012) for crossover designs, testing first for carry-over effects, followed by testing for 
treatment effects.35 An alpha level p= 0.05 was used for significance.  
 
Sample Size 
Breen et al. (2011) reported an effect size of 2 for an increase in the rate glucose 
disappearance after a single session of resistance exercise in healthy men.36 Therefore, a 
conservative effect size of 1.5 was expected due to the potential blunted responses to resistance 
exercise in men with prediabetes. Therefore, our anticipated samples size was seven to achieve 
90% power to detect differences on a paired t-test for glucose disposal (at a two-tailed alpha 




Nine male (n=9) participants were enrolled in the study. Participants were middle-aged, 
obese, and sedentary. All participants were prediabetic, with the group means for HbA1c, 2-hour 
plasma glucose of the OGTT, and fasting plasma glucose all within the prediabetic range (Table 
1). Four (n=4) participants had HbA1c values > 5.7%, n=6 had fasting plasma glucose values 
>100 mg/dL (5.5 mmol/L), and n=4 participants had 2-hour OGTT values >140 mg/dL (7.8 
mmol/L). The average % body fat was in the 75th percentile for individuals in their age group as 
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established by the NHANES.36 Participants also demonstrated insulin resistance according to the 
HOMA2 model (HOMA2-IR, HOMA2-%S), with compensatory increases in beta cell function 
(HOMA2-%B). Participants also presented with  elevated total triglycerides (>150 mg/dL), LDL 
>100 mg/dL), and slightly lower HDL (<40 mg/dL,) (all Table 1).  
 
Plasma Glucose Concentration 
Plasma glucose concentrations were significantly elevated immediately after resistance 
exercise (-10 min in Fig. 1, p=0.008) and at 170 minutes (p=0.016), but significantly lower at 
270 minutes (p=0.034), and 330 minutes (p=0.049) compared to the rest condition (Figure 2). 
There were no interactions between treatment and order (p=.379), time and order (p=.540), or 
treatment, time and order (p=.945) indicating absence of a carry-over effect between treatments. 
Plasma glucose concentrations returned to baseline after the 3-hour basal period after the 
exercise/rest session prior to meal consumption (Figure 2). The postprandial glucose area under 
the curve (AUC), and integrated AUC (iAUC), were both significantly lower following 
resistance exercise compared to rest (p=0.046, p=0.021 respectively).  No carry-over effect was 
found for either AUC analysis (total AUC: p=.356, iAUC: p=0.136). 
 
Plasma Insulin Concentration 
There was a main effect of time (p<0.001) and a main effect of treatment (F (1,7)=6.065, 
p=0.045), but no interaction between treatment and time for plasma insulin concentration (Figure 
2). There were no significant interactions between order and time (p=0.948), order and treatment 
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(p=0.170), or order treatment, and time (p=0.145) indicating the absence of a carry-over effect 
for plasma insulin concentration. The postprandial insulin AUC and iAUC was significantly 
lower after resistance exercise (p=0.037 and p=0.046 respectively) (Figure 2). There were no 
carry-over effects identified for total AUC or iAUC (p=0.226, p=0.213 respectivley).  
 
Insulin Sensitivity and Beta Cell Function 
Oral glucose insulin sensitivity (OGIS) tended to increase following resistance exercise 
(Rest: 280.7 ± 10 ml•min-1m-2, Exercise: 307.6 ± 18 ml•min-1m-2, p=0.071), without evidence for 
a carry-over effect (p=0.506). Total glucose-stimulated insulin secretion (Insulinogenic Index) 
tended decline after resistance exercise versus rest (Rest: 13.4 ± 1.2 umol/uU, Exercise: 11.4 ± 
1.4 umol/uU, t(8)=-2.14, p=0.063), with no carry-over effect (t(8)=-.709, p=0.498). Glucose 
tolerance was significantly greater after the resistance exercise session compared to rest (Rest:  
arbitrary units.49 ± .16 arbitrary units, Exercise: 65 ± .20, t(8)= -2.509, p=.036) without a carry-
over effect (t(8)=-.618, p=0.553).  Finally, the Oral Disposition Index was not different after the 
resistance exercise session (Rest: 7.18 ± 2.26, Exercise: 5.75 ± 1.86, t(8)=.685, p=.512) 
compared to rest, and no cross-over effect was found (t(8)=-.802, p=0.445). 
 
Glucose Kinetics 
Glucose rate of appearance (Ra) was significantly higher after the resistance exercise 
session measured at the end of the basal/recovery period, as was the rate of disappearance (Rd) 
compared to rest (steady state, Figure 3). In the post-prandial period, glucose Rd normalized to 
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plasma insulin tended to be higher at the end of the basal period (measured from time points 160-
180 min), suggesting a trend toward improved insulin sensitivity after the exercise session before 
the meal (Rest: 1.05 ± .15 umol/kg FFM/min/uU/ml, Exercise: 1.41 ± .26 umol/kg 
FFM/min/uU/ml, t(8)=1.96, p=0.085). Additionally, there was a significant main effect of 
treatment for glucose Rd normalized for plasma insulin concentration (F (1,8)=19.172, p=0.002), 
suggesting a greater rate of glucose clearance per unit of insulin during the overall postprandial 
period. There were no crossover interactions in the Rd/insulin analysis (see Figure 3). After the 
resistance exercise session, there were no effects of treatment on total glucose Ra or Rd, or the 
Ra and Rd AUC (no interaction between treatment and time, or main effects of treatment, all 
p>.05). The glucose metabolic clearance rate (p=.035) was significantly elevated, as was 
peripheral insulin sensitivity (p=.008)  after training (Table 2).  
 
Carbohydrate Oxidation Rate 
There was a significant interaction between treatment and time for the respiratory 
exchange ratio (RER) (F (7, 56)=2.746, p=.016). Main effects analysis indicated the RER was 
significantly reduced after resistance exercise at time point 140 min (p=.029), indicating a 
reduction in carbohydrate oxidation (possibly due to increased glycogen replenishment) with a 
trend toward elevated RER at time point 390 minutes (p=.091). There was only a main effect of 
time (F(1,7)=5.378) for carbohydrate oxidation rate (grams/min), but no interaction between 
treatment and time (F(8,49)=1.457, p=.205, Figure 4). However, total post-prandial carbohydrate 
oxidation iAUC was significantly elevated in the postprandial period after resistance exercise 
compared to rest with no evidence of a carry-over effect (t(8)=.801, p=.446). Concurrent with the 
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improvements in postprandial carbohydrate oxidation, skeletal muscle mitochondrial respiration 
analysis indicated a significant increase in pyruvate-supported respiration (t(7)=2.799, p=.012), 
as well as maximal oxidative phosphorylation capacity (t(7)=13.48, p<.001) following resistance 
exercise compared to rest. No carry-over effects were found for either outcome. 
 
Discussion 
The effects of an acute bout of resistance exercise on postprandial glucose metabolism in 
individuals with prediabetes are poorly understood.16,17 Previous studies have reported that post-
meal resistance exercise in individuals with prediabetes/type 2 diabetes reduces postprandial 
glucose excursions.15,37 To our knowledge, only one study has evaluated the effect of pre-meal 
resistance exercise on post-prandial glucose metabolsim, which effectively reduced postprandial 
glucose and insulin iAUC in individuals with type 2 diabetes.15 We have confirmed these 
previous studies but expanded on them to demonstrate, for the first time, that a single bout of 
resistance exercise performed 4.5 hours before a mixed meal reduces postprandial glycemia and 
insulin concentrations, and that these changes were associated with improvements in peripheral 
insulin sensitivity, glucose clearance rates, and whole-body and skeletal muscle mitochondrial 
carbohydrate oxidation in obese men with prediabetes. Furthermore, we found that a single 
resistance exercise bout had no effect on beta cell function or Disposition Index in men with 
prediabetes, which suggests repeated bouts of exercise (ie. training) may be required to elicit 
positive adaptations in beta cell function in these individuals.  
 Previous studies have found that the contribution of postprandial glycemia to plasma 
HbA1c increases as the degree of glycemic control increases.38,39 Therefore, in individuals with 
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prediabetes who have only marginally impaired glycemic control, reducing the degree of 
postprandial glycemia could be an integral component of their treatment. In individuals with 
obesity and type 2 diabetes, chronic resistance exercise training has been shown to improve 
postprandial glycemia following an OGTT.14-19 Our results extend these findings to men with 
prediabetes after consumption of a mixed meal, which more closely approximates free-living 
conditions. In our study, postprandial glucose concentrations were significantly lower following 
acute resistance exercise by 90 minutes after meal consumption – a reduction that persisted to 
150 minutes post-meal. In fact, plasma glucose was, on average, lower throughout the 6-hour 
postprandial period after resistance exercise compared to rest. This is reflected by the reduction 
in the total and integrated area under the postprandial glucose concentration curve; a finding 
consistent with those from Andersen et al. (2007) and Lopez et al. (2014).40,41 
Plasma glucose concentration did however, spike immediately following resistance 
exercise (at -10 min) significantly relative to the rest condition. Previous studies have found that 
high intensity aerobic exercise increases glucose production 7-8 fold, while glucose clearance 
only increased 3-4-fold, thereby resulting in a transient increase in plasma glucose.42 This rise in 
plasma glucose we found this this study could be caused by a transient increase in hepatic insulin 
resistance (in combination with the influence of a number of other hormones (e.g. cortisol, 
growth hormone)), hepatic glucagon sensitivity, or increased gluconeogenesis in response to 
increased availability of substrate (lactate, free fatty acids), to provide glucose to the recovering 
muscle for glycogen replenishment and energy.42 In support of this notion, we found that hepatic 
insulin resistance tended to increase following resistance exercise when measured at the end of 
the basal period, and that this corresponded with a significant increase in endogenous glucose 
production (Figure 3).  The increase in plasma glucose following acute resistance exercise is 
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typically matched by a similar spike in plasma insulin to restore normoglycemia and promote 
insulin uptake.42 While not significantly different than baseline, we did identify a spike in insulin 
after the resistance exercise session at the same time as the spike in plasma glucose. 
Additionally, plasma glucose concentrations typically return to baseline within 1-2 hours of 
resistance exercise cessation.15 In our study, although plasma glucose and insulin concentrations 
returned to baseline by the end of the basal period, the total glucose rate of appearance remained 
significantly elevated over 3 hours after exercise. The return of plasma glucose to baseline 
appeared to be due to a concomitant, significant increase in plasma glucose rate of 
disappearance, and a trend toward increased insulin sensitivity (rate of disappearance per unit of 
insulin) that occurred post-exercise. 
  In contrast to the basal period, postprandial total glucose Ra and Rd were not 
significantly different compared to rest. However, when the rate of glucose disappearance was 
normalized to the plasma glucose concentration (i.e. the metabolic clearance rate), postprandial 
glucose clearance was significantly elevated after resistance exercise compared to rest. In 
addition, peripheral insulin sensitivity (expressed as both the metabolic clearance rate per unit of 
plasma insulin, and as the Rd normalized to plasma insulin) was increased following resistance 
exercise compared to rest. Therefore, improvements in postprandial plasma glucose following 
acute resistance exercise are most likely related to increases in glucose clearance rather than 
reductions in glucose appearance (the combination of glucose absorption and endogenous 
glucose production). Additional studies examining the effect of resistance exercise on 
endogenous versus exogenous glucose kinetics during the postprandial period following 
resistance exercise are needed to confirm this. Modulating postprandial glucose metabolism 
appears important in individuals with type 2 diabetes as postprandial suppression of endogenous 
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glucose production is delayed.43,44 Also, the rate of glucose clearance in those with type 2 
diabetes is impaired, suggesting that interventions designed to suppress endogenous glucose 
production and improve glucose clearance (such as resistance exercise) could be highly effective 
in preventing the progression of prediabetes to overt type 2 diabetes.  
 Concurrent with declines in postprandial glucose concentrations, postprandial insulin 
concentrations were reduced after acute resistance exercise (main effect of treatment and reduced 
AUC and iAUC). Reductions in plasma insulin following resistance exercise suggest improved 
skeletal muscle insulin sensitivity or increases in GLUT4 (a known response to resistance 
exercise in skeletal muscle).45,46  This could also be driven by the reduction in plasma glucose (ie. 
less insulin needed), or changes in beta cell insulin secretion. Importantly, we only found a trend 
toward a reduction in the insulinogenic index after resistance exercise, with no change observed 
in the disposition index, indicating a decline in peripheral insulin resistance. Consistent with this 
finding, Heden et al (2013) found that one hour of treadmill walking (55-60% VO2peak) 
significantly reduced the postprandial insulinogenic index in obese subjects compared to no-
exercise obese controls.15 Moreover, insulin secretion rates were shown to be lower than non-
obese controls following a single session of moderate-intensity aerobic exercise.47 Slentz et al. 
(2009) found that after vigorous, high-intensity aerobic exercise (65-80% VO2peak) the insulin 
sensitivity index increased, with compensatory declines in the acute insulin response to 
intravenous glucose in sedentary, overweight adults.48 The mechanisms for the decline in insulin 
secretion after aerobic and resistance exercise are poorly understood, but could be related to 
declines in circulating free fatty acids or amino acids, declines in insulinotropic hormones such 
as GIP or GLP-1, or changes in adrenergic activation.49 Future studies are needed to elucidate the 
effects of resistance exercise on beta cell function. 
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The Disposition Index is a ratio of insulin secretion to insulin resistance and has been 
shown to be a significant predictor of the development of type 2 diabetes. Lorenzo et al. (2010) 
found that a one standard deviation increase in the Disposition Index reduced the odds of 
developing type 2 diabetes by 32% in 1,625 prediabetic individuals in the Insulin Resistance 
Atherosclerosis study.50 Heden et al. demonstrated that a single bout of moderate intensity 
aerobic exercise improved the Disposition Index by increasing insulin sensitivity without 
reducing glucose-stimulated insulin secretion.47 We found the a single bout of resistance exercise 
did not significantly affect Disposition Index in obese, prediabetic men. Additional studies are 
needed to determine if resistance exercise can improve the disposition index by modifying the 
prescription parameters (eg. intensity, time, free-weights vs. machines). Individuals with 
prediabetes may be more resistant to exercise adaptations than the healthy population studied by 
Heden et al.47 If so, a single bout of resistance exercise may not be enough to improve beta cell 
function in prediabetes – repeated bouts might be necessary (ie. training).  
After the meal, the RER and total carbohydrate oxidation rate increased in both the rest 
and exercise conditions, but to an even greater extent after resistance exercise (indicated by the 
greater postprandial AUC for carbohydrate oxidation). The signaling mechanisms responsible for 
the transition between lipid and glucose oxidation is not completely understood, but has been 
linked to glucose-induced malonyl-coA production via supression of 5’ AMPK, which normally 
inhibits acetyl-CoA carboxylase and activates  malonyl CoA decarboxylase. Malonyl-CoA has 
been shown to bind to and inhibit CPT-1, thereby reducing fatty acid oxidation.52 This shift in 
substrate oxidation manifests as a rise in the RER and total rate of carbohydrate oxidation. The 
greater increase in carbohydrate oxidation during the postprandial period could be due to 
increased removal of lipid intermediates that interfere with insulin signaling and glycolysis 
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during the recovery period (evidenced by the decline in the RER we identified in our study).53. 
The lipid overload hypothesis posits that excess delivery of fatty acids to mitochondria leads to 
incomplete beta oxidation and the accumulation of lipid intermediates, including acetyl-coA, 
NADH, diacylglycerols, cytosolic citrate, and long-chain acyl carnitine CoA, which negatively 
regulate insulin signaling and glycolytic enzyme activity through Randle Cycle Inhibition.54,55 
Previous studies have reported elevated levels of these toxic intermediates in skeletal muscle of 
individuals with prediabetes, suggesting that the increased clearance of these byproducts in the 
recovery period from exercise could enhance postprandial glucose oxidation.53 
 Coincident with greater postprandial carbohydrate oxidation, using high-resolution 
respirometry of permeabilized muscle fibers collected 90 minutes after meal consumption, we 
found elevated rates of pyruvate-supported mitochondrial respiration and total oxidative 
phosphorylation following resistance exercise compared to rest. While we did not measure 
changes in protein phosphorylation, the enhanced rates of mitochondrial private-supported 
oxidation could be due to changes in glycolytic enzyme function, or other changes in kinase 
activity. This notion is supported by Perry et al. who demonstrated that two hours of cycling 
increased respiratory sensitivity to pyruvate and glutamate, suggesting complex I of the electron 
transport chain may become more sensitive to NADH following exercise.56 Further research is 
needed to determine if mitochondria prefer pyruvate after resistance exercise as opposed to other 
substrates (like free fatty acids), or of the increase in pyruvate oxidation was driven more-so by 





There are several limitations to this study. First, while we used an infused glucose tracer 
to track dilution from meal glucose, we could not distinguish exogenous from endogenous 
glucose production, which would be important to determine changes in hepatic insulin sensitivity 
as opposed to meal glucose rate of appearance. This study only enrolled adult men thus the 
results cannot be generalized to women and children.  Additionally, the study sample size was 
based on anticipated differences in glucose rate of disappearance following resistance exercise 
and not powered to detect differences in other variables. Despite this, we found differences in 
peripheral insulin sensitivity, carbohydrate oxidation, and glucose tolerance following resistance 
exercise.   
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Table 1. Participant Characteristics (N=9) 
Measure Mean (SE) 
Age 50 (11) 
Height (cm) 178 (5.4) 
Weight (kg) 104.5 (9.9) 
BMI (kg/m2) 33 (3) 
WB Fat (kg) 32.7 (2.2) 
WB Lean (kg) 66.3 (1.5) 
% Fat 31.8 (1.4) 
HbA1c (%) 5.7 (.2) 
2-hr OGTT (mmol/L) 9.0 (.5) 
Fasting glucose (mmol/L) 5.9 (.4) 
Fasting Insulin (uU/mL) 22 (2) 
HOMA2-IR 2.6 (.4) 
HOMA2-%B 134.4 (17) 
HOMA2-%S 75.6 (37) 
Triglycerides (mg/dL) 162.7 (7.5) 
Total Cholesterol (mg/dL) 184.5 (11.4) 
HDL (mg/dL) 38.4 (1.7) 
LDL (mg/dL) 117.9 (10.3) 
% Time Sedentary 69 (6.1) 
% Time Light Activity 21 (3.6) 
% Time Moderate Activity 10 (3) 
% Time Vigorous Activity 0 (0) 
Values are presented as mean (standard error). % of time spent in each activity were derived 
from accelerometry data (see methods). WB = whole body. 2-hr OGTT is plasma glucose at 2-
hours after a 75 gram oral glucose challenge. HOMA2 calculated using the HOMA2 calculator 



























(umol/ kg FFM/min) 
-- -- Tx: F(1,8) = .508, p=.496 
Time: F(14,112) = 12.928, p<.001* 




-- -- Tx: F(1,8) = 1.134, p=.318 
Time: F(14,112) = 28.339, p<.001* 
Interaction: F(14,112) =.1.183, p=0.298 
NS 
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Ra = glucose rate of appearance. Rd = glucose rate of disappearance. AUC = area under the 
curve determined using the trapezoid rule. Values are mean (SE). A 2x2 mixed repeated 
measures ANOVA was used to determine main effects of treatment (rest vs. resistance exercise), 
time (time-point in the postprandial period), and the interaction between treatment and time. 
Carry-over effects for total Ra and Rd were determined by assessing for interactions between 
treatment, time, and study order (rest>exercise or exercise>rest). * denotes significance at p<.05. 












































Plasma glucose and insulin concentrations measured throughout the study (mean (SE)). The time 
0 corresponds to the start of the glucose tracer. A. plasma glucose (mmol/L). There was a 
significant interaction between treatment and time (p=.001) with significantly elevated plasma 
glucose at -10 minutes (post-exercise blood draw) and 180 minutes (end of basal/recovery 
period), and significantly lower plasma glucose at 270 and 300 minutes. Postprandial total and 
integrated area under the curve (AUC) were significantly reduced in the resistance exercise 
condition compared to rest (p<.05). B. Plasma insulin concentrations measured throughout the 
study. There was a main effect of treatment on plasma insulin, indicating overall plasma insulin 
levels were reduced in the resistance exercise condition compared to the rest condition. 






Figure 3. Basal Glucose Kinetics and Postprandial Insulin Sensitivity 
 
All values are mean (SE). A. Basal glucose rate of appearance (Ra) measured at the end of the 
basal/recovery period (160-180 min) just prior to eating the standardized mixed meal. B. Hepatic 
insulin resistance index tended to be increased after resistance exercise, but did not reach 
significance. C. Basal glucose rate of disappearance (Rd). D. Postprandial insulin sensitivity 
determined by normalizing plasma glucose Rd (calculated from Steele’s non-steady state 
equations) to plasma insulin. There was a main effect of treatment (p=.002), indicating that 
peripheral insulin sensitivity was significantly elevated after the resistance exercise session 






Figure 4. Carbohydrate oxidation and mitochondrial respiration 
 
All values are presented as mean (SE). A. Total carbohydrate oxidation (grams/min) determined 
using indirect calorimetry. There no differences between the resistance exercise condition and 
rest at any time-points, but the integrated are under the curve in the postprandial period (180-540 
min) was significantly reduced after resistance exercise compared to rest. B. Pyruvate-supported 
mitochondrial respiration was significantly elevated after resistance exercise, as was total 
oxidative phosphorylation (D). Maximal oxidative phosphorylation. * denotes significant 









Chapter 3: Acute Effects of Resistance 
Exercise on Postprandial Lipid Metabolism 

























Prediabetes is an interim state of elevated blood glucose above normal levels, but below 
the levels diagnostic of type 2 diabetes. Prediabetes is highly prevalent in the United States - 
affecting nearly one in three US adults (> 84 million).1 In addition, it’s estimated that <12% of 
those with prediabetes are aware of their condition.1 Considering that prediabetes has been 
shown to increase the risk for life-threatening complications including nephropathy, neuropathy, 
cardiovascular disease (CVD), stroke, and type 2 diabetes, there is an urgent need for treatment 
approaches capable of restoring normoglycemia in these individuals.2,3 
Postprandial glycemia is thought to contribute to up to 70% of daytime. hyperglycemia, 
and is a better predictor of glycemic control than pre-meal glycemia.4,5,6 Moreover, postprandial 
hyperglycemia increases the risk for CVD, elevated blood pressure, increased intraocular 
pressure, obesity, inflammation, and all cause mortality.7-10 However, the postprandial period is 
not solely characterized by elevations in plasma glucose. Plasma triglycerides (in the form of 
chylomicrons and very low density lipoproteins (VLDL)) are elevated after a meal and can 
contribute to CVD risk if the response is exaggerated or prolonged (termed postprandial 
dyslipidemia).11 Large cohort studies have confirmed that postprandial dyslipidemia increases the 
risk for myocardial infarction, ischemic heart disease, cardiac death, and ischemic stroke in both 
men and women independent of fasting triglyceride concentration.11,12  
 In human and rodent studies of prediabetes, hypertriglyceridemia is identified as a major, 
early indicator of disease progression.13,14 Elevations in postprandial triglycerides, VLDL and 
chylomicrons pool sizes (collectively termed triglyceride-rich lipoproteins (TRL-TG)), and 
increased lipoprotein production rates have all been identified in individuals with prediabetes 
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compared to lean, healthy controls.15 An imbalance between lipoprotein production and clearance 
promotes elevated lipemia, which can contribute to ectopic fat accumulation in non-adipose 
tissues (e.g. liver, skeletal muscle) and reduce insulin sensitivity.16,17,18 Individuals with 
prediabetes also have abnormalities in skeletal muscle lipid handling, including deficiencies in 
intramyocellular triglyceride (IMTG) synthesis (an important route of fatty acid clearance), 
prolonged retention of intramyocellular fatty acids, reduced beta oxidation capacity, lipid-
induced oxidative stress, and mitochondrial DNA damage: all contributing to dyslipdemia.19-22 
Resistance exercise is a central component of exercise recommendations for individuals 
with type 2 diabetes and prediabetes, but the effect of resistance exercise on postprandial lipid 
metabolism is not known. There is some evidence in healthy lean and healthy obese men and 
women demonstrating that regular physical activity can improve postprandial lipid metabolism.23 
For example, in healthy, obese men and women, acute resistance exercise reduced triglyceride 
concentration, VLDL triglyceride concentrations and mean residence time, improved fatty acid 
oxidation rate, and increased IMTG turnover in both the fasted and postprandial state24-28; 
however, not all studies found these improvements.29,30 In addition, one study in individuals with 
type 2 diabetes found no effect of pre-meal and a modest effect of post-meal resistance exercise 
on postprandial triglyceride area under the curve.31 Thus, evidence in healthy and diabetic 
populations suggests that resistance exercise might improve postprandial lipid metabolism in 
individuals with prediabetes, however this has not been previously studied. Moreover, the 
potential mechanisms of improved postprandial lipid handling after resistance exercise in those 
with prediabetes (or other populations) remain unknown. Therefore, the overall aim of this study 
was to determine the acute effects of resistance exercise on postprandial lipid metabolism in 
overweight/obese men with prediabetes.  We hypothesized that resistance exercise would reduce 
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the concentration of exogenous lipid to circulating TG pools (chylomicrons, VLDL, FFA), and 




Participants were recruited from the Washington University School of Medicine Diabetes 
Clinic, Washington University’s Volunteers for Health, the Center for Community Based 
Research, and from the surrounding St. Louis Community. Inclusion criteria were: 1) male sex, 
2) age 30-65 years, 3)BMI: 28-45 kg/m2, 4) sedentary (routine exercise ≤ 2x/week within the 
previous 6 months) and 5) diagnosis of prediabetes (HbA1c >5.7 but <6.5%, or fasting plasma 
glucose >100 mg/dl, or 2-hour OGTT >140 mg/dL but <200 mg/dL). Exclusion criteria included: 
1) diagnosis of type 2 diabetes, 2) use of insulin, 3) significant history of CVD, 4) coagulation 
disorder (platelets <100,000, PT >2 seconds above control or INR >1.5), 5) anemia (hemoglobin 
<10.0 g/dL), and 6) any orthopedic (including joint replacement within past year), neurologic or 
metabolic condition that would limit the ability to perform resistance exercise. Each participant 
read and signed an IRB-approved protocol and informed consent that was approved by the 
Human Research Protection Office at Washington University in St. Louis, MO. 
 
Study Protocol 
This study employed a randomized crossover design to assess changes in postprandial 
lipid metabolism after a single bout of resistance exercise versus an equivalent period of rest. 
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Participants who qualified for the study were then randomly assigned to one of two treatment 
orders: a rest visit followed by an exercise visit, or an exercise visit followed by a rest visit. In 
both groups, participants completed the rest and exercise visits on separate days >1 week apart.  
 
Screening Visit: Participants were screened prior to enrollment to confirm diagnosis of 
prediabetes and absence of exclusion criteria. After an overnight fast, participants reported to the 
Washington University Clinical Research Unit (CRU) where their height, weight, BMI, and body 
composition were measured (using dual x-ray absorptiometry, DXA) and a medical history and 
physical were performed by the study physician. An intravenous (IV) catheter was inserted into 
the antecubital vein to collect fasting blood samples, which were analyzed for plasma glucose, 




Each participant received whole-body dual energy X-ray absorptiometry (DXA) scans 
(Hologic Discovery GDR 1000/W, software version 12.6.2 OD; Waltham, MA) to assess 
regional and composite lean and fat mass in grams. Image analysis and sub-region (thigh, leg, 
trunk, upper extremities) composition quantification were performed following the guidelines 
provided by Hologic GDR software. 
 
Oral Glucose Tolerance Test (OGTT) 
 
 93 
A two-hour, 75-gram OGTT was performed after a 12-hour overnight fast. All OGTTs 
were started between 7am and 9am. Plasma glucose was measured by the glucose oxidase 
method (YSI Stat Plus, Yellow Springs, OH) and insulin by double antibody radioimmunoassay. 
 
Strength Testing 
One repetition maximum (1RM) assessments were performed on a Hoist single pod 
machine (San Diego, CA, USA) according to guidelines established by the American College of 
Sports Medicine.35 The maximum weight lifted through the full range of motion with proper 
form was recorded for the leg press, bench press, biceps curl, seated row, pull down, knee 
extension, and shoulder press. 
 
Accelerometry 
Daily physical activity over one-week was determined using a ActiGraph GT3X+ 
accelerometer (ActiGraph LLC, Pensacola, FL). The GTX3+ was placed on the non-dominant 
wrist with Actigraph non-removable wristbands following the OGTT. The wristbands were cut 
off by the study team when they returned for their rest or exercise visit to ensure the 
accelerometers were worn for the entire data collection period. ActiGraph data was collected for 
seven consecutive days at 30 Hz. The accelerometer output was sampled by a 12-bit analog-to-
digital converter. The percentage of time spent sedentary as well as the amount of time spent 
participating in different categories of physical activity including light, lifestyle, moderate, and 




Rest Visit: The day prior to the rest visit, subjects consumed a standardized breakfast (522 Kcal), 
lunch (722 Kcal, snack 180 Kcal), and dinner (779 Kcal) provided by the Washington University 
Institute of Clinical and Translational Sciences Bionutrition Service.  Participants also consumed 
a liquid formula (Ensure; Ross Laboratories, Columbus, OH) containing 250 kcal (40 g 
carbohydrates, 6.1 g fat, and 8.8 g protein) to ensure complete filling of hepatic glycogen stores 
as a snack before bedtime. Participants then fasted overnight (10hrs) with nothing taken by 
mouth except water and reported to  the CRU at 0730 the following morning. After admission, 
height and weight were measured using a standard scale and stadiometer, and an IV catheter was 
inserted into the antecubital vein to collect baseline fasting blood samples. Fasting blood samples 
were collected in heparinized tubes for glucose, insulin, c-peptide, citrate-lined tubes for PT-
INR, and EDTA lined tubes for lipid kinetics analysis.  
 Following collection of baseline blood samples, participants rested quietly in the semi-
recumbent position for 1 hour. At the end of the rest period the antecubital catheter was prepared 
for the administration of a prime-constant infusion of stable isotope tracers. Additionally, a 
second catheter was inserted into a hand vein on the contralateral arm, with the hand warmed to 
55°C using a thermostatically controlled hot box to obtain arterialized blood samples. 30 minutes 
after the rest period, a primed, constant infusion of [6,6-2H2]glucose (28 μmol/kg prime and 
0.28 μmol•kg-1•min-1 continuous infusion), was administered for 180 minutes to achieve 
isotopic steady state (data not presented in this paper). 60 minutes after the start of the glucose , a 
primed, constant infusion of NaH13CO3 (1 umol/kg priming dose), and [U-13C16]palmitate (.0053 
μmol•kg-1•min-1 continuous infusion) were administered for 120 minutes to achieve isotopic 
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steady state. Blood samples were collected at -10, 160, 170, and 180 minutes from the start of the 
glucose tracer infusion to quantify basal (i.e. fasting) free fatty acid kinetics. The constant 
infusion of [U-13C16]palmitate was continued through the postprandial period. 
 Following the 210 minute Baseline Period, participants consumed a liquid test meal 
consisting of 20 Kcal/FFM, with a composition of 47.8% CHO, 36.1% fat, and 16.1% protein. 10 
mg/kg body weight of [1,1,1,2,2,2,3,3,3,4,4,4-13C12]tripalmitin was added to the test meal and 
thoroughly mixed. The tripalmitin was emulsified in lecithin and vegetable oil, which was 
microwaved for 5 minutes to warm. The emulsified mixture was then added to Boost Plus, 
microwaved, and sonicated to evenly distribute the tracer. To ensure meal consistency for both 
visits, one large mixture was prepared and then split in half (each half consumed during the rest 
and exercise visit). Participants were asked to consume the liquid meal within 16 minutes (1/4 of 
the meal provided every 4 minutes). The sides of the liquid meal container were rinsed with 10 
ml of water and the rinse was also consumed to ensure participants ingested the entire study 
meal. Lastly, 30 minutes after consuming the meal, a 75 umol/kg bolus infusion of (1,1,2,3,3-
2H5)glycerol was initiated to quantify lipoprotein kinetics. Blood samples were collected at 0, 15, 
30, 45, 60, 90, 120, 150, 180, 240, 300, and 360 minutes post-meal ingestion. Samples of the 
liquid test meal, as well as the tracers used were collected for enrichment analysis. Water was 
consumed ad libitum during the basal period, but aside from the test meal, study participants 
consumed no other beverages and no food until the 360-min postprandial measurement period 
ended. An overview of the study protocol is provided in Figure 1. All stable isotope tracers were 




Exercise Visit: The exercise visit was identical to the rest visit except participants performed ~1 
hour of resistance exercise rather than rest. The exercise session consisted of 8 lifts (bench press, 
pull down, seated row, biceps curl, knee extension, leg press, and overhead press) performed for 
3 sets of 8-12 reps at 80% of their measured 1RM until volitional fatigue. Participants were 
given no more than 1 minute of rest between sets, and no more than 3 minutes rest between 
exercises. All exercise sessions were supervised by a licensed physical therapist. 
 
Indirect Calorimetry 
Whole body carbohydrate oxidation was measured using indirect calorimetry (Parvo 
Medics, Sandy, UT) and the ventilated hood technique prior to, and throughout, the postprandial 
period. VO2, and VCO2 were measured continuously for 15 minutes for the determination of 
resting energy expenditure, respiratory exchange ratio and carbohydrate oxidation while the 
participant laid quietly in bed. Measurements were taken at baseline (prior to exercise/rest 
period, 120 minutes after the start of the exercise/rest period, and then at 30, 60, 150, 210, 270, 
and 330 min after consuming the liquid test meal. Total carbohydrate oxidation rate 
(grams/minute) was calculated as previously described.37  
 
Sample Processing 
Blood samples were placed in chilled tubes containing EDTA and placed on ice. Plasma 
was recovered by low speed centrifugation within 30 min of sample collection. An aliquot of 
plasma (3 ml) was kept in the refrigerator for subsequent isolation of lipoprotein fractions, and 
the remaining plasma was frozen at ︎ -80C for further processing. 
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 The TRL fraction was isolated by ultracentrifugation. Two milliliters of each plasma 
sample was transferred into Optiseal tubes (Beckman Instruments, Inc., Palo Alto, CA), covered 
with a saline solution (d=1.006 g/ml), and centrifuged in an ultracentrifuge (Beckman 
Instruments, Inc.) for 16 h at 45000 rpm and 8°C in a 50.4 Ti rotor. The top layer, containing 
TRL, was removed by tube slicing (Beckman Instruments, Inc.). The exact volume that was 
recovered (~1.3 ml) was recorded, and the samples were stored at -80°C. Chylomicrons were 
recovered by over layering 1 ml of plasma with the same saline solution, followed by 
ultracentrifugation for 35 minutes at 25000 rpm, 16°C, in a SW41 swinging bucket rotor 
(Beckman Instruments, Palo Alto, CA). 
 TRL-TG and chylomicrons were isolated by thin layer chromatography (TLC) on LK6D 
silica gel plates (Whatman, Clifton, NJ) using heptane-diethyl ether-formic acid (80:20:2, v/v/v) 
and visualized with 0.01% rhodamine 6G. TLC scrapings containing TGs were recovered, 
extracted with chloroform-methanol (3:1, v/v), transferred to 13 mm screw-top vials and dried 
under vacuum. Fatty acid methyl esters (FAMEs) were prepared by adding 0.5 ml of 10% acetyl 
chloride in methanol, capping the tubes with Teflon-lined caps, incubated at 70°︎ C for 30 min, 
and dried under vacuum. The glycerol liberated by the transmethylation reaction was derivatized 
by the addition of 200 ul of 5% heptafluorobutyric (HFB) anhydride in ethyl acetate. Capped 
vials were incubated at 70°C for 30 min. After drying under vacuum, 100 ul ethyl acetate was 
added and samples were transferred to autosampler vials for GC-MS analysis of HFB- glycerol 
and palmitate methyl ester in the same run.  
 Plasma glycerol and palmitate were recovered from 0.25 ml plasma after precipitation of 
plasma proteins with acetone and extraction of the aqueous phase with hexane. The aqueous 
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phase containing glycerol was dried under vacuum (SpeedVac) and derivatized with 100 ul of 
HFB anhydride-ethyl acetate (1:1, v/v) at 70°C for 10 min. After drying in a SpeedVac, the 
samples were dissolved in 100 ul ethyl acetate. The tracer-to-tracee ratio (TTR) of all oral and 
infused tracers (13C4-palmitate, 13C16-palmitate, and 2H5-glycerol) in all TG and FFA pools was 
determined using gas chromatography–mass spectrometry (GC-MS) (Hewlett-Packard MSD 
5973 system with capillary column) as previously described.38 
 
Sample Analysis 
Blood for plasma hormone and metabolite analysis was collected from an antecubital 
vein, immediately placed in chilled EDTA tubes, centrifuged at 2000xg for 10 minutes, and the 
supernatant collected and frozen at -80°C until analysis. Fasting samples were analyzed were 
used for comprehensive metabolic panel, lipid panel, CBC, and HbA1cand plasma insulin 
concentration was measured by radioimmunoassay; all performed HbA1c by the Washington 
University Core Lab for Clinical Studies. Total plasma, TRL, and chylomicron triglyceride 
concentrations were measured using an in vitro colorimetric assay (Wako L-Type TG Kit, Wako 
Diagnostics). VLDL concentrations were measured by subtracting chylomicron TG content from 
TRL-TG content. Selected ion abundances were compared against external standard curves for 
calculation of FFA concentration using quantitative GC/MS as previous described.38  
 
Calculations 
The concentration of 13C4-palmitate and 13C16-palmitate in TRL-TG, chylomicrons, and 
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The concentration of 13C4-palmitate and 13C16-palmitate in VLDL was calculated by subtracting 
tracer concentrations in chylomicrons from TRL-TG (chylomicrons + VLDL).  
 During the last 300 minutes of the baseline period (160, 170, and 180 minutes), a 
physiological and isotopic state was present, and therefore Steele’s equation for steady state was 
used to calculate free fatty acid flux (rate of appearance [Ra] and rate of disappearance [Rd]). Ra 
was calculated by dividing the 13C16-palmitate infusion rate (umol/min) by the plasma tracer 
enrichment (TTR, mean of all three measurements). FFA Rd was calculated as FFA Ra + 13C16-
palmitate infusion rate. Ra was normalized to kg FM, while Rd was normalized per kg of fat-free 
mass (FFM) derived from DXA. The adipose tissue insulin resistance index (ATIRI) was 
calculated as the product of basal FFA Ra and plasma insulin concentration. 
After mixed meal ingestion, the total FFA rate of appearance (Ratotal) was calculated from 
13C16-palmitate TTR using Steele’s equation:  
𝑅𝑎!"! =   
𝐼𝑅 − 𝐶 𝑡 ∗ 𝑉 ∗   𝑑  13𝐶16  𝑇𝑇𝑅(𝑡)𝑑𝑡
13𝐶16  𝑇𝑇𝑅(𝑡)  
where IR is the 13C16-palmitate infusion rate, C is the plasma FFA concentration, and V is the 
volume of distribution (55 ml/kg, fixed).39 Before applying Steele’s equation, plasma 13C16 TTR 
data were smoothed using a spline fitting approach to stabilize the calculation of the derivative of 
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enrichment. Rate of disappearance (Rd) was calculated as:  
Rd 𝑡 =   𝑅𝑎!"! 𝑡 −   
𝑑𝐶 𝑡
𝑑𝑡 ∗ 𝑉 
Ra was normalized to kg FFM, and Rd was normalized to kg FFM. The FFA metabolic clearance 
rate (MCR) was estimated as the average Rd during the meal divided by the average plasma FFA 
concentration. Rd(t) was also divided by plasma insulin at each point during the postprandial 
period to track changes in insulin sensitivity over time. The total area under the curve was also 
calculated for total Ra and total Rd using the trapezoid rule. 13C4-palmitate and 13C16-palmitate 
absorption in each TG or FFA pool was also measured during the ascending portion of the 
concentration curves (a period when absorption outpaces clearance and is the primary contributor 
to the concentration), which corresponded to the period from 180-360 minutes (from the start of 
the meal to 3 hours post-meal). We identify this period as the “Absorptive Period,” in the results 
below. 
 The fractional turnover rate (FTR) of TRL-TG and chylomicrons was determined using 
the monoexponential approach.40 The plasma clearance rate of TRL-TG and chylomicrons 
(ml/min), which is an index of the efficiency of TRL-TG and chylomicron removal from the 
circulation via all possible routes, was calculated as the FTR times plasma volume. The mean 
residence time (MRT) of TRL-TG and chylomicrons in the circulation (min) was calculated as 
1/FTR as described previously.  
 From the plasma glucose and insulin values on the OGTT, an index of insulin resistance 
(IR), beta cell function (HOMA-%B), and insulin sensitivity (HOMA-%S) were calculated using 





Participant demographics were analyzed using mean ± SE. Data were analyzed for 
normality using the Shapiro-Wilk test. Differences between rest and exercise conditions on 
measures of tracer concentrations concentration, TTR, and FFA kinetics were assessed using a 
2x2 mixed, repeated measures ANOVA with treatment (rest or exercise) and time (time the 
sample was collected in the study) entered as repeated measures, and order (rest>exercise or 
exercise>rest) as a between subjects factor to rule out confounding by carryover effects (to 
determine if the washout period between the rest and exercise visits was sufficient). The 
assumption of sphericity was assessed using Mauchly’s test. Huyn-feldt adjusted F values were 
used in cases of the violation of the assumption of sphericity. Significant interactions between 
treatment and time were further analyzed using paired t-tests. The Benjamini–Hochberg 
procedure was used to control for multiple comparisons. The two-way interaction between time 
and order, treatment and order, and the three-way interaction between treatment, time, and order 
were tested identify the presence of a carry-over effect. Areas under the curve between 
conditions were analyzed according to the procedures outlined by Wellek and Blettner (2012) for 
cross-over designs, testing first for carry-over effects, followed by testing for treatment effects.42 






Nine (n=9) male participants were enrolled in the study. Participants were middle-aged, 
obese, and sedentary (Table 1). All participants were prediabetic, with the group means for 
HbA1c, 2-hour plasma glucose from the OGTT, and fasting plasma glucose all within the pre-
diabetic range (Table 1). Four (n=4) participants had HbA1c values > 5.7%, six had fasting 
plasma glucose values >100 mg/dL (5.5 mmol/L), and n=7 participants had 2-hour OGTT values 
>140 mg/dL (7.8 mmol/L). The average % body fat was in the 75th percentile for individuals in 
their age group as established by the NHANES.36 Participants also demonstrated insulin 
resistance according to the HOMA2 model (HOMA2-IR, HOMA2-%S), with compensatory 
increases in beta cell function (HOMA2-%B). Participants also presented with elevated total 
triglyceride (>150 mg/dL), LDL (normal: >100 mg/dL), with slightly reduced HDL (<40 mg/dL) 
concentrations (Table 1).  
 
Total Plasma Triglyceride and Free Fatty Acid Concentration 
Following resistance exercise, total postprandial integrated area under the curve (iAUC) 
for total plasma triglyceride concentration (p=.012), chylomicron triglyceride concentration 
(p=.036), and TRL-TG concentration (p=.0004) were significantly reduced. VLDL concentration 
iAUC (p=.065) tended to be reduced compared to the resting condition (Figure 2). Resistance 
exercise also tended to reduce postprandial plasma FFA concentration (p=.068) compared to rest. 
 
Exogenous Lipid Metabolism Kinetics 
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13C4-palmitate (isotopically labeled palmitate from the Tripalmitin tracer added to the test 
meal) kinetics in chylomicrons, VLDL, TRL-TG, and plasma FFA were quantified throughout 
the postprandial period to determine meal-derived (exogenous) lipid handling. There was a 
significant interaction between treatment (i.e. exercise/rest) and time (p=.017) for  exogenous 
palmitate concentration in chylomicrons and TRL-TG p=.046) (Figure 3). Time-points that were 
significantly different between exercise and rest are indicated in Figure 3. There were no carry-
over effects identified for any of these measures (all p>.05). There was only a main effect of time 
for the exogenous palmitate concentration in VLDL (p<.001). The concentration of exogenous 
palmitate in plasma FFA tended to be reduced after resistance exercise (main effect treatment: 
(p=.071), and also showed a main effect of time (p<.001). Resistance exercise significantly 
reduced the total AUC for exogenous in TRL-TG (p=.043), chylomicrons (p=.049), and tended 
to reduce exogenous palmitate AUC in VLDL-TG (p=.078) (Figure 3). The resistance exercise 
session also tended to reduce the total AUC for 13C4-palmitate in plasma FFA (p=.078) compared 
to rest.  
 
Endogenous Lipid Metabolism Kinetics 
13C16-palmitate (an infused isotopically labeled fatty acid) concentration and enrichment 
in chylomicrons, VLDL, TRL-TG, and plasma FFA were quantified throughout the postprandial 
period to determine endogenous lipid handling.  There was a significant interaction between 
treatment and time for both chylomicrons (p=.012) and TRL-TG (p=.035) for the concentration 
of endogenous palmitate (Figure 4). The time-points significantly different between rest and 
resistance exercise for chylomicrons and TRL-TG are shown in Figure 4. We also found a main 
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effect of treatment and a main effect of time for the concentration of endogenous palmitate in 
plasma FFA (Treatment: p=.049, time: p<.001), indicating that the resistance exercise session 
reduced postprandial endogenous palmitate concentrations overall compared to the rest session 
(Figure 4). We did not find any treatment effects for endogenous palmitate concentration in 
VLDL-TG (p=.168) due to large standard deviations for this measure. We also found that 
resistance exercise reduced the AUC for endogenous palmitate in TRL-TG (p=.041), 
chylomicrons (p=.024), and plasma FFA (p=.009), with no difference in the endogenous 
palmitate AUC for VLDL (p=.127) (Figure 4). 
 
Absorptive Period Lipid Kinetics 
Exogenous palmitate and endogenous palmitate absorption in each TG or FFA pool was 
also measured during the ascending portion of the concentration curves (a period when 
absorption outpaces clearance and is the primary contributor to the concentration), which 
corresponded to the period from 180-360 minutes (i.e. from the start of the meal to 3 hours post-
meal). Similar to the total AUC, the absorptive AUC of  exogenous palmitate was significantly 
reduced after resistance exercise in chylomicrons (Rest: 993.1 ± 353 umol/L•180 min vs Ex: 
542.9 ± 209.7 umol/L•180 min, t(8)=2.37, p=.045) and TRL-TG (Rest: 1437.9 ± 313.2 
umol/L•180 min vs Ex: 1020. 2 ± 261.8 umol/L•180 min, t(8)=3.29, p=.044), and tended to 
reduce the AUC in plasma FFA (Rest: .42 ± .08 umol/ml•360 min, Ex: .29 ± .06 umol/ml•180 
min, t(8)= 2.20, p=.058). There were no differences in the exogenous palmitate concentration 
AUC in VLDL from 180-360 minutes (p=.203). Likewise, we also found significant reductions 
in the absorptive phase of the endogenous palmitate AUC for chylomicrons (Rest: 141.7 ± 43.2 
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umol/L•180 min vs Ex: 103.1 ± 34.8 umol/L•180 min, t(8)=2.82, p=.022), TRL-TG (Rest: 328.9 
± 51.2 umol/L•180 min vs Ex: 274.9 ± 36.4 umol/L•180 min, t(8)=2.86, p=.021), but not for 
VLDL (p=.236), or plasma FFA (p=.319). 
 
Basal/Recovery Period Free Fatty Acid Kinetics 
One hundred eighty minutes (180 min) following the exercise/rest session, a steady state 
of U13C palmitate was reached and U13C rate of appearance and disappearance and adipose tissue 
insulin resistance index, were determined (Table 2). Resistance exercise resulted in a significant 
increase in U13C palmitate acid rate of appearance and disappearance compared to rest (Table 2). 
There was also a trend (p=0.07) toward an increase in adipose tissue insulin resistance following 
resistance exercise compared to rest (Table 2). 
 
Postprandial Free Fatty Acid Kinetics 
There was a significant interaction between treatment and time for total FFA Rd (Table 
2). Simple main effects analysis revealed total FFA Rd was significantly elevated after resistance 
exercise at time points 180 min, 196 min, and 480 min. We also found a trend toward an 
interaction between treatment and time for postprandial FFA total Ra (Table 2). However, 
postprandial FFA metabolic clearance rate, AUC for postprandial FFA total Rd, or the AUC for 




Lipoprotein Turnover and Clearance Kinetics 
Using incorporation and clearance of the 2H5-glycerol in chylomicrons and TRL-TG, fractional 
turnover rate, mean residence time, and clearance rate for TRL-TG and chylomicrons were 
quantified (Table 3). Resistance exercise significantly reduced the TRL-TG mean residence time, 
and tended (p=0.083) to increase the fractional turnover rate and clearance rate (p=0.074). 
Additionally, we found significant reductions in the chylomicron mean residence time and 




There was a significant interaction between treatment and time for lipid oxidation rate (p=.007) 
(Figure 5). Simple main effects demonstrated that lipid oxidation was significantly elevated at 
140 minutes (p=.014) and 210 minutes (p=.015) post exercise/rest, with trends toward significant 
elevations at time points 240 (p=.092) and 330 (p=.072) above the rest condition after a single 
bout of resistance exercise. Lipid oxidation AUC was significantly greater after the resistance 
exercise session compared to rest (p=.048). 
 
Discussion 
Elevated postprandial lipemia is an early feature of prediabetes and contributes to an 
increased risk for cardiovascular disease and progression to type 2 diabetes.15 Evidence from 
other populations suggest that resistance exercise may improve postprandial lipid metabolism, 
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however the effect of resistance exercise in individuals with prediabetes is unknown.24,25 Our 
study demonstrated the novel finding that a single bout of resistance exercise, performed 210 
minutes before consuming a mixed carbohydrate and lipid meal, reduced total plasma TG, 
chylomicron and TRL-TG concentrations, and tended to reduce VLDL plasma FFA 
concentrations in men with prediabetes. In addition, our study revealed for the first time, that 
declines in plasma triglyceride concentration following acute resistance exercise were due to 
reductions of both exogenous (meal-derived) and endogenous (originating internally) 
triglycerides and fatty acids. Moreover, acute resistance exercise increased lipoprotein turnover, 
FFA clearance rate, and postprandial lipid oxidation rate. These data support the use of resistance 




Postprandial chylomicron concentrations were reduced after resistance exercise compared 
to rest. This reduction was caused by: 1) a significant decline in the content exogenous 
triglycerides (reflected by reduced 13C4-palmitate concentration); and 2) a decline in endogenous 
FFA content (reflected by the reduced 13C16-palmitate concentration). The decline in exogenous 
triglyceride content following resistance exercise could be caused by a lower amount of meal-TG 
absorption or delayed meal-TG absorption. Aerobic exercise has been shown to reduce 
splanchnic blood flow by 45-80% depending on the duration and intensity of the exercise 
session.43 Reductions in splanchnic blood flow reduce gastrointestinal motility and gastric 
emptying and could therefore change amount or timing of absorption of meal-derived TG or 
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FFA.43 Aerobic exercise has also been shown to increase the expression of genes that control 
enterocyte lipid anabolism, fatty acid oxidation, and mitochondrial content.44,45 Increases in 
enterocyte fatty acid oxidation have been shown to limit the triglyceridemic response to a meal 
by reducing the substrate available for triglyceride synthesis and chylomicron secretion.45,46,47 If 
similar to aerobic exercise, these data suggest that resistance exercise may have modulated 
exogenous lipid absorption, enterocyte metabolism, or lipid handling (eg. changes in triglyceride 
synthesis or packaging of chylomicrons, changes in cytosolic lipid droplet kinetics). However, 
we did not measure these factors directly, and their role in the changes we observed after 
resistance exercise requires further investigation. 
 In addition to reductions in exogenous lipid contribution to chylomicrons we also found 
evidence that resistance exercise altered endogenous lipid contributions to these lipoproteins. 
Endogenous FFA can be taken up by the enterocyte from the portal system, re-esterified, and 
packaged into chylomicrons.48 Therefore, the reduction in 13C16-palmitate in chylomicrons in our 
study could have been caused by a reduction in the amount of endogenous palmitate in the 
circulation. Since 13C16-palmitate was infused at a constant rate, declines in 13C16-palmitate 
concentrations in the plasma could have been caused by an increase in plasma FFA clearance. 
Indeed, using non-steady state modeling, we found that the FFA Rd was elevated during the 
postprandial period after resistance exercise compared to rest, suggesting the 13C16-palmitate 
might have been cleared before it had a chance to be re-esterified by the enterocyte. The decline 
in 13C16-palmitate concentration could also have been due to undefined changes in the handling of 
endogenous FFA by the enterocyte (i.e. redirecting endogenous FFA toward storage as rather 
than re-esterification into chylomicrons), reductions in splanchnic blood flow after resistance 
exercise (thereby limiting the availability of endogenous FFA for enterocyte uptake), or 
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enhanced VLDL clearance prior to meal consumption (which would reduce the amount of 
endogenous lipid available for enterocyte uptake). However, we did not measure these factors 
directly, so they warrant further investigation. 
 Finally, there was a significant reduction in the chylomicron mean residence time and an 
increase in the chylomicron clearance rate after resistance exercise, which might have been 
caused by an increase in chylomicron hydrolysis by lipoprotein lipase. However, we did not 
measured LPL activity and thus further research is needed to explore the contribution of these 
various mechanisms to the decline in both exogenous and endogenous lipids to chylomicrons 
after resistance exercise. Overall, postprandial chylomicron exposure (represented by the AUC) 
following resistance exercise was reduced, which is important in decreasing postprandial 
lipemia, reducing body weight, and reducing the risk for severe complications such as CVD. 
 
VLDL Metabolism 
Unlike chylomicrons, we found only a trend toward reduction in the amount of 
exogenous palmitate in VLDL after resistance exercise. The appearance of exogenous palmitate 
in VLDL is likely from spillover of meal palmitate liberated after chylomicron hydrolysis but not 
taken up by skeletal muscle or adipose tissue.49 Meal-derived FFA can be taken up by the liver, 
re-esterified, and incorporated into VLDL. The spill-over of dietary FFA has been shown to 
account for > 25% of postprandial FFA flux and could therefore be an important contributor to 
CVD risk and prediabetes.49 Mitigating meal FFA spill-over to the liver may subsequently lower 
VLDL production by reducing substrate for lipidation of apoB-100. It may also promote weight 
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loss by reducing the amount of FFA available for adipose tissue esterification in the postprandial 
period.  
 In contrast to exogenous lipid contributions to VLDL, endogenous palmitate in VLDL did 
not significantly change following resistance exercise. However, the total AUC for the amount of 
endogenous palmitate in VLDL tended to be lower (by ~ 60 umol/L). Resistance exercise may 
not have a strong effect on hepatic uptake of plasma FFA, evidenced by the similarity between 
endogenous palmitate concentration in VLDL between rest and exercise conditions. The lack of a 
difference in endogenous palmitate in VLDL might also be explained by a reduction in the 
availability of meal-derived FFA as a substrate for VLDL synthesis. With reduced exogenous 
FFA substrate, VLDL particles produced in the liver could be expected to have a larger 
contribution from endogenous FFA, thereby masking any true differences between rest and 
exercise conditions. Of the two sources of FFA for VLDL synthesis, the results of our study 
suggest reductions in the availability of exogenous FFA may more strongly contribute to 
reductions in postprandial VLDL concentrations after resistance exercise. Our results agree with 
those reported by Davitt et al. (2013), who found that resistance exercise performed 30 minutes 
prior to a meal reduced exogenous FFA concentrations but not endogenous FFA.32 
 Several previous studies have also confirmed that VLDL and chylomicrons compete for 
lipoprotein lipase in the postprandial period, and that lipoprotein lipase tends to prefer 
chylomicrons rather than VLDL for hydrolysis.50 Previous studies have shown that VLDL 
particles accumulate in the plasma after lipid ingestion due to a delay in their lipolysis, which 
can be attributed to LPL’s preference for larger lipoproteins, and to their reduced efficiency at 
hydrolyzing VLDL 51,52 If so, the trend toward reduction in VLDL concentration might be due to 





Further support for the diminished clearance of VLDL comes from partitioning of 
exogenous and endogenous lipids in TRL-TG - the combination of VLDL and chylomicrons. In 
TRL-TG we found significant reductions in both exogenous palmitate and endogenous palmitate, 
with greater reductions in chylomicrons than VLDL. When assessing TRL-TG turnover, we 
found only a significant reduction for mean residence time following resistance exercise. The 
difference between chylomicron clearance and TRL-TG clearance could be attributed to the 
VLDL contribution to the TRL-TG pool. Since chylomicron clearance rate was increased, and 
VLDL clearance was not significantly increased after resistance exercise, the effect size for 
lipoprotein clearance of TRL-TG was likely diluted by the smaller changes in VLDL 
metabolism. 
 
Pre-Meal Free Fatty Acid Metabolism Kinetics 
Following resistance exercise, pre-meal FFA Ra and Rd were increased and adipose 
tissue insulin resistance index tended to increase. FFA Ra from adipose tissue lipolysis has been 
shown to increase ~5 fold above resting conditions after moderate intensity aerobic exercise, and 
this increase can persist for 3-6 hours to increase the supply of FFA for recovering muscle in 
healthy subjects.53 Elevated levels of catecholamines and reductions in insulin are thought to 
contribute to the stimulation of adipose tissue lipolysis, which could be further augmented by 
increases in adipose tissue blood flow.54 We did not measure plasma catecholamines, but we did 
find that plasma insulin was reduced after the resistance exercise session (previously described). 
 
 112 
The slight increase identified in adipose tissue insulin resistance (Table 2) would also serve to 
augment adipose tissue lipolysis and increase circulating FFA in the post-exercise period.  
 While we did not find a significant reduction in total postprandial plasma FFA (Figure 2) 
following resistance exercise, we did find significant reductions in endogenous FFA and a trend 
toward reduced exogenous FFA in plasma. The reduction in endogenous FFA suggests that 
plasma FFA clearance is elevated after resistance exercise, which coincides with our measure of 
increased postprandial FFA rate of disappearance (Table 2). FFA metabolic clearance rate and 
total FFA Rd AUC tended to increase following resistance exercise, which, taken together, 
suggests that resistance exercise improves postprandial plasma FFA clearance. Finally, we likely 
failed to find a difference in total FFA iAUC due to the large standard deviations in this measure, 
or because of increases in plasma FFA Ra (which tended to increase, though it did not reach 
significance). The increases in Ra could negate reductions in total FFA concentration that would 
have been driven by an unopposed increase in FFA Rd.  
 
Lipid Oxidation 
Whole-body lipid oxidation rate was significantly elevated after resistance exercise, that 
this increase persisted for more than 5 hours (2.5 of which were after the meal), and that 
participants oxidized significantly more lipid across the entire study compared to their rest visit. 
It is well-established that aerobic exercise increases FFA skeletal muscle uptake and oxidation in 
healthy subjects.58 In our study, we provide the novel evidence that resistance exercise can 
promote the similar effects in prediabetes, which might have important implications for long-
term weight loss.  
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 It also important to note that lipid oxidation rate returned to baseline levels 3.5 hours 
into the postprandial period. At this point, we identified a rapid increase in the RER, indicating a 
shift toward greater use of carbohydrates for energy in the later half of the postprandial period. 
Previous studies have shown that consumption of a mixed meal results in a rapid switch to 
carbohydrate oxidation, even in high-fat meals.59 Previous studies have also shown that the acute 
effects of aerobic exercise on postprandial lipid metabolism dissipate over time lasting from 12-
16 hours.60,26 The dissipation in effectiveness of a single bout of resistance exercise on 
postprandial lipid metabolism could have been due to meal-induced switching of primary fuel 
sources. Further investigation is needed to elucidate the effects of chronic resistance exercise (i.e. 
training) on postprandial lipid metabolism. 
 
Conclusion 
In our study, we found that a single bout of resistance exercise reduced postprandial 
lipemia in obese men with prediabetes. Using a stable isotope tracer approach, we found that 
resistance exercise lowers exogenous and endogenous lipid contributions to both plasma FFA, 
chylomcirons, and VLDL, increased plasma FFA rate of disappearance, and increased 
lipoprotein clearance rates – all of which contributed to reduced plasma TG concentrations. 
Moreover, we found that acute resistance exercise increased total lipid oxidation, the lipid 
oxidation rate, and the contribution of energy derived from lipid oxidation. Aerobic exercise may 
be difficult for many sedentary, obese individuals who are just beginning an exercise-training 
program or for those with balance or gait abnormalities. Resistance exercise is often more 
accommodating for individuals with little exercise experience, and may be easier to adhere to 
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due to the intermittent nature of the exercise and the lower time commitment needed to derive 
benefit. We provide evidence to suggest that resistance exercise can be highly beneficial for 
individuals with prediabetes, and may help reduce their risk of CVD and other for life-
threatening complications associated with derangements in postprandial lipid metabolism.  
 
Limitations 
There are several limitations to this study. We did not isolate VLDL lipoproteins independent of 
chylomicrons. Therefore, we could not calculate the TTR or concentration of 13C4 or 13C16-
palmitate in VLDL directly. Likewise, we also could not measure VLDL concentration directly. . 
This study only enrolled adult men thus the results cannot be generalized to women and children. 
Additionally, the study sample size was limited and should be expanded to increase the validity 














1. Centers for Disease Prevention. National diabetes statistics report, 2017. 
https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf. 
Accessed 4/2018. 
2. Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M. Prediabetes: A high-risk state 
for developing diabetes. Lancet. 2012; 379(9833): 2279-2290. doi:10.1016/S0140-
6736(12)60283-9 
3. Brannick B, Wynn A, Dagogo-Jack S. Prediabetes as a toxic environment for the initiation 
of microvascular and macrovascular complications. Experimental Biology and Medicine. 
2016;241(12):1323-1331. doi:10.1177/1535370216654227. 
4. Yokota N, Miyakoshi T, Sato Y et al. Predictive models for conversion of prediabetes to 
diabetes. J Diabetes Complications. 2017 Aug; 31(8): 1266-1271 
5. Blaak EE, Antoine J-M, Benton D, et al. Impact of postprandial glycaemia on health and 
prevention of disease. Obesity Reviews. 2012; 13(10): 923-984. doi:10.1111/j.1467-
789X.2012.01011.x 
6. Avignon A, Radauceanu A, Monnier L. Nonfasting plasma glucose is a better marker of 
diabetic control than fasting plasma glucose in type 2 diabetes. Diabetes Care. 1997; 
20:1822–1826 
7. Balkau B. The DECODE study. Diabetes epidemiology: collaborative analysis of diagnostic 
criteria in Europe. Diabetes Metab. 2000 Sep; 26(4): 282-6. 
8. DECODE Study Group, the European Diabetes Epidemiology Group. Glucose tolerance and 
cardiovascular mortality. Comparison of fasting and 2-h di- agnostic criteria. Arch Intern 
Med. 2001; 161(3): 397-404 
9. Hanefeld M, Fischer S, Julius U et al. Risk factors for myocardial infarction and death in 
newly detected NIDDM: the Diabetes Intervention Study, 11-year follow- up. Diabetologia. 
1996; 39: 1577-1583 
10. Wu CJ, Fang WH, Kao TW, et al. Postprandial Glucose as a Risk Factor for Elevated 
Intraocular Pressure. PLoS ONE. 2016;11(12): e0168142. 
https://doi.org/10.1371/journal.pone.0168142  
11. Leon-Acuña A, Alcala-Diaz JF, Delgado-Lista J, et al. Hepatic insulin resistance both in 
prediabetic and diabetic patients determines postprandial lipoprotein metabolism: from the 
CORDIOPREV study. Cardiovascular Diabetology. 2016; 15:68. doi:10.1186/s12933-016-
0380-y. 
12. Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM. Fasting compared with 
nonfasting triglycerides and risk of cardiovascular events in women. JAMA. 2007; 298(3): 
309-16. 
13. Burgeiro A, Cerqueira MG, Varela-Rodríguez BM, et al. Glucose and lipid dysmetabolism 
in a rat model of prediabetes induced by a high-sucrose diet. Nutrients. 2017;9(6):638. 
doi:10.3390/nu9060638. 
14. Goossens GH, Moors CCM, Jocken JWE, et al. Altered skeletal muscle fatty acid handling 
in subjects with impaired glucose tolerance as compared to impaired fasting glucose. 
Nutrients. 2016; 8(3): 164. doi:10.3390/nu8030164. 
15. Shojaee-Moradie F, Ma Y, Lou S, Hovorka R, Umpleby AM. Prandial hypertriglyceridemia 
in metabolic syndrome is due to an overproduction of both chylomicron and VLDL 
triacylglycerol. Diabetes. 2013; 62(12): 4063-4069. doi:10.2337/db13-0935 
 
 116 
16. van Herpen NA1, Schrauwen-Hinderling VB. Lipid accumulation in non-adipose tissue and 
lipotoxicity. Physiol Behav. 2008 May 23;94(2):231-41 
17. Saponaro C, Gaggini M, Carli F, Gastaldelli A. The Subtle Balance between Lipolysis and 
Lipogenesis: A critical point in metabolic homeostasis. Nutrients. 2015;7(11):9453-9474. 
doi:10.3390/nu7115475 
18. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle. Its role in 
insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1963; 1: 785–
789. 
19. Schenk S, Horowitz JF. Acute exercise increases triglyceride synthesis in skeletal muscle 
and prevents fatty acid induced insulin resistance. J Clin Invest 2007; 117:1690–1698 
20. Goossens GH, Moors CCM, Jocken JWE, et al. Altered skeletal muscle fatty acid handling 
in subjects with impaired glucose tolerance as compared to impaired fasting glucose. 
Nutrients. 2016; 8(3): 164. doi:10.3390/nu8030164. 
21. Fabbri E, Chia CW, Spencer RG, et al. Insulin resistance is associated with reduced 
mitochondrial oxidative capacity measured by 31P-magnetic resonance spectroscopy in 
participants without diabetes from the Baltimore longitudinal study of aging. Diabetes. 
2017;66(1):170-176. doi:10.2337/db16-0754. 
22. Hayder A, Herbert A, Jelinek F. 8-Hydroxy-2-deoxy-guanosine identifies oxidative DNA 
damage in a rural prediabetes cohort. Redox Report. 2010; 15:4: 155-160, DOI: 
10.1179/174329210X1265050662368 
23. Homer AR, Fenemor SP, Perry TL. Regular activity breaks combined with physical activity 
improve postprandial plasma triglyceride, nonesterified fatty acid, and insulin responses in 
healthy, normal weight adults: A randomized crossover trial. J Clin Lipidol. 2017 Sep - 
Oct;11(5):1268-1279.e1. doi: 10.1016/j.jacl.2017.06.007. 
24. Magkos F, Tsekouras YE, Prentzas KI, et al. Acute exercise-induced changes in VLDL-
triglyceride kinetics leading to hypotriglyceridemia manifest more readily after resistance 
than endurance exercise. J Appl Physiol. 2008; 105: 1228-1236  
25. Davitt PM, Arent SM, Tuazon MA, Golem DL, Henderson GC. Postprandial triglyceride 
and free fatty acid metabolism in obese women after either endurance or resistance exercise. 
J Appl Physiol. 2013; 114: 1743– 1754, 2013.  
26. Zotou E, Magkos F, Koutsari C, et al. Acute resistance exercise attenuates fasting and 
postprandial triglyceridemia in women by reducing triglyceride concentrations in 
triglyceride-rich lipoproteins. Eur J Appl Physiol. 2010; 110: 869–874 
27. Bruinsma, Tyler J., "High intensity versus resistance exercise on postprandial triglycerides 
in healthy college students" (2017). Celebrating Scholarship & Creativity Day. 124. 
28. Petitt, Darby S., Sigurbjo ̈ rn A ́ . Arngrı ́msson, and Kirk J. Cureton. Effect of resistance 
exercise on postprandial lipemia. J Appl Physiol. 2002; 94: 694–700, doi: 
10.1152/japplphysiol.00377.2002 
29. Burns SF, Corrie H, Holder E, Nightingale T, Stensel DJ. A single session of resistance 
exercise does not reduce postprandial lipaemia. J Sports Sci. 2005;23(3):251-60. 
PMid:15966343 http://dx.doi.org/10.1080/02640410410001730142 
30. Burns SF, Broom DR, Miyashita M, Ueda C, Stensel DJ. Increased postprandial 
triacylglycerol concentrations following resistance exercise. Med Sci Sports Exerc. 2006 
Mar;38(3):527-33 
31. Heden TD, Winn NC, Mari A, et al. Postdinner resistance exercise improves postprandial 
risk factors more effectively than predinner resistance exercise in patients with type 2 
 
 117 
diabetes. Journal of Applied Physiology. 2015; 118(5): 624-634. 
doi:10.1152/japplphysiol.00917.2014 
32. Davitt PM, Arent SM, Tuazon MA, Golem DL, Henderson GC. Postprandial triglyceride 
and free fatty acid metabolism in obese women after either endurance or resistance exercise. 
J Appl Physiol. 2013; 114: 1743– 1754, 2013.  
33. Freese EC, Gist NH, Cureton KJ. Effect of prior exercise on postprandial lipemia: an 
updated quantitative review. J Appl Physiol 116: 67–75, 2014. 
34. Malin SK, Haus JM, Solomon TP, Blaszczak A, Kashyap SR, Kirwan J. Insulin sensitivity 
and metabolic flexibility following exercise training among different obese insulin-resistant 
phenotypes. Am J Physiol Endocrinol Metab. 2013 Nov 15; 305(10):E1292-8 
35. American College of Sports Medicine. 2000. ACSM’s guidelines for exercise testing and 
prescription Baltimore: Lippincott, Williams & Wilkins. 
36. Freedson PS, Melanson E, Sirard J. Calibration of the computer science and applications, 
Inc. accelerometer. Med Sci Sports Exerc. 1998; 30:777–781. doi: 10.1097/00005768-
199805000-00021 
37. Frayn KN. Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl 
Physiol Respir Environ Exerc Physiol. 1983; 55(2):628–634. [PubMed: 6618956] 
38. Mittendorfer B, Horowitz JF, Klein S. Gender differences in lipid and glucose kinetics 
during short-term fasting. J Appl Physiol. 2001; 281(6): E1333-E1339 
39. Van Loon LJC, Greenhaff PL, Constantin-Teodosiu D, Saris WHM, Wagenmakers AJM. 
The effects of increasing exercise intensity on muscle fuel utilisation in humans. The 
Journal of Physiology. 2001;536(Pt 1):295-304. doi:10.1111/j.1469-7793.2001.00295.x. 
40. Patterson, B. W., B. Mittendorfer, N. Elias, R. Satyanarayana, and S. Klein. Use of stable 
isotopically labeled tracers to measure very low density lipoprotein-triglyceride turnover. J. 
Lipid Res. 2002. 43: 223–233 
41. Diabtes Trials Unit. HOMA calculator. University of Oxford. Accessed from 
https://www.dtu.ox.ac.uk/homacalculator/ 
42. Wellek S, Blettner M. On the Proper Use of the Crossover Design in Clinical Trials: Part 18 
of a Series on Evaluation of Scientific Publications. Deutsches Ärzteblatt International. 
2012; 109(15):276-281. doi:10.3238/arztebl.2012.0276. 
43. ter Steege RW, Kolkman JJ. Review article: the pathophysiology and management of 
gastrointestinal symptoms during physical exercise, and the role of splanchnic blood flow. 
Aliment Pharmacol Ther. 2012 Mar; 35(5): 516-28 
44. Hung Y, Linden MA, Gordon A, Scott Rector R, Buhman KK. Endurance exercise training 
programs intestinal lipid metabolism in a rat model of obesity and type 2 diabetes. 
Physiological Reports. 2015;3(1):e12232. doi:10.14814/phy2.12232. 
45. Kimura R, Takahashi N, Murota K. Activation of peroxisome proliferator-activated 
receptor-α (PPARα) suppresses postprandial lipidemia through fatty acid oxidation in 
enterocytes. Biochem Biophys Res Commun. 2011 Jun 24; 410(1):1-6 
46. Demignot S, Beilstein F, Morel E. Triglyceride-rich lipoproteins and cytosolic lipid droplets 
in enterocytes: key players in intestinal physiology and metabolic disorders. Biochimie. 
2014 Jan;96:48-55.  
47. Vaugelade P, Posho L, Darcy-Vrillon B et al. Intestinal oxygen uptake and glucose 




48. Jacome-Sosa M, Parks EJ, Bruno RS, et al. Postprandial Metabolism of Macronutrients and 
Cardiometabolic Risk: Recent Developments, Emerging Concepts, and Future Directions. 
Advances in Nutrition. 2016;7(2):364-374. doi:10.3945/an.115.010397. 
49. Muthusamy K, Nelson RH, Singh E, et al. Effect of Insulin Infusion on Spillover of Meal-
Derived Fatty Acids. The Journal of Clinical Endocrinology and Metabolism. 2012; 
97(11):4201-4205. doi:10.1210/jc.2012-1468. 
50. van Beek AP, van Barlingen HH, de Ruijter-Heijstek FC, et al. Preferential clearance of 
apoB-48-containing lipoproteins after heparin-induced lipolysis is modulated by lipoprotein 
lipase activity. J Lipid Res. 1998 Feb; 39(2):322-32 
51. Nakajima K, Nakano T, Tokita Y, et al. Postprandial lipoprotein metabolism; VLDL vs 
chylomicrons. Clinica Chimica Acta; International Journal of Clinical Chemistry. 2011; 
412(15-16): 1306-1318. doi:10.1016/j.cca.2011.04.018 
52. Xiang SQ, Cianflone K, Kalant D, Sniderman AD. Differential binding of triglyceride-rich 
lipoproteins to lipoprotein lipase. The Journal of Lipid Research. 1999; 40:1655-1662 
53. Magkos F, Mohammed BS, Patterson BW, Mittendorfer B. Free fatty acid kinetics in the 
late phase of postexercise recovery: importance of resting fatty acid metabolism and 
exercise-induced energy deficit. Metabolism: clinical and experimental. 2009;58(9):1248-
1255. doi:10.1016/j.metabol.2009.03.023 
54. Bulow J, Madsen J. Adipose tissue blood flow during prolonged, heavy exercise. Pflugers 
Arch. 1976; 363(3): 231-4  
55. Bickerton AST, et al. Preferential uptake of dietary fatty acids in adipose tissue and muscle 
in the postprandial period. Diabetes. 2007; 56(1): 168–176 
56. Kiens B. Skeletal muscle lipid metabolism in exercise and insulin resistance. Physiol Rev. 
2006; 86: 205–243,  doi:10.1152/physrev.00023.2004. 
57. Hallsworth K, Fattakhova G, Hollingsworth KG, et al. Resistance exercise reduces liver fat 
and its mediators in non-alcoholic fatty liver disease independent of weight loss. Gut. 
2011;60(9):1278-1283. doi:10.1136/gut.2011.242073. 
58. Turcotte LP1, Richter EA, Kiens B. Increased plasma FFA uptake and oxidation during 
prolonged exercise in trained vs. untrained humans. Am J Physiol. 1992 Jun; 262(6 Pt 
1):E791-9 
59. Melzer K. Carbohydrate and fat utilization during rest and physical activity. E-SPEN,. 2011; 
6: e42-e45 
60. Zhang JQ, Ji LL, Fogt DL, Fretwell VS. Effect of exercise duration on postprandial 









Table 1. Participant Characteristics (N=9) 
Measure Mean (SEM) 
Age 50 (11) 
Height (cm) 178 (5.4) 
Weight (kg) 104.5 (9.9) 
BMI (kg/m2) 33 (3) 
WB Fat (kg) 32.7 (2.2) 
WB Lean (kg) 66.3 (1.5) 
% Fat 31.8 (1.4) 
HbA1c (%) 5.7 (.2) 
2-hr OGTT (mmol/L) 9.0 (.5) 
Peak Postprandial TG (mmol/L) 2.5 (.2) 
Fasting glucose (mmol/L) 5.9 (.4) 
Fasting Insulin (uU/mL) 22 (2) 
HOMA2-IR 2.6 (.4) 
HOMA2-%B 134.4 (17) 
HOMA2-%S 75.6 (37) 
Triglycerides (mg/dL) 162.7 (7.5) 
Total Cholesterol (mg/dL) 184.5 (11.4) 
HDL (mg/dL) 38.4 (1.7) 
LDL (mg/dL) 117.9 (10.3) 
% Time Sedentary 69 (6.1) 
% Time Light Activity 21 (3.6) 
% Time Moderate Activity 10 (3) 
% Time Vigorous Activity 0 (0) 
Values are presented as mean (standard error). % of time spent in each activity were derived 
from accelerometry data (see methods). WB = whole body. 2-hr OGTT is plasma glucose at 2-
hours after a 75 gram oral glucose challenge. TG = triglycerides. HOMA2 calculated using the 











Values are mean ± SE. ATIRI = Adipose tissue insulin resistance index (higher = more insulin 
resistant). Ra=rate of appearance. Rd=rate of disappearance. FM=Fat mass. FFM= Fat-free mass. 
* denotes significant at p<.05 level. ‡ denotes exercise condition is greater than rest condition at 





Measure	   Rest	   Resistance 
Ex.	  
Sig.	   Carry-over	  
Effects	  
Basal FFA Ra	  
(umol/kg FM/min)	  
4.46 ± .49	   5.59 ± .70	   t(8)=2.4, p=.043* NS	  
Basal FFA Rd	  
(umol/kg FFM/min)	  
2.57 ± .37	   3.50 ± .55	   t(8)=2.66, p=.028*	   NS	  
ATIRI	  
(umol/min/mU/ml)	  
2.45 ± .44	   3.23 ± .76	   t(8)=2.091, p=.070	   NS	  
Postprandial FFA total Rd	  
(umol/kg FFM/min)	  
--	   --	   F(11,77)=2.49, p=.01* 
180 min (p=.043)‡ 
196 min (p=.016) ‡ 
480 min (p=.031) ‡ 
NS	  
Postprandial FFA total Ra	  
(umol/kg FM/min)	  
--	   --	   F(12,84)=1.736, p=.073	   NS	  
FFA Metabolic Clearance Rate	  
(L/kg FFM/min)	  
2.98 ± .40	   3.84 ± .67	   t(8)=2.01, p=.079	   NS	  
Postprandial FFA total Rd AUC	  





t(8)=2.03, p=.076	   NS	  










Table 3. Lipoprotein Kinetics 
Values are mean ± SE. FTR=Fractional turnover rate. Chylo=chylomicron. TRL-












Measure Rest EX Sig. Carry-over 
Effects 
TRL-TG FTR (pools/min) -0.004 (0.0006) -0.007(0.0014) .083 NS 
TRL-TG Mean Residence Time (min) 255.5 (34.1) 174.8 (24.1) .020* NS 
TRL-TG Clearance Rate (ml/min) -16.1( 2.1) -25.1 (4.5) .074 NS 
Chylo FTR (pools/min) -0.007 (0.0006) -0.010 (0.001) .054 NS 
Chylo Mean Residence Time (min) 153.5(14.0) 109.5 (11.03) .035* NS 
Chylo Clearance Rate (ml/min) -24.6 (2.05) -35.1 (3.4) .048* NS 
 
 122 














Figure 2. Change in total plasma triglycerides and free fatty acids 
 
Values are mean ± SE. A. Postprandial chylomicron iAUC in the rest and resistance exercise 
conditions. B. Postprandial VLDL iAUC in the rest and resistance exercise conditions. C. 
Postprandial TRL-TG iAUC in the rest and resistance exercise conditions. D. Postprandial total 
plasma TG iAUC in the rest and resistance exercise conditions. E. Postprandial FFA iAUC in the 
rest and exercise conditions. * Denotes significant difference between rest and exercise at p<.05. 












Values are mean ± SE. Black circles = rest condition. Gray circles = exercise condition. A. 13C4-
palmitate tracer to trace ratio (TTR) in chylomicrons, with the area under the curve (AUC) 
shown in the bar graph to the right throughout the study. There was a significant interaction 
between treatment and time for TTR of 13C4-palmitate in chylomicrons.  B. 13C4-palmitate 
concentration in chylomicrons, with the area under the curve (AUC) shown in the bar graph to 
the right. There was a significant interaction between treatment and time for the amount of 13C4-
palmitate in chylomicrons, and the total area under the curve for the amount of 13C4-palmitate in 
chylomicrons was significantly reduced after the resistance exercise session. C. 13C4-palmitate 
TTR in TRL-TG, with the area under the curve (AUC) shown in the bar graph to the right. There 
was a significant interaction between treatment and time for TTR of 13C4-palmitate in TR-TG. 
D. 13C4-palmitate concentration in TRL-TG, with the area under the curve (AUC) shown in the 
bar graph to the right. There was a significant interaction between treatment and time for the 
amount of 13C4-palmitate in TRL-TG, and the total AUC was significantly reduced after 
resistance exercise compared to rest. E. 13C4-palmitate TTR in plasma FFA, with the area under 
the curve (AUC) shown in the bar graph to the right. F. 13C4-palmitate concentration in plasma 
FFA, with the area under the curve (AUC) shown in the bar graph to the right. There was a main 
effect of treatment for the amount of 13C4-palmitate in plasma FFA (exercise lower than rest), and 
there was a trend toward a reduction in the total 13C4-palmitate AUC in plasma FFA. G. 13C4-
palmitate concentration in VLDL, with the area under the curve (AUC) shown in the bar graph to 
the right. There was a trend toward a reduction in the total 13C4-palmitate AUC after resistance 
exercise compared to rest. Meal indicates timing of mixed meal consumption. * Denotes 
significant difference between rest and exercise (p<.05). § Denotes trend toward significant 
















Values are mean ± SE. Black circles = rest condition. Gray circles = exercise condition. A. 13C16-
palmitate tracer to trace ratio (TTR) in chylomicrons, with the area under the curve (AUC) 
shown in the bar graph to the right throughout the study. There was a main effect of treatment 
(exercise lower than rest) for the TTR in chylomicrons.  B. 13C16-palmitate concentration in 
chylomicrons, with the area under the curve (AUC) shown in the bar graph to the right. There 
was a significant interaction between treatment and time for the amount of 13C16-palmitate in 
chylomicrons, and the total area under the curve for the amount of 13C16-palmitate in 
chylomicrons was significantly reduced after the resistance exercise session. C. 13C16-palmitate 
TTR in TRL-TG, with the area under the curve (AUC) shown in the bar graph to the right. D.  
13C16-palmitate concentration in TRL-TG. There was a significant interaction between treatment 
and time for the amount of 13C16-palmitate in TRL-TG, and the total AUC was significantly 
reduced after resistance exercise compared to rest. E. 13C16-palmitate TTR in plasma FFA, with 
the area under the curve (AUC) shown in the bar graph to the right. F. 13C16-palmitate 
concentration in plasma FFA, with the area under the curve (AUC) shown in the bar graph to the 
right. There was a main effect of treatment for the amount of 13C16-palmitate in plasma FFA 
(exercise lower than rest), and there was a significant reduction in the total 13C16-palmitate AUC 
in plasma FFA. G. 13C16-palmitate concentration in VLDL, with the area under the curve (AUC) 
shown in the bar graph to the right. Meal indicates timing of mixed meal consumption. * Denotes 
significant difference between rest and exercise (p<.05). § Denotes trend toward significant 













Figure 5. Lipid Oxidation 











Values are mean ± SE. A. Shows the rate of lipid oxidation (grams per minute) in the rest (black 
solid circles) and exercise (gray circles) conditions. Meal indicates timing of mixed meal 
consumption. Gray box labeled “Rest/Exercise” denotes timing of the rest or exercise session. 
Box labeled “Recovery Period” denotes timing of the 180 minute recovery period. B. Total AUC 
for lipid oxidation rate in A. There was a significant interaction between treatment and time for 
lipid oxidation rate (see Results for details). * denotes significantly different between rest and 






Chapter 4: Acute Effects of Resistance 
Exercise on Skeletal Muscle Mitochondrial 
Respiration, and Skeletal Muscle and 
Adipose Tissue Gene Expression in Obese 














Prediabetes is a metabolic state characterized by elevated fasting and/or postprandial 
glucose that develops in response to the onset and progression of peripheral insulin resistance.1 
One of the major contributors to insulin resistance is excessive delivery of triglycerides and fatty 
acids to non-adipose tissues such as skeletal muscle and liver (termed lipid overload).2 
Prediabetes is also characterized by elevated fasting and postprandial lipemia, which may 
develop secondary to a poor diet, changes in adipose tissue lipolytic activity, reductions in 
mitochondrial oxidative capacity, and deficits in fatty acid and lipoprotein clearance across 
multiple organs.3 Alterations in lipid metabolism typically antedate the onset of prediabetes and 
type 2 diabetes, and should, therefore, be a major focus of treament.4 
Recently, Straczkowski et al. found that skeletal muscle from individuals with impaired 
glucose tolerance, and from offspring of diabetic parents, had elevated levels of ceramide.5 
Accumulation of ceramide and other lipid intermediates such as acetyl-coA, NADH, 
diacylglycerols, cytosolic citrate, and long-chain acyl carnitine CoA have been shown to induce 
insulin resistance in skeletal muscle through inhibition of key protein kinases in the insulin 
signaling pathway.6,7 Overabundance of these intermediates as seen in prediabetic skeletal 
muscle could be caused by an imbalance between free fatty acid delivery (elevated lipolytic rate 
and lipemia) and clearance (lower mitochondrial beta oxidation or re-esterification as 
intramyocellular triglyceride).8 Similarly, deficits in oxidative enzyme activity, oxidative 
phosphorylation pathway activity, and intramyocellular triglyceride synthesis have been 
identified in obesity and in non-diabetic individuals with a family history of type 2 diabetes – 
providing additional evidence for the role of lipid imbalance in disease progression.9 
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While the mechanisms of diminished oxidative capacity in prediabetes are not fully 
understood, previous studies have shown that reactive oxygen species induce mitochondrial 
structural alterations, mitochondrial DNA damage, and mitochondrial dysfunction.10 Markers of 
mitochondrial DNA damage (8-OHdG, a marker of oxidation of deoxyguanosine) and reactive 
oxygen species are known to be elevated in prediabetes, along with reductions in uncoupling 
protein 3 – a protein known to protect the mitochondrial matrix from lipid-induced damage.11,12  
Taken together, these studies suggest that reductions in mitochondrial oxidative capacity, driven 
by lipid overload, excessive reactive oxygen species production, mitochondrial DNA damage, 
and a reduced protective capacity, contribute to insulin resistance and the development of 
prediabetes. Therefore, treatment approaches that increase mitochondrial oxidative capacity and 
lipid clearance are potentially important in the treatment of prediabetes and prevention of type 2 
diabetes. 
Physical inactivity is known to reduce insulin sensitivity and reduce mitochondrial 
respiration in skeletal muscle.13 In contrast, increasing physical activity can increase skeletal 
muscle oxidative capacity and improve lipid metabolism in healthy lean and obese populations.14-
18 Much less is known regarding the benefits of exercise on skeletal muscle oxidative capacity in 
those with prediabetes and type 2 diabetes. In particular, the mitochondrial response to  
resistance exercise has received little investigative attention despite being a central component of 
exercise recommendations for these individuals. Therefore, the purpose of this study was to 
investigate the impact of a single bout of acute resistance exercise on skeletal muscle 
mitochondrial oxidative capacity and skeletal muscle and adipose tissue gene expression in the 
postprandial state in obese, sedentary, prediabetic males. We hypothesized that acute resistance 
exercise would improve measures of skeletal muscle mitochondrial lipid and pyruvate 
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respiration, and that these changes would be accompanied by increases in gene expression 




Participants were recruited from the Washington University School of Medicine Diabetes 
Clinic, Washington University’s Volunteers for Health, the Center for Community Based 
Research, and from the surrounding St. Louis Community. Participants were included if they 
were male, aged 30-65 years with, a BMI of 28-45 kg/m2, and diagnosis of prediabetes (HbA1c 
>5.7 but <6.5%, or fasting plasma glucose >100 mg/dl, or 2-hour OGTT >140 mg/dL but <200 
mg/dL). Participants were excluded for having diagnosis of type 2 diabetes, use of insulin, 
participation in regular exercise (≥ 2x/week) within the previous 6 months; history or evidence of 
serious pulmonary or cardiovascular disease; coagulation disorders (platelets <100,000, PT >2 
seconds above control or INR >1.5); anemia (hemoglobin <10.0 g/dL); any orthopedic, 
neurologic, metabolic or other medical condition that would prohibit the ability to perform 
resistance exercise; or joint replacement within the last year. Each participant read and signed an 
IRB-approved protocol and informed consent that was approved by the Human Research 





This study utilized a randomized crossover design to assess changes in skeletal muscle 
mitochondria lipid and pyruvate respiration and gene expression after a single bout of resistance 
exercise vs. an equivalent period of rest. Participants who qualified for the study were then 
randomly assigned to one of two treatment orders: a rest visit followed by an exercise visit, or an 
exercise visit followed by a rest visit. In both groups, participants completed the rest and exercise 
visits on separate days >1 week apart.  
 
Screening Visit: Participants were screened prior to enrollment to confirm diagnosis of 
prediabetes and absence of exclusion criteria. After an overnight fast, participants reported to the 
Washington University in St. Louis Clinical and Translational Research Unit (CTRU) where 
height (stadiometry), weight, BMI, and body composition were measured and a history and 
physical were performed by a licensed endocrinologist. An intravenous catheter was inserted into 
the antecubital vein to collect baseline fasting blood samples, which were analyzed for plasma 
glucose, HbA1c, a lipid panel, a comprehensive metabolic panel (CMP), and complete blood 
count (CBC).  
 
Body Composition 
Each participant received whole-body dual energy x-ray absorptiometry (DXA) scans (Hologic 
Discovery GDR 1000/W, software version 12.6.2 OD; Waltham, MA) to assess regional and 
composite lean and fat mass in grams. Image analysis and sub-region (thigh, leg, trunk, upper 
extremities) composition quantification was carried out following the guidelines provided by 




Oral Glucose Tolerance Test (OGTT) 
Two-hour, 75-gram OGTTs were performed at baseline after a 12-hour overnight fast during the 
screening visit. All OGTTs were started between 7am and 9am. 2-hour plasma glucose values 
were used to identify individuals with our without prediabetes. Plasma glucose was measured 
with the glucose oxidase method (YSI Stat Plus, Yellow Springs, OH) and insulin by double 
antibody radioimmunoassay. An index of insulin resistance (IR), beta cell function (HOMA-
%B), and insulin sensitivity (HOMA-%S) were calculated using the Homeostatic model 
assessment (HOMA) 2 using the HOMA2 calculator.19 
 
Strength Testing 
One repetition maximum (1RM) assessments were performed on a Hoist single pod machine 
(San Diego, CA, USA) according to guidelines established by the American College of Sports 
Medicine. The maximum weight lifted through the full range of motion with proper form was 




Daily physical activity of participants was determined by actigraphy (ActiGraph GT3X+ 
accelerometer, ActiGraph LLC, Pensacola, FL). The GTX3+ was placed on the non-dominant 
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wrist with Actigraph non-removable wristbands at the completion of the Screening visit. The 
wristbands were cut off by the study team when participants returned for their second visit to 
ensure the accelerometers were worn for the entire data collection period. ActiGraph data was 
collected for seven consecutive days at 30 Hz. The accelerometer output was sampled by a 12-bit 
analog-to-digital converter. The percentage of time spent sedentary as well as the amount of time 
spent participating in different categories of physical activity including light, lifestyle, moderate, 
and vigorous were calculated using algorithms from Freedson in the ActiGraph software.20 
 
Rest and Exercise Visits: Figure 1 depicts the study schedule. For the rest and exercise visits, 
participants reported to the CTRU the morning after an overnight fast (10 h) with nothing taken 
by mouth except water. Study participants were instructed to maintain their current dietary and 
activity habits throughout the entire duration of the study. The day prior to the study visit, 
subjects were provided a standardized meal for breakfast (522 Kcal), lunch (722 Kcal, snack 180 
Kcal), and dinner (779 Kcal) made by the Washington University CTRU Metabolic Kitchen. 
Participants were also instructed to consume a liquid formula (Ensure; Ross Laboratories, 
Columbus, OH) containing 250 kcal (40 g carbohydrates, 6.1 g fat, and 8.8 g protein) to ensure 
complete filling of hepatic glycogen stores as a snack before bedtime. After admission, height 
and weight was measured using a standard scale and stadiometer, and an IV catheter was inserted 
into the antecubital vein to collect a baseline fasting blood samples. Fasting blood samples were 
collected in heparinized tubes for glucose, insulin, and c-peptide, citrate-lined tubes for a PT-
INR (for safety of muscle biopsy), and EDTA-lined tubes for lipid kinetics analysis.  
One hour after the baseline IV placement and blood draws, participants completed either 
one hour of resistance exercise, or one hour of rest. During the rest visit, participants laid in bed 
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for 1 hour without physical activity. During the exercise visit, participants completed 1 hour of 
resistance exercise. The exercise session consisted of 8 exercises (bench press, pull down, seated 
row, biceps curl, knee extension, leg press, and overhead press) all performed for 3 sets of 8-12 
repetitions at 80% of their measured 1RM until volitional fatigue. Participants were given no 
more than 1 minute of rest between sets, and no more than 3 minutes rest between exercises. All 
exercise sessions were supervised by a licensed physical therapist.  
Following completion of the exercise or rest session, the antecubital catheter was 
prepared for the administration of prime-constant infusions of stable isotope tracers. 
Additionally, a second catheter was inserted into a hand vein on the contralateral arm, with the 
hand warmed to 55°C using a thermostatically controlled hot box to obtain arterialized blood 
samples. The catheter was kept patent throughout the study day, using a 0.9% saline solution. 30 
minutes after the rest or exercise session, a primed, constant infusions of [6,6-2H2]glucose (28 
μmol/kg prime and 0.28 μmol•kg-1•min-1 continuous infusion), was administered for 180 
minutes to achieve isotopic steady state (data not presented in this paper). 90 minutes after the 
rest or exercise session, primed, constant infusions of [NaH13CO3 (1 umol/kg priming dose), and 
[U-13C16]palmitate (.0053 μmol•kg-1•min-1 continuous infusion) were administered for 120 
minutes to achieve isotopic steady state. Blood samples were collected at -70, 100, 110, and 120 
minutes from the start of the palmitate tracer infusion. Blood was collected in EDTA tubes for 
lipid kinetics analysis. 
Following the 210-minute Baseline Period, participants consumed a liquid test meal 
consisting of 20 Kcal/FFM, with a composition of 47.8% CHO, 36.1% fat, and 16.1% protein. 10 
mg/kg body weight of [1,1,1,2,2,2,3,3,3,4,4,4-13C12]tripalmitin was added to the test meal and 
thoroughly mixed. The tripalmitin was emulsified in lecithin and vegetable oil, which was 
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microwaved for 5 minutes to warm. The emulsified mixture was then added to Boost Plus, 
microwaved, and sonicated to evenly distribute the tracer. To ensure individuals ate from the 
same meal on each visit, one large mixture was prepared and then split in half (each half 
consumed during the rest and exercise visit). Participants were asked to consume the liquid meal 
within 16 minutes for consistency (1/4 of the meal provided every 4 minutes). The sides of the 
container were rinsed with 10 ml of water and the rinse was also consumed to ensure participants 
ingested the whole meal. Finally, 30 minutes after consuming the meal, a 75 umol/kg bolus 
infusion of (1,1,2,3,3-2H5)glycerol was initiated to track lipoprotein turnover kinetics. The 
infusions of the [U-13C16]palmitate and [6,6-2H2]glucose were continued throughout the 
postprandial period. Blood samples were collected at 0, 15, 30, 45, 60, 90, 120, 150, 180, 240, 
300, and 360 minutes post-meal ingestion. Water was consumed ad libitum during recovery, but 
aside from the test meal, study participants consumed no other beverages and no food until the 
400-min postprandial measurement period ended.   Isolated plasma was analyzed for free fatty 
acid, triglyceride, glycerol, and glucose tracer enrichment. Samples of the liquid test meal, as 
well as the tracers used were collected for enrichment analysis. All tracers were purchased from 
Cambridge Isotopes (Cambridge, MA).  
 
Sample Analysis 
Blood for plasma hormone and metabolite analysis was collected from an antecubital vein, 
immediately placed in chilled EDTA tubes, centrifuged at 2000xg for 10 minutes, and the 
supernatant collected and frozen at -80°C until analysis. Fasting samples were analyzed were 
used for comprehensive metabolic panel, lipid panel, CBC, and HbA1c. Plasma insulin 
concentration was measured by radioimmunoassay. The plasma insulin assay range is 2–300 
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µU/mL and the interassay coefficient of variation is 4% in the low (10.5 uU/mL) and high 




Muscle biopsy samples were obtained from the vastus lateralis under local anesthesia (lidocaine, 
2%) 90 minutes after consuming the liquid test meal using a Tilley-Henkel forceps. One sample 
was immediately transferred into ice-cold relaxing medium (BIOPS) containing 10 mmol/l 
Ca2+/EGTA buffer, 20 mmol/l imidazole, 50 mmol/l K+-4-morpholinoethanesulfonic acid 
(Mes), 0.5 mmol/l dithiothreitol, 6.56 mmol/l MgCl2, 5.77 mmol/l ATP; 15 mmol/l 
phosphocreatine at pH 7.1 for mitochondrial respirometry analysis. A second sample was flash 
frozen in liquid nitrogen and stored at -80 until further analysis.  
Subcutaneous Adipose Tissue 
Abdominal adipose tissue was obtained by needle aspiration. The biopsy site was anesthetized 
with 1% lidocaine, and adipose tissue was aspirated with a 10-mL syringe and a 14-gauge 
needle. Tissue samples were vigorously irrigated with iced saline and flash frozen in liquid 
nitrogen. Adipose samples were stored at -80 until analysis 
 
Skeletal Muscle Mitochondrial Respiration 
Subsamples of 5 mg wet weight (Ww) were transferred into BIOPS onto a small petri dish on an 
ice-cold metal plate and separated using forceps with sharp tips. To ensure complete 
permeabilization the fibers were incubated by gentle agitation at 4°C in BIOPS solution 
containing 50 μg/ml saponin for 20 min. Fibers were washed for 10 min at 4°C in ice-cold 
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mitochondrial respiration medium [MiR06; 0.5 mM EGTA, 3 mM MgCl2, 60 mM K-
lactobionate, 20 mM taurine, 10 mM KH2PO4, 20 mM HEPES, 110 mM sucrose and 1 g/l BSA 
essentially fatty acid free, adjusted to pH 7.1, 2,800 units/mg solid catalase lypophilized 
powder], and wet weight of the fibers was measured on a microbalance (Mettler Toledo, 
Greifensee, Switzerland). With this method, the cholesterol-rich plasma membrane is selectively 
permeabilized, leaving intracellular membrane structures, such as mitochondria intact, and the 
entire mitochondrial population can be studied in the muscle sample. 
Three milligrams (3mg) wet weight was used per respirometer chamber (Oxygraph-2k; 
Oroboros Instruments, Innsbruck, Austria) containing 2.090 ml MiR06 at 37°C. Oxygen 
concentration (μM = nmol/ml) and oxygen flux (pmol·s−1·mg−1; negative time derivative of 
oxygen concentration, divided by muscle mass per volume) were recorded using DatLab 
software (Oroboros Instruments). The Oxygraph-2k is a two-chamber titration-injection 
respirometer with a limit of detection of volume-specific oxygen flux of 1 pmol·s−1·ml−1. 
Instrumental background oxygen flux was corrected online, accounting for sensor oxygen 
consumption and oxygen diffusion between the medium and the chamber boundaries. The 
oxygen concentration in the chamber was maintained between 150 and 400 μM to avoid oxygen 
limitation of fiber respiration. Intermittent re-oxygenations were achieved by injecting .5 mL 
oxygen. 
The substrate-uncoupler-inhibitor titration protocol (Table 1) was as follows (final 
concentrations): palmitoylcarnitine (0.05 mM), L-carnitine (5 mM), and Malate (.5 mM) to 
support electron entry from fatty acid β-oxidation through electron-transferring flavoprotein 
(ETF) and Complex I (CI) to coenzyme Q. Prior to the addition of ADP, oxygen utilization 
occurs due to proton slip across the inner mitochondrial membrane (LEAK respiration). ADP (4 
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mM) was then added to stimulate fatty-acid supported oxidative phosphorylation (ETF + CI)Lip. 
The subsequent addition of pyruvate (10 mM) stimulates glycolytic oxidative phosphorylation. 
Glutamate (10 mM) was then added, followed by succinate (10 mM) to recapitulate the TCA 
cycle and stimulate maximal oxidative phosphorylation [(ETF + CI + CII)Lip + Pyr] through both 
ETC complex I and complex II. Cytochrome c (10 μM) is added to test the integrity of the outer 
mitochondrial membrane. The increase of flux with cytochrome c was on average 3.3 ± 0.4%. 
Electron transfer system capacity (CI+IIE) was reached by stepwise (.5 μM) addition of the 
uncoupler carbonylcyanide p-trifluoromethoxyphenylhydrazone (FCCP). Finally, the addition of 
rotenone (0.5 μM), an inhibitor of complex I was used measure succinate-supported ETS 
capacity (CIIE). Figure 2 and Table 1 outlines the titration protocol used in this study, and the 
respiratory states included in this analysis. Table 3 outlines the flux control and substrate control 
ratios calculated in this study. 
 
Real-Time Polymerase Chain Reaction (RT-PCR) 
Total RNA was isolated from skeletal muscle and subcutaneous adipose tissue samples using 
Trizol reagent (#15596018; Invitrogen, Carlsbad, CA) and RNeasy mini kit (#74104; Qiagen, 
Valencia, CA) respectively. Total RNA was reverse transcribed into cDNA by using the High-
Capacity cDNA Reverse Transcription Kit (#4368813; Invitrogen).  Relative gene expression 
was determined by using an ABI 7500 real-time PCR system (Invitrogen) and SYBR Green 
Master Mix (Invitrogen) as previously described (PMID: 29634313; 29294006; 27498863;   
27732859; 26916363; 29687616).  The expression of each gene was determined by normalizing 
the Ct (cycle threshold) value of each sample to the housekeeping control gene, ribosomal 





Participant demographics were analyzed using mean ± SE. Data were analyzed for normality 
using the Shapiro-Wilk test. Differences between rest and exercise on respiration and qPCR 
outcomes were analyzed according to the procedures outlined by Wellek and Blettner (2012) for 
cross-over designs, testing first for carry-over effects, followed by testing for treatment effects.22 




Nine male participants were enrolled in the study. Participants had a mean age of 50, were obese 
(mean BMI: 33 ± 3), and mostly sedentary (mean % time sedentary: 69 ± 6.1%). All participants 
were pre-diabetic, with the group means for HbA1c, 2-hour plasma glucose of the OGTT, and 
fasting plasma glucose all within the pre-diabetic range (Table 1). Four (n=4) participants had 
HbA1c values > 5.7%, n=6 had fasting plasma glucose values >100 mg/dL (5.5 mmol/L), and 
n=4 participants had 2-hour OGTT values >140 mg/dL (7.8 mmol/L). The average % body fat 
was in the 75th percentile for individuals in their age group as established by the NHANES.36 
Participants also demonstrated insulin resistance according to the HOMA2 model (HOMA2-IR, 
HOMA2-%S), with compensatory increases in beta cell function (HOMA2-%B). Participants 
also presented with  elevated total triglycerides (normal: <150 mg/dL, participant mean: 162.7 
mg/dL), LDL (normal: <100 mg/dL, participant mean: 117.9 mg/dL), with slightly reduced HDL 





Muscle biopsies were obtained from n=8  participants. Acute resistance exercise significantly 
increased maximal lipid oxidation (t(7)= 4. 49, p=.003), maximal complex I supported lipid + 
pyruvate oxidation (t(7)= 6.93, p<.001), maximal oxidative phosphorylation through complex I 
and II (t(7)= 5.64, p<.001), maximal electron transport capacity (t(7)= 3.31, p=.012), and 
maximal complex II supported respiration (t(7)= 3.51, p=.009). Leak respiration was not 
significantly elevated following the exercise session (t(7)= 1.24, p=.254) compared to the rest 
condition. No carry-over effects were identified for any of the variables (Figure 3). 
 
Skeletal Muscle Mitochondrial Flux and Substrate Control Ratios 
Following acute resistance exercise, OXPHOS control ratio and the respiratory control ratio 
significantly increased compared to the rest condition, however phosphorylation control ratio or 
leak control ratio were not different between acute resistance exercise and rest conditions (Table 
5). Complex I supported lipid respiration normalized to maximal oxidative phosphorylation, 
complex I supported lipid respiration normalized to maximal electron transport capacity, the 
lipid to glucose oxidation ratio, and the free oxidative phosphorylation capacity following acute 
resistance exercise significantly increased compared to rest (Table 5). 
 
Skeletal Muscle Gene Expression 
RNA was isolated in muscle biopsy samples from n=8 participants. However, RNA in n=1 
sample was degraded therefore data was analyzed from samples for qPCR analysis in n=7 
participants. Following acute resistance exercise, expression of PGC1alpha increased ~1.8 fold 
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(p=0.014), PDK4 increased 4.8-fold (p=0.006) compared to the rest condition, FOXO1 increased 
1.62-fold above rest (p<.05), and MURF1 increased 2.46 above rest (p<0.05) (Figure 4). 
Lipoprotein lipase (LPL) expression tended to increase after resistance exercise (1.8-fold above 
rest condition, p=0.120) (Figure 4). SREBF1 (SREBP1) expression decreased after resistance 
exercise compared to the rest condition (p=0.016) (Figure 4). Expression of fatty acid synthase 
(FASN, p=.455), acetyl-CoA Carboxylase alpha (ACACA, p=.580), carnitine 
palmitoyltransferase 1 beta ( CPT1B, p=.0195), carnitine palmitoyltransferase 1 alpha ( CPT1A, 
p=0.847), uncoupling protein 3 ( UCP3, p=0.321), or CD36 (p=.0502) were not different 
between resistance exercise and rest. 
 
Abdominal Subcutaneous Adipose Tissue Gene Expression 
Abdominal subcutaneous tissue biopsies were collected from n=6 participants. The resistance 
exercise session resulted in a significant 1.4-fold increase in FOXO1 expression (p=0.034), a 
1.4-fold increase in PDK4 expression (p=0.028), a 1.3-fold increase in LPL expression 
(p=0.041), a 1.27-fold increase in HSL expression (p=0.039), and a 1.28-fold increase in 
ADIPOQ expression (p=0.038) (Figure 5). There was, likewise, a trend toward increased CD36 
expression (1.2-fold increase, p=0.070), and ATGL expression (1.23-fold increase p=0.100). 
 
Discussion 
In this study, we found that a single bout of moderate intensity resistance exercise 
increased skeletal muscle maximal lipid respiration, as well as coupled and uncoupled respiration 
in in obese men with prediabetes. To our knowledge, this is the first study to demonstrate that 
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acute resistance exercise increases the contribution of lipid oxidation to overall energy 
production (evidenced by increased lipid oxidation relative to maximal oxidative 
phosphorylation and the lipid to glucose oxidation ratio) and that these increases occurred 
concurrently with increased expression of PGC1alpha, PDK4, and FOXO1, as well as reductions 
in SREBP1. This pattern of gene expression in skeletal muscle could be expected to promote 
glucose storage and lipid oxidation in skeletal muscle.23,24 Previous studies have found reduced 
skeletal muscle lipid oxidation capacity (or rate) in individuals with prediabetes, which has been 
implicated in the development of insulin resistance.8 Increasing lipid oxidation with resistance 
exercise could potentially prevent the development of lipotoxicity by clearing lipid and toxic 
intermediates that are known to interfere with insulin signaling.6 Therefore, improvements in 
mitochondrial respiration and oxidative gene expression could be important in preventing disease 
progression and reducing the risk for cardiovascular disease. 
Additionally, we found that a single session of resistance exercise increased the 
expression of FOXO1, PDK4, HSL, ADIPOQ, and LPL in adipose tissue. These genes work 
cooperatively to mobilize stored FFA and increase lipoprotein hydrolysis (while storing glucose) 
in adipose tissue, which supports our previous findings of increased FFA rate of appearance (i.e. 
adipose tissue lipolytic rate) after resistance exercise.25,26,27 Increases in FFA availability 
complements the increase in FFA oxidation we observed in skeletal muscle mmitochondria. 
Compared with healthy people,  individuals with prediabetes demonstrate diminished 
responses to exercise, even after high-intensity interventions.28 Likewise, in mouse models of 
diabetes, chronic resistance exercise failed to improve state 3 (coupled) respiration in cardiac 
mitochondria, suggesting that resistance exercise may not be enough of a stimulus to improve 
mitochondrial function in striated muscle.29 In contrast to these results, we were able to find 
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significant improvements in skeletal muscle mitochondrial respiration in obese men with 
prediabetes after just a single session of moderate intensity resistance exercise. Of note, the 
greatest improvements in respiration occurred in complex I-supported respiration, which 
coincides with work by Porter et al. (2015) and van Schaardenburgh et al. (2016), who found that 
resistance exercise tended to increase protein content of complex I only, and that changes in 
complex I-supported respiration occur in as little as 15 minutes after resistance exercise. 16,30 
Further research is needed to identify the mechanism of this rapid response.   
The mechanisms associated with improvements in skeletal muscle mitochondria 
following acute resistance exercise in individuals with prediabetes are not known. Following 
acute resistance exercise, we found increased gene expression of PGC1alpa, PDK4, and FOXO1, 
as well as reduction in SREBP1.  PGC1alpha is a transcription co-activator that regulates several 
transcription factors including those associated with adaptive thermogenesis, mitochondrial 
biogenesis, glucose and fatty acid metabolism, fiber-type switching to oxidative phenotypes, and 
cardiac development.31,32 Knockout of skeletal muscle PGC1alpha results in declines in state 3 
and state 4 respiration in both subsarcolemmal and intramyofibrillar mitochondria.33 In contrast, 
cardiac myocytes overexpressing PGC1alpha demonstrate 2.8-fold greater rate in mitochondrial 
oxygen consumption secondary to amplification of coupled respiration.34 Previous studies have 
shown that PGC1alpha expression increases mRNA content of genes involved in the electron 
transport chain (most notably in subunits complexes II, IV, and cytochrome C) as well most 
genes involved in the tricarboxylic acid cycle, β-oxidation, and fatty acid transport.35-37 While 
PGC1alpha may exert the majority of its influence on coupled respiration, overexpression of 
PGC1alpha in myotubes has also been shown to increase uncoupled respiration above control 
cells.36 Although PGC1alpha regulates many aspects of oxidative metabolism, previous research 
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is conflicting with regard to the ability of resistance exercise to increase PGC1alpha expression. 
Some studies have found increases in PGC1alpha mRNA content (38, 39, 40), while other have 
not (41,42) following acute and chronic resistance exercise in mice and healthy humans. In the 
current study, we found a 1.76-fold increase in PGC1alpha mRNA content, providing support for 
the capacity for resistance exercise to induce skeletal muscle PGC1alpha expression. The 
increases in coupled and uncoupled respiration we identified in this study are consistent with the 
known functions of PGC1alpa in skeletal muscle. 
Acute resistance exercise also increased the expression of PDK4 (pyruvate 
dehydrogenase kinase 4). PDK4 has been shown to stimulate free fatty acid oxidation by: 1) 
inhibiting pyruvate dehydrogenase kinase, reducing the concentration of acetyl-coA, and limiting 
malonyl-coA production (inhibits fatty acid entry into the mitochondria); and 2) by shunting 
absorbed glucose to glycogen storage rather than oxidation.43,44 Following aerobic or resistance 
exercisefox, the combined signals from glycogen depletion and increased FFA availability may 
be a strong stimulus for PDK4 expression via activation of forkhead box (FOXO) transcription 
factors 1 and 3 to the nucleus, where FoxO1 can bind directly to the promoter region of the 
PDK4 gene.45 FOXO1 is highly sensitive to changes in FFA and insulin concentrations, and has 
therefore been implicated in the balance between lipid and carbohydrate oxidation and storage.45 
Similar to PDK4, we found increased expression of FOXO1 gene expression, indicating an 
upregulation of this signaling pathway after resistance exercise to promote lipid oxidation. 
Indeed, we found a significant increase in the ratio of lipid to carbohydrate oxidation -- 
suggesting a greater contribution from free fatty acid to oxidation, which closely mirrors the 
known influence of both PDK4 and PGC1alpha. In healthy men, Gallagher et al. (2013) found 
that acute moderate-intensity resistance exercise (3 sets of knee extensor resistance exercise at 
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90% of their 10-repetition maximum) increased PDK4 gene expression in type I and type II 
muscle fibers (7.4-fold and 8.1-fold respectively).45  These results, together with the current 
study, suggest that acute moderate intensity resistance exercise increases skeletal muscle lipid 
oxidation through activation of PDK4 in both healthy and prediabetic men. Of note, previous 
studies have shown that overexpression of PGC1alpha increases PDK4 mRNA content and slows 
glycolytic flux – providing a potential mechanistic link between PGC1alpha and PDK4.23 
In response to acute resistance exercise, we also found reductions in skeletal muscle 
Sterol Regulatory Element Binding Protein 1 (SREBP1) expression. SREBP proteins are 
transcription factors that control lipid metabolism and cholesterol synthesis primarily in 
lipogenic tissues (liver and adipose tissue).46 In skeletal muscle, SREBP1 may play a role in the 
anabolic response to resistance exercise, with previous studies demonstrating that overexpression 
SREBP1 in myoblasts inhibits the expression of myogenic regulatory factors (e.g. myogenin, 
MyoD, and MEF2C) needed for myogenic differentiation.47 Moreover, overexpression of 
SREBP1 reduced protein synthesis rates and increased protein degradation, providing a 
mechanistic link between SREBP1 expression and muscle size and hypertrophy.46 Previous 
studies have found that SREBP1 expression increases fatty acid synthase activity and 
intramyocellular triglyceride content and could therefore play a role in skeletal muscle lipid 
balance.48 After acute resistance exercise, we found a significant reduction in SREBP1 
expression, as well as fatty acid synthase expression (trend toward significant). This pattern of 
expression is consistent with the changes in PGC1alpha and PDK4 in that it promotes free fatty 
acid mobilization and oxidation rather than storage. However, we did not measure 
intramyocelluar triglyceride content in the current study is should be further studied. 
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While SREBP1 has been shown to regulate the expression of myogenic regulatory 
factors, MURF1 is an E3 ligase expressed in striated skeletal muscle where is involved in the 
ubiquitination and proteolysis of muscle proteins.49 A recent review by Murton and Greenhaff 
found that MuRF1 mRNA expression was upregulated 1-4 hours after acute bouts of resistance 
exercise in healthy subjects.49 MuRF1 expression, like PDK4, is stimulated by FOXO1 and is 
believed to be a central component of protein breakdown needed for muscle remodeling after 
resistance exercise.49  Taken together, MuRF1 expression may have been stimulated by resistance 
exercise as part of skeletal muscle remodeling responses to the exercise session. 
Acute resistance exercise also tended to increase skeletal muscle lipoprotein lipase (LPL) 
expression 4.5 hour following exercise. One of the major contributors to increased FFA 
availability in the postprandial period is the secretion of triglyceride-rich lipoproteins in the form 
of chylomicrons (from the small intestine), and very low density lipoproteins (VLDL from the 
liver).42 These lipoproteins are hydrolyzed by LPL in the endothelium of the vasculature of 
peripheral tissues, including skeletal muscle and adipose tissue.50 Few studies have examined 
changes in skeletal muscle lipoprotein lipase expression after resistance exercise, and the results 
have been conflicting. Tsintzas et al. (2017) found that an acute bout of resistance exercise (leg 
press and knee extension) did not have an effect on skeletal muscle mRNA content of LPL in 
healthy young men.51 In contrast, Kiens et al. (1989) reported that single leg knee extensions 
increased muscle LPL activity 4-hours after exercise, but not after 8 hours in healthy young 
men.44 Our data support the findings by Kiens et al. although our data lacked statistical 
significance. Individuals with prediabetes might have a blunted LPL response to acute resistance 
exercise; however this requires further study.52  In individuals with prediabetes and type 2 
diabetes, there is a positive correlation between insulin sensitivity and skeletal muscle LPL 
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activity, suggesting a role of lipoprotein metabolism in disease progression.53 Resistance exercise 
might increase LPL expression and with chronic resistance exercise, increase LPL content, 
thereby improving lipoprotein and FFA clearance, reducing postprandial triglycerides, thus 
reducing the risk for cardiovascular disease. However, this requires further investigation. 
In addition to changes in skeletal muscle gene expression, we also found differences in 
genes regulating glucose and lipid metabolism in subcutaneous adipose tissue, including 
FOXO1, PDK4, LPL, HSL, and adiponectin. Like skeletal muscle, FOXO1 expression plays a 
central role in lipid and glucose metabolism in adipose tissue. In periods of stress, cold exposure, 
or nutrient deprivation, FOXO1 is redistributed to the nucleus and is transcriptionally active.25 
Consistent with its role in skeletal muscle, FOXO1 activates a gene network involved in lipid 
mobilization, inhibition of lipid storage and fat accumulation, and sparing of glucose.54 This 
function compliments it’s role in skeletal muscle by mobilizing fatty acids to support FOXO1-
driven increases in lipid oxidation.1 In contrast, insulin mediates FOXO1 nuclear exclusion 
through phosphorylation by Akt.55 We found a trend toward a significant increase in ATGL, 
which is responsible for the bulk of triglyceride lipolysis in adipose tissue.25 Previous studies 
have shown that FOXO1 expression in adipose tissue induces ATGL expression, and that insulin 
inhibits the expression of ATGL in adipocytes by restraining the nuclear localization of 
FOXO1.25 Likewise, we also found a significant increase in hormone sensitive lipase (HSL), 
another important lipolytic enzyme with function consistent with ATGL.25 
Upregulation of PDK4 expression in adipose tissue results in an increase in 
glyceroneogenesis – a pathway that uses pyruvate, alanine, glutamine or any substances from the 
TCA cycle as precursors to synthesize glycerol-3-phosphate.26 The increase in glycerol-3-
phosphate may promote re-esterification of non-esterified fatty acids from lipolysis, thereby 
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limiting excessive plasma FFA production while also reducing substrate for glucose oxidation.27 
To the author’s knowledge, no previous studies have explored PDK4 expression in adipose tissue 
after resistance exercise. This is the first study to show that a single session of resistance exercise 
may influence glyceroneogenesis in adipose tissue, which could play a role in adipocyte size and 
body fat accumulation. Likewise, lipoprotein lipase is the rate-limiting enzyme for the uptake of 
chylomicron and VLDL triglyceride-derived fatty acids in adipose tissue.56 Increased LPL 
expression, as we found with resistance exercise, could facilitate increased FFA uptake in the 
postprandial period, as adipose tissue is a major source of endogenous and exogenous FFA 
clearance.56  
Adiponectin is an adipokine that is reduced in obesity and insulin resistance, including 
type 2 diabetes.57 Adiponectin has been shown to play a central role in the modulation of glucose 
and lipid metabolism by promoting glucose uptake and storage, while augmenting lipid oxidation 
in skeletal muscle.58 It has also been shown to increase skeletal muscle insulin sensitivity, 
increase muscle fatty acid transport, and reduce inflammation in endothelial, muscle, and 
epithelial cells.58 We found that resistance exercise significantly increased the adiponectin 
(ADIPOQ) gene expression, which could, together with increased protein translation, improve 
lipoprotein clearance, free fatty acid uptake in adipose tissue, and further augment lipid oxidation 
in skeletal muscle. Previous studies on the effects of acute resistance exercise in healthy men and 
women found that resistance exercise did not increase plasma levels of adiponectin despite 
lowering plasma glucose when measured 15 hours post-exercise.59 We found elevated ADIPOQ 
expression  4.5 hours after resistance exercise. Taking these studies together, it may be that 1) 
the acute effects of resistance exercise on adiponectin levels may dissipate in less than 15 hours, 
or 2) that the magnitude of adiponectin mRNA expression after resistance exercise may not be 
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enough to change adiponectin protein concentrations after just a single session.59 However, this is 
unclear as we did not measure plasma adiponectin concentration in the current study. 
In conclusion, we found that a single bout of resistance exercise increased mitochondrial 
respiratory capacity and lipid oxidation in obese men with prediabetes. These adaptations 
occurred concurrently with changes in skeletal muscle (PGC1alpha, PDK4, SREBP1, FOXO1, 
and MURF1) and adipose tissue (FOXO1, PDK4, HSL, ADIPOQ, and LPL) gene expression. 
Together, these genes cooperate to mobilize stored FFA and increase lipoprotein hydrolysis (and 
storing glucose) in adipose tissue, while increasing lipid uptake and oxidation in skeletal muscle. 
Improvements in lipid clearance through oxidation could reduce the risk for progression from 
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Table 1. Substrate-uncoupler-inhibitor titration (SUIT) protocol. 
 
FFA = free fatty acids. P and OXPHOS = oxidative phosphorylation (couples respiration). E and 
ETS = electron transport chain capacity/uncoupled respiration. ETF = electron transport 
flavoprotein. CI = electron transport chain complex I. L and LEAK = leak respiration. Lip = 
respiration in response to palmitylcarnitine titration. CII = electron transport chain complex II. 
PC = palmitoylcarnitine, Mal = malate. Pyr = pyruvate. Glut = glutamate. Succ = succinate. 






















Definition Abbreviation Flux State Titration 
Leak (ETF + CI)LEAK L PC + Mal 
FFA Oxidation through CI (ETF + CI)Lip  PC + Mal + ADP  
Combined FFA and 
Pyruvate Oxidation 
Through CI 
(ETF + CI)Lip+Pyr 
 
 PC + Mal + ADP + Pyr + Glut 
Max OXPHOS (ETF + CI + 
CII)Lip+Pyr 
 
P PC + Mal + ADP + Pyr + Glut + 
Succ 
Maximal ETS (ETF + CI + CII)E 
 
E PC + Mal + ADP + Pyr + Glut + 
Succ + FCCP 
CII Supported Respiration (CII)E  PC + Mal + ADP + Pyr + Glut + 















Gene Accession No. Forward (F) and reverse (R) primer 
FOXO1 NM_002015 F: 5’- TCGTCATAATCTGTCCCTACACA -3’ 
 
 R: 5’- CGGCTTCGGCTCTTAGCAAA -3’ 
PPARGC1A NM_013261 F: 5’- TCTGAGTCTGTATGGAGTGACAT -3’ 
 
 R: 5’- CCAAGTCGTTCACATCTAGTTCA -3’ 
PDK4 NM_002612 F: 5’- GGAGCATTTCTCGCGCTACA -3’ 
 
 R: 5’- ACAGGCAATTCTTGTCGCAAA -3’ 
LPL NM_000237 F: 5’- TCATTCCCGGAGTAGCAGAGT -3’ 
 
 R: 5’- GGCCACAAGTTTTGGCACC -3’ 
SREBF1 NM_001005291 F: 5’- ACAGTGACTTCCCTGGCCTAT -3’ 
 
 R: 5’- GCATGGACGGGTACATCTTCAA -3’ 
MURF1 NM_032588 F: 5’- CTTCCAGGCTGCAAATCCCTA -3’ 
 
 R: 5’- ACACTCCGTGACGATCCATGA -3’ 
CD36 NM_000072 F: 5’- ATGTTGGAGCATTTGATTGAAAAAT -3’ 
 
 R: 5’- AGGAAATGAACTGATGAGTCACAGA -3’ 
HSL NM_005357 F: 5’- AGTTAAGTGGGCGCAAGTC -3’ 
 
 R: 5’- GGTCAGGTTCTTGAGGGAAT -3’ 
ATGL NM_020376 F: 5’- ACGTGGAACATCTCGTTCG -3’ 
 
 R: 5’- CTTCCGGGCCTCTTTAGATAC -3’ 
ADIPOQ NM_001177800 F: 5’- GGCTTTCCGGGAATCCAAGG -3’ 
 
 R: 5’- TGGGGATAGTAACGTAAGTCTCC -3’ 
RPLP0 NM_001002 F: 5’- GTGATGTGCAGCTGATCAAGACT -3’ 
 
 R: 5’- GATGACCAGCCCAAAGGAGA -3’ 
 
 158 














Flux Control Ratios 
Leak Control  L/E 
OXPHOS Control Ratio  P/E 
Respiratory Acceptor Control Ratio  P/L 
Phosphorylation Control Ratio  L/P 
Substrate Control Ratios 
CI Lipid Normalized to Max OXPHOS    (ETF + CI)Lip /P 
CI Lipid + Pyruvate Normalized to Max OXPHOS (ETF + CI)Lip+Pyr /P 
CI Lipid Normalized to Max ETS Capacity (ETF + CI)Lip /E 
CI Lipid + Pyruvate Normalized to Max ETS capacity (ETF + CI)Lip+Pyr  / E 
CII Respiration normalized to Max OXPHOS (CII)E /P 
CII Respiration normalized to Max ETS Capacity (CII)E/ E 
Other 
Lipid/Glucose Balance (ETF + CI)Lip/ ((ETF + 
CI)Lip+Pyr - (ETF + CI)Lip) 
ETS Coupling Efficiency (E-L)/E 
Excess E-P Capacity (E-P) E-P 
Excess E-P Capacity Ratio (E-P/E) (E-P/E) 
Free OXPHOS Capacity (P-L) (P-L) 
Net OXPHOS Control Ratio (P-L)/E (P-L)/E 
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Values are presented as mean (standard error). % of time spent in each activity were derived 
from accelerometry data (see methods). WB = whole body. 2-hr OGTT is plasma glucose at 2-
hours after a 75 gram oral glucose challenge. TG = triglycerides. HOMA2 calculated using the 






Measure Mean (SEM) 
Age 50 (11) 
Height (cm) 178 (5.4) 
Weight (kg) 104.5 (9.9) 
BMI (kg/m2) 33 (3) 
WB Fat (kg) 32.7 (2.2) 
WB Lean (kg) 66.3 (1.5) 
% Fat 31.8 (1.4) 
HbA1c (%) 5.7 (.2) 
2-hr OGTT (mmol/L) 9.0 (.5) 
Peak Postprandial TG (mmol/L) 2.5 (.2) 
Fasting glucose (mmol/L) 5.9 (.4) 
Fasting Insulin (uU/mL) 22 (2) 
HOMA2-IR 2.6 (.4) 
HOMA2-%B 134.4 (17) 
HOMA2-%S 75.6 (37) 
Triglycerides (mg/dL) 162.7 (7.5) 
Total Cholesterol (mg/dL) 184.5 (11.4) 
HDL (mg/dL) 38.4 (1.7) 
LDL (mg/dL) 117.9 (10.3) 
% Time Sedentary 69 (6.1) 
% Time Light Activity 21 (3.6) 
% Time Moderate Activity 10 (3) 
% Time Vigorous Activity 0 (0) 
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Table 5. Effect of exercise on flux and substrate control ratios (n=8) 
Measure Rest Exercise Sig. 
Flux Control Ratios 
Leak Control  .077  ± .008 .074 ± .003 P=.731 
OXPHOS Control Ratio  .82 ± .07 .92 ± .07 P=.041* 
Respiratory Acceptor Control Ratio  12 ± 1.4 14.8 ± .83 P=.031* 
Phosphorylation Control Ratio  .10 ± .03 .09 ± .02 P=.334 
Substrate Control Ratios 
CI Lipid Normalized to Max OXPHOS    .31 ± .03 .36 ± .04 P=.043* 
CI Lipid + Pyruvate Normalized to Max OXPHOS .54 ± .02 .55 ± .03 P=.459 
CI Lipid Normalized to Max ETS Capacity .25 ± .02 .31 ± .01 P=.012* 
CI Lipid + Pyruvate Normalized to Max ETS capacity .45 ± .04 .49 ± .03 P=.107 
CII Respiration normalized to Max OXPHOS .73 ± .09 .67 ± .09 P=.117 
CII Respiration normalized to Max ETS Capacity .58 ± .03 .56 ± .02 P=.468 
Other 
Lipid/Glucose Balance .47 ± .08 .67 ± .13 p=.043* 
ETS Coupling Efficiency .92 ± .01 .93 ± .003 p=.730 
Excess E-P Capacity (E-P) (pmolO2·mg wt wt-1) 7.9 ± 3 5.9 ± 5.7 p=.616 
Excess E-P Capacity Ratio (E-P/E) .15 ± .07 .08 ± .08 p=.119 
Free OXPHOS Capacity (P-L) (pmolO2·mg wt wt-1) 60.7 ± 10.8 80.6 ± 12.8 p=.019* 
Net OXPHOS Control Ratio (P-L)/E .77 ± .07 .85 ± .08 p=.079 
 































Figure 2. Sample plot from mitochondrial respirometry measurements 
 
Figure shows an example of a respiration curve recorded from permeabilized muscle fibers from 
the vastus lateralis. Purple lines denote the timing of substrate titrations. The substrate added at 
each time point is listed to the left of each line. Subsequent substrates were added only after O2 
flux reached a plateau as shown. Respiratory states are listed along the top. For corresponding 

















Values are mean ± SE. Resistance exercise significantly increases complex I-supported lipid 
[(ETF + CI)Lip] and lipid + pyruvate respiration [(ETF + CI)Lip+pyr], as well as lipid + pyruvate 
respiration through complexes I and II [(ETF + CI + CII)Lip+pyr], maximal electron transport 
capacity [(ETF + CI + CII)E] (uncoupled respiration), and complex II supported respiration 
[(CII)E] (measured after inhibition of complex I with rotenone). *denotes significantly different 











Values are mean fold change above rest ± SE. Resistance exercise significantly increases skeletal 
muscle expression of PGC1alpha (A), PDK4 (B), FOXO1 (C), MURF1 (F), and tended to 
increase LPL gene expression (E). The exercise session also significantly reduced expression of 
SREBF1 (also known as SREBP1) relative to rest (D). We also found a trend toward an increase 
in lipoprotein lipase. * Denotes significant difference between rest and exercise. § Denotes trend 













Resistance exercise significantly increases adipose tissue expression of FOXO1, PDK4, LPL, 
HSL, ADIPOQ, and tended to increase CD36 and ATGL expression. * denote significant 








5. Overall Summary 
5.1 Significance of Key Findings 
The primary purposes of this dissertation were to determine the influence of an acute bout 
of resistance exercise on: 1) postprandial glucose kinetics (appearance, disappearance), insulin 
sensitivity, and oxidation; 2) postprandial lipid handling, kinetics, and oxidation; 3) skeletal 
muscle mitochondrial oxidative capacity; and 4) muscle and adipose tissue gene expression in 
obese, sedentary men with prediabetes.  
 
5.1.1 Chapter 2 
Recent evidence suggests that postprandial hyperglycemia is a major, independent risk 
factor for cardiovascular disease (CVD) and other comorbidities associated with prediabetes, 
including hypertension, BMI, intraocular pressure, progression to type 2 diabetes, and all cause 
mortality.1,2 Despite the strong connection between postprandial hyperglycemia and disease 
severity, no studies have evaluated the influence of pre-meal resistance exercise on postprandial 
glucose metabolism after consumption of a mixed meal in individuals with prediabetes. 
Moreover, the mechanisms for the potential effects of resistance exercise on postprandial glucose 
metabolism including beta cell function, insulin sensitivity, hepatic insulin sensitivity, and 
skeletal muscle glucose oxidation in individuals with prediabetes, are not known. Therefore, the 
purpose of this chapter was to determine the effects of a single bout of resistance exercise on 
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postprandial glucose metabolism following a mixed-meal in obese, sedentary men with 
prediabetes. 
We found that a single bout of resistance exercise performed 4.5 hours before a mixed 
meal reduces postprandial glycemia and insulin concentrations, and that these changes were 
associated with improvements in peripheral insulin sensitivity, glucose clearance rates, and 
whole-body and skeletal muscle mitochondrial carbohydrate oxidation. These results provide 
preliminary evidence for the potential application of resistance exercise as a non-invasive means 
of improving postprandial glucose metabolism.  
 
5.1.2 Chapter 3 
Resistance exercise is a central component of exercise recommendations for individuals 
with type 2 diabetes and prediabetes, but the effect of resistance exercise on postprandial lipid 
metabolism is not known. There is some evidence in healthy lean and healthy obese men and 
women demonstrating that regular physical activity can improve postprandial lipid metabolism.3 
For example, in healthy, obese men and women, acute resistance exercise reduced triglyceride 
concentration, VLDL triglyceride concentrations and mean residence time, improved fatty acid 
oxidation rate, and increased IMTG turnover in both the fasted and postprandial state; however, 
not all studies found these improvements.4-10 In addition, one study in individuals with type 2 
diabetes found no effect of pre-meal and a modest effect of post-meal resistance exercise on 
postprandial triglyceride area under the curve.11 Thus, evidence in healthy and diabetic 
populations suggests that resistance exercise might improve postprandial lipid metabolism in 
individuals with prediabetes, however this has not been previously studied. Moreover, the 
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potential mechanisms of improved postprandial lipid handling after resistance exercise in those 
with prediabetes (or other populations) remain unknown. Therefore, the overall aim of this 
chapter was to determine the acute effects of resistance exercise on postprandial lipid 
metabolism in obese men with prediabetes.   
This study demonstrated that a single bout of resistance exercise, performed 210 minutes 
before consuming a mixed carbohydrate and lipid meal, reduced total plasma TG, chylomicron 
and TRL-TG concentrations, and tended to reduce VLDL plasma FFA concentrations in men 
with prediabetes. In addition, our study revealed for the first time, that declines in plasma 
triglyceride concentration following acute resistance exercise were due to reductions of both 
exogenous (meal-derived) and endogenous (originating internally) triglycerides and fatty acids. 
Moreover, acute resistance exercise increased lipoprotein turnover, FFA clearance rate, and 
postprandial lipid oxidation rate. These data support the use of resistance exercise as a non-
invasive treatment approach to reduce postprandial lipemia in men with prediabetes. 
 
5.1.3 Chapter 4 
Physical inactivity is known to induce insulin resistance and reduce mitochondrial 
respiration in skeletal muscle.12 In contrast, increasing physical activity can increase skeletal 
muscle oxidative capacity and improve lipid metabolism in healthy and obese populations.13-17 
Much less is known regarding the benefits of exercise on skeletal muscle oxidative capacity in 
those with prediabetes and type 2 diabetes. In particular, the mitochondrial response to an acute 
bout of resistance exercise has received little investigative attention despite being a central 
component of exercise recommendations for these individuals. Therefore, the purpose of this 
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chapter was to investigate the impact of a single bout of acute resistance exercise on skeletal 
muscle mitochondrial oxidative capacity and skeletal muscle and adipose tissue gene expression 
in the postprandial state in obese, sedentary, pre-diabetic males. 
In this study, we found that a single bout of resistance exercise increased mitochondrial 
respiratory capacity and lipid oxidation in obese men with prediabetes. These adaptations 
occurred concurrently with changes in skeletal muscle (PGC1alpha, PDK4, SREBP1, FOXO1, 
and MURF1) and adipose tissue (FOXO1, PDK4, HSL, ADIPOQ, and LPL) gene expression. 
Together, these genes cooperate to mobilize stored FFA and increase lipoprotein hydrolysis (and 
storing glucose) in adipose tissue, while increasing lipid uptake and oxidation in skeletal 
muscle.18,19 Improvements in lipid clearance through oxidation could reduce the risk for 
progression from prediabetes to type 2 diabetes, as well as facilitate weight loss and lower the 
risk for cardiovascular disease. 
 
5.1.4 Overall Conclusions 
This dissertation found that in obese, sedentary men with prediabetes, a single session of 
resistance exercise:1) significantly improved postprandial glucose metabolism by increasing 
glucose clearance, insulin sensitivity, and carbohydrate oxidation; 2) significantly reduced 
postprandial exogenous and endogenous lipid contributions to chylomicrons, VLDL and free 
fatty acids, as well as increased lipoprotein clearance, FFA clearance, and lipid oxidation; and 3) 
increased skeletal muscle oxidative capacity, as well as the expression of genes regulating lipid 
metabolism in skeletal muscle and adipose tissue. The implications of these findings are 
summarized in Figure 5.1. In healthy individuals, the uptake of lipid and glucose from the meal  
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is balanced by the clearance of these substrates in peripheral tissues, such as skeletal muscle, 
adipose tissue, and the liver through oxidation or storage as glycogen or triglyceride. In obesity 
and prediabetes, poor diets can contribute to excessive uptake of glucose and lipid, which may be 
exacerbated by reductions in oxidative capacity or clearance (see discussion section). This 
imbalance leads to prolonged and excessive postprandial glucose and lipid concentrations, which 
contribute to CVD and disease progression. Resistance exercise may be beneficial by reducing 
the uptake of meal-derived nutrients (most notably chylomicron triglycerides), and increasing the 
clearance of lipoproteins, FFA, and glucose through oxidation. Taken together, these 
improvements may restore balance between substrate uptake and clearance, thereby reducing the 
risk for disease progression or life-threatening complications. These support the use of resistance 
exercise to improve postprandial metabolism in obese men with prediabetes.  






5.2 Future Directions 
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Future studies are needed to investigate the effects of post-meal resistance exercise on 
postprandial lipid and glucose metabolism. Previous studies have shown that post-dinner 
resistance exercise was more effective at reducing postprandial triglyceride and glucose 
concentrations in obese individuals with type 2 diabetes.11 Therefore, while we found beneficial 
effects for pre-meal resistance exercise in men with prediabetes, post-meal resistance exercise 
may be a more effective option for these individuals. Additionally, clarifying the timing of 
resistance exercise relative to the meal that maximizes postprandial responses (eg. pre-meal vs. 
post-meal, amount of time between exercise and the meal) will be needed to create exercise 
recommendations for individuals with prediabetes.  
Future studies should also investigate the influence of resistance exercise on exogenous 
and endogenous glucose metabolism. This would be needed to understand if the reductions in 
post-prandial glucose after resistance exercise were due to an increase in suppression of 
endogenous glucose production, or a suppression of the rate of appearance of oral glucose from 
the GI tract, or both. Previous studies have shown that individuals with type 2 diabetes present 
with elevated endogenous glucose production that is not suppressed appropriately in the post-
prandial period.20 In contrast, the oral glucose rate of appearance appears normal.20 Therefore, 
understanding if resistance exercise suppresses endogenous glucose production could have a 
particularly strong impact on disease progression from prediabetes to type 2 diabetes. 
Further measurement of VLDL kinetics in isolation will also be needed to understand 
changes in hepatic function in response to resistance exercise. Since we only measured VLDL 
kinetics indirectly, additional research is needed to specifically identify changes in postprandial 
VLDL metabolism after resistance exercise. Future studies that use a compartmental modeling 
approach would be particularly effective at clarifying the organs and metabolic pathways that are 
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responding to the resistance exercise session. Previous studies suggest that chylomicrons are the 
preferred substrate for lipoprotein lipase, and that postprandial triglyceride levels may be due 
mostly to the accumulation of VLDL that are not hydrolyzed by LPL.21 We found trends for most 
of the outcomes for VLDL, which may be explained by a preference for chylomicrons by LPL in 
the postprandial period. However, we could not confirm this in this study.  
Additionally, experiments employing repeat biopsies would be needed to determine the 
changes in gene expression throughout the postprandial period, and how these changes correlate 
with improvements in lipid versus glucose oxidation. Further studies are also needed to 
determine if these changes in gene expression result in significant changes in protein expression, 
and if these changes in protein expression correspond to the improvements in mitochondrial 
respiration and substrate selection. Furthermore, there are multiple different types of exercise 
that should receive further investigation for their impact on postprandial metabolism. These 
include eccentric resistance exercise, high-intensity interval training, and low-impact exercises 
such as yoga. All of these could be beneficial for individuals with prediabetes, but haven’t been 
investigated with respect to the postprandial period.  
Finally, this study should be repeated with female participants. Previous studies have 
shown that women demonstrate increased lipid oxidation and reduced carbohydrate oxidation, 
deplete less muscle glycogen, and have lower endogenous glucose production during exercise 
than men.22 There are also differences between men and women on insulin signaling and insulin 
secretion due to estrogen activity, as well as the rates adipose triglyceride synthesis and 
lipolysis.23 All of these factors could alter the effects of of resistance exercise on postprandial 




First, this study only enrolled adult men. Thus, the results cannot be generalized to 
women and children. Postprandial responses to resistance exercise may be different between men 
and women and therefore requires further study. We also had participants consume a liquid test 
meal. While the nutrient composition of this meal reflects the composition of a typical meal, the 
liquid composition may change the absorption of carbohydrate and lipid compared to solid 
meals. Further investigation is needed to examine the influence of liquid versus solid meals on 
absorption and nutrient handling.  Additionally, the study sample size was limited and should be 
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